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Abstract 
Background and aims 
The advent of volar locking plates designed specifically for fractures 
of the distal radius has resulted in a major shift away from 
percutaneous fixation of these injuries.  However, comparative 
studies have not always demonstrated better outcomes than those 
achieved with less invasive and potentially less expensive 
established techniques.  
The present study was a randomized controlled trial comparing the 
outcome of displaced distal radius fractures when treated with a 
volar locking plate or closed reduction and percutaneous wire 
fixation, with supplemental bridging external fixation when 
required. The primary research objective was to ascertain whether 
the use of volar locking plates improves functional outcome in the 
short and medium term. The secondary objective was to 
determine, through economic evaluation, whether the use of volar 
locking plates for distal radius fractures is of financial benefit to the 
health service.   
Methods 
A single-centre randomized controlled trial of pragmatic design, 
conducted in a tertiary care institution, with accompanying 
economic evaluation. 130 patients with displaced distal radius 
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fractures were randomised to either volar locking plate (n=66) or 
conventional percutaneous fixation methods (n=64). Outcome 
assessments were conducted at 6 weeks, 12 weeks and 1 year. 
The primary outcome measure was the PEM score at one year. 
Secondary outcomes included the QuickDASH, PRWE, EQ-5D and 
SF-12 scores, range of motion, grip strength, radiographic and cost 
parameters.  
A cost-effectiveness analysis was performed from the perspective 
of the NHS, and in line with NICE guidance on the methods of 
technology appraisal ³%RWWRP XS´ PLFUR-costing methods were 
used to calculate costs for each treatment pathway, prospectively 
collecting information on consumables, inpatient and outpatient 
resource use, complications and additional procedures up to a year 
post surgery.  
Main findings 
Patients in the volar locking plate group had significantly better 
PEM, QuickDASH, PRWE scores and range of motion at 6 weeks, 
with no differences at 12 weeks and 1 year. Grip strength was 
better for the plate group at all time points. The volar locking plate 
was better at restoring the radiographic parameters of palmar tilt 
and radial height. Despite the early functional advantage, patients 
did not return to work sooner. 
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Quality of life scores were marginally, but not significantly, better 
for the plate group at early follow-up. Both groups returned to 
baseline at one year. NHS costs for the plate group were 
significantly higher. For an additional £713, VLP fixation offered 
0.018 additional QALYs in the year post surgery. The incremental 
cost effectiveness ratio (ICER) for VLP fixation at NHS list price was 
£40,068.  
Conclusion 
The current study showed that use of a volar locking plate resulted 
in better early post-operative function. However, there was no 
significant difference at, or after 12 weeks. The volar locking plate 
achieved better radiographic reduction and measured grip strength, 
but this did not translate to a difference in function at 12 weeks 
and 1 year. The earlier recovery of function may be of advantage 
to some patients. However, in spite of their increasing use and 
popularity, volar locking plates were cost-ineffective according to 
NICE threshold criteria.  
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Chapter 1 - Introduction  
1.1 Distal radius fractures  
1.1.1 Demographics of distal radial fractures 
Fractures of the distal radius and/or ulna are the most common 
fractures of the upper extremity (Wulf et al., 2007). They are also 
the most common fracture overall under the age of 75, when they 
are surpassed by hip fractures in the female population (Cummings 
et al., 1985). It has been estimated that, at 50 years of age, a 
Caucasian woman in Northern Europe has a 15% lifetime risk of a 
distal radial fracture. For men the risk is 2% (Cummings et al., 
1985). 
Distal radius fractures account for more than 20% of all fractures 
seen in the emergency department in the United States (Grewal et 
al., 2005), where these numbers do not include those treated by 
medical practitioners in the community. One in five patients with a  
distal radius fracture will require a hospital admission (O'Neill et 
al., 2001), with the majority of those admitted undergoing some 
form of intervention. 
Distal radial fractures are more common in females overall (Larsen 
and Lauritsen, 1993), though the incidence appears to be higher in 
males around the second and third decades (Figure 1.1). The same 
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study described a fall as the mechanism of injury in 73% of cases, 
a direct blow in 22%, crush in 2% and insufficiency in 3% of cases. 
 
 
Figure 1.1 Age- and sex-specific incidence rates of distal radial 
fractures per 10,000 inhabitants per year in the municipality of 
Odense, Denmark (with 95% confidence intervals) (Larsen and 
Lauritsen, 1993). 
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In the United Kingdom, a multi-centre study of patients aged 35 
and above reported an annual incidence of 9/10,000 in men and 
37/10,000 in women. This computes to 58 000 women and 13 000 
men per year. One in 5 men and women (19.4%) were admitted to 
hospital. Below the age of 50 years, 22.6% of those with fracture 
required admission. Above 50 years the proportion admitted rose 
gradually with age, from 14.5% at age 50±59 years, to 26% at age 
80 years and over (O'Neill et al., 2001). 
Current and past clinical data indicate a gradual increase in the 
incidence of distal radius fractures in recent years. The origin of 
this increase is unclear (Nellans et al., 2012). However, when 
coupled with the expanding indications for operative fixation 
(Mattila et al., 2011, Chung et al., 2009) and the increasing use of 
expensive internal fixation implants over other techniques, it is 
likely that the impact of these fractures on NHS resources is 
significant.  Nevertheless, as they are not associated with the high 
morbidity and mortality of, for example hip fractures, distal radius 
fractures are often overlooked as relatively minor injuries. 
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1.1.2 Classification systems: what are we treating?   
Distal radial fractures were originally described by Pouteau in 1783 
and then Colles in 1814 (Colles, 1814, Peltier, 1984). They were 
then associated with universally good outcomes. Colles, Barton and 
Smith are well known eponyms assigned to common fractures, but 
eponyms give little information on stability, treatment and 
prognosis of a particular fracture pattern. 
Burnstein defined the ideal classification system as one that is 
reliable and repeatable (demonstrating intra- and inter-observer 
agreement), has a good correlation with clinical outcome and can 
be used as the basis for choice of treatment (Burstein, 1993). Over 
the years, several classification systems have attempted to address 
these criteria. Early attempts were made by Watson-Jones 
(Watson-Jones, 1962) and then Gartland and Werley (Gartland and 
Werley, 1951), the first to make a distinction between treatment of 
extra- and intra-articular fractures.  Contemporary systems include 
the Older (Older et al., 1965), Frykman (Frykman, 1967), Melone 
(Melone, 1984), Universal (Cooney, 1993) , Mayo (Cooney, 1993), 
Fernandez (Fernandez and Jupiter, 2002) and Comprehensive 
classifications (Muller, 1995). It is worth noting that, though 
progress has been made from early eponyms, numerous studies 
comparing current systems have found them falling short in terms 
of repeatability and reliability (Naqvi et al., 2009, Andersen et al., 
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1996, Kreder et al., 1996a, Illarramendi et al., 1998, Flikkila et al., 
1998). 
There is as yet no universally agreed gold standard classification 
(Diaz-Garcia and Chung, 2012). Important points to consider when 
assessing and planning treatment are: 
x Fracture displacement 
x Articular involvement 
x Associated ulnar fracture or disruption of the distal radioulnar 
joint 
x Comminution  
x Bone quality 
Equally, in evaluating radiographs the following parameters are 
noted: 
x Radial length 
x Radial  inclination 
x Volar / palmar angulation 
x Intra-articular step-off or gap 
Definition of the three most commonly reported radiological 
parameters are reported in Table 1.1 and demonstrated in Figure 
1.2.  
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Table 1.1 Definitions for key radiological parameters (Handoll, 2008) 
Parameter Definition Normal value 
Dorsal angulation 
(dorsal or palmar or 
volar tilt) 
Angle between a line 
which connects the 
most distal points of 
the dorsal and volar 
cortical rims of the 
radius and the line 
drawn perpendicular 
to the longitudinal 
axis of the radius. 
Lateral radiograph. 
11 ± 12 degrees 
where positive 
values indicate a 
palmar angulation 
and negative values 
indicate angulation 
dorsally beyond 
neutral 
Radial length Distance between a 
line drawn at the tip 
of the radial styloid 
process, 
perpendicular to the 
longitudinal axis of 
the radius and a 
second perpendicular 
line at the level of 
the distal articular 
surface of the ulnar 
head. PA* 
radiograph. 
11 -12mm 
Radial angle or 
inclination  
Angle between the 
line drawn from the 
tip of the radial 
styloid process to the 
ulnar corner of the 
articular surface of 
the distal end of the 
radius and the line 
drawn perpendicular 
to the longitudinal 
axis of the radius. 
PA* radiograph. 
22-23 degrees 
*PA = Posterior to Anterior   
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Figure 1.2 Key radiographic parameters.  
 
A. Dorsal angulation (dorsal or palmar or volar tilt) 
 
 
B. Radial length  
 
 
C. Radial angle or inclination  
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1.1.3 The question of instability 
Definitions of fracture instability can broadly be divided into two 
categories: those which refer to the behaviour of a fracture at 
presentation and those which refer to the outcome, usually 
radiographic, after initial treatment. 
Below is an example of each: 
'HILQLWLRQ³DWSUHVHQWDWLRQ´ 
³Stable fractures are those who present in acceptable alignment 
and will not displace into unsatisfactory alignment if the limb is left 
free anGPRELOLVHG«8QVWDEOHIUDFWXUHVDUHWKRVHZKLFKPD\XQLWH
into unacceptable alignment if WUHDWHG E\ HDUO\ PRELOLVDWLRQ´
(Bruser and Gilbert, 1999). 
'HILQLWLRQ³DIWHUWUHDWPHQW´ 
³7KH GHILQLWLRQ RI DQ XQVWDEOH IUDFWXUH «LV XVXDOO\ PDGH E\
observation of the behaviour of the fracture after initial treatment 
in a FDVW«(DUO\ LQVWDELOLW\ ZDV GHILQHG DV D IUDFWXUH WKDW ZDV
displaced (or re-displaced following closed reduction) 
radiographically within two weeks after the injury. Late instability 
was defined as a fracture that was displaced radiographically at the 
time of union and had not previously demonstrated early 
instability´ (Mackenney et al., 2006). 
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Such definitions are descriptive rather than predictive, and so are 
not very useful in early decision making. 
There have been many attempts to identify factors predictive of 
distal radius fracture instability in order to aid management 
(Lafontaine et al., 1989, Abbaszadegan et al., 1989, Hove et al., 
1994, Leone et al., 2004, Mackenney et al., 2006). A summary of 
the main representative attempts is presented in Table 1.2. The 
heterogeneity of study populations could, in part, explain 
discrepancies between reports. These studies may have identified 
certain risk factors for instability, but whether any of the suggested 
algorithms are actually predictive is open to debate, as validating 
studies are lacking. 
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Table 1.2 Summary of main studies attempting to predict distal 
radial fracture instability 
Reference  
Number of 
fractures 
Predictors identified  
(Lafontaine et al., 
1989) 
 
112 Dorsal angulation  
Dorsal comminution 
Intra-articular involvement 
Ulna fracture 
Age >60 years 
(Abbaszadegan et al., 
1989) 
267 Radial length 
Age  
Lidström classification  
(Hove et al., 1994) 645 Dorsal angulation 
Radial length 
Age  
Older type 
(Leone et al., 2004) 71 Radial length 
Volar tilt 
Dorsal comminution 
Age  
(Mackenney et al., 
2006) 
4000 Metaphyseal comminution 
Ulnar variance  
Age  
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The most popular criteria were devised by Lafontaine (Lafontaine et 
al., 1989). He examined the correlation of radiographic criteria to 
risk of displacement using 112 fractures. Correlation, however, 
does not imply cauVDOLW\7KHSRSXODULW\RI/DIRQWDLQH¶VFULWHULDOLHV
in the simplicity and applicability of his conclusions. He suggested 
five factors that indicate instability. The presence of three or more 
of these factors correlated with loss of position despite cast 
immobilisation.  
Probably the most methodologically robust attempt was made by 
MacKenney et al., who looked at 4000 distal radius fractures 
(Mackenney et al., 2006). They concluded that patient age, 
metaphyseal comminution and ulnar variance where the most 
consistent predictors of radiographic outcome. However, the 
predictive formulas reported in this study are mathematically 
complex and remain non-validated.  
There is currently no predictive, easy to use, validated algorithm.  
In all attempts to predict instability, it is assumed that a correlation 
exists between the severity of the primary displacement and an 
expectant loss of reduction over a given time period when treating 
with cast immobilisation. This does not take into account that a 
small percentage of fractures, which present in acceptable 
alignment, still displace over time (Leone et al., 2004). 
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It can also be argued that the above attempts are inherently 
flawed, as predictive factors should, by definition, be independent. 
Radiographic determinants of a fracture are not. For example, 
magnitude of radial shortening, ulnar variance and dorsal tilt are 
descriptors of the same fracture, when measured from a different 
angle/perspective. They are also not independent of the degree of 
fracture comminution present. 
Finally, all the referenced attempts rely on the definition of what is 
³XQDFFHSWDEOHDOLJQPHQW´ LQ WHUPVRI UDGLRJUDSKLFPHDVXUHPHQWV
This definition varies greatly and is a matter of ongoing debate as 
« ³WKH DQDWRPLF UHVXOWV RI IUDFWXUH WUHDWPHQW KDYH QR PHDQLQJ
unless they are conVLGHUHG LQ OLJKW RI WKH IXQFWLRQDO RXWFRPH´
(Slutsky, 2005). The relationship between radiographic malunion 
and function is considered in the following section. 
In conclusion, fracture instability is multi-factorial and not solely 
dependent on radiographic parameters. Mechanism of injury 
(energy), quality of the bone, condition of the soft tissues, quality 
of the initial reduction and plaster and even patient compliance 
must also be taken into account. In the absence of definitive 
evidence, the decision for early fixation remains dependent on both 
surgeon judgement and patient choice. 
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1.1.4 Sequelae of distal radius fractures and the malunion 
debate  
A further source of controversy in the management of distal radius 
fractures has been the effect on outcome of radiographic malunion.  
Jupiter and Fernandez published the criteria most commonly used 
to describe the presence of extra-articular malunion: less than 20° 
of radial inclination, dorsal angulation past neutral and shortening 
of 2mm or more in comparison with the contra-lateral wrist 
(Fernandez and Jupiter, 2002). The presence of a visible intra-
articular step is also considered an indication for intervention 
(Lichtman et al., 2011). 
A number of biomechanical studies (Short, Palmer et al. 1987; 
Pogue, Viegas et al. 1990; Kazuki, Kusunoki et al. 1993) have 
shown parameters of malunion to affect distribution of forces 
across the wrist. Following on from these studies, is a common yet 
unsubstantiated belief that anatomical reduction of deformity, 
especially intra-articular, is a requirement for restoration of 
function (Diaz-Garcia and Chung, 2012). As percutaneous methods 
cannot always correct or maintain radiographic parameters to 
perfection, this belief has fuelled the increase of open reduction 
and internal fixation of fractures. Attempts to correlate 
radiographic parameters and clinical outcome (Stewart et al., 1985, 
Jenkins and Mintowt-Czyz, 1988, Kopylov et al., 1993, Young et 
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al., 2003, Goldfarb et al., 2006) suffer from methodological 
shortfalls, including small study numbers and lack of validated 
outcome data (Karantana and Davis, 2012).  
The most cited paper in the relevant literature is by Knirk and 
Jupiter (Knirk and Jupiter, 1986), investigating the outcome of 
intra-articular distal radius fractures in young adults at an average 
6.7 year follow-up. The authors found that 65% of their population 
developed radiographic evidence of osteoarthritis and 39% had a 
poor or fair result. They inferred that one was the result of the 
other. They concluded that accurate articular restoration was the 
most critical factor in achieving a successful result. 
Despite being very influential and widely cited (Porrino et al., 
2008), this study has important limitations. Due to a lack of 
validated instruments at the time of publication, the investigators 
failed to measure patient-rated functional outcomes. Conclusions 
were based on the Gartland and Werley score, an non-validated, 
physician-rated system which has not been found to correlate with 
patient-rated outcomes and function (MacDermid, Richards et al. 
2000). Furthermore this scoring system incorporates radiographic 
measurements into what should be purely a clinical score, 
introducing bias. In addition there were methodological issues 
related to the use of correlation statistics, such as the use of 
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3HDUVRQ¶s correlation for categorical and non-parametric data and 
the assumption of causality. 
Haus and Jupiter revisited their article in 2009, citing its flaws in 
methodology and limitations in its interpretations (Haus and 
Jupiter, 2009). The authors acknowledged their absence of controls 
and lack of assessment of observer reliability regarding radiologic 
analysis of arthritis and articular incongruity. They reviewed their 
original radiographs, showing that a substantial number of the 
patients had carpal instability that likely influenced function and 
promoted the progression to arthritis (Diaz-Garcia and Chung, 
2012). 
Although radiographic measurements of radial height, angulation, 
dorsal tilt and step-off reflect the accuracy of surgical reduction, 
the link between malunion and function is still under debate and 
acceptable values for reduction have not been established 
scientifically. While many studies have investigated the relationship 
between extra-articular malunion and outcome after fractures of 
the distal radius, there is little consensus on the amount of 
malunion that can be tolerated without loss of function (Karantana 
and Davis, 2012). 
Of the studies that correlate radiographic parameters and outcome 
using a patient-centred functional outcome measure, Anzarut and 
Johnson (Anzarut et al., 2004) found no correlation between dorsal 
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angulation and function using the SF-12 (Brazier, Roberts et al. 
2002) and Disabilities of the Arm, Shoulder and Hand 
Questionnaire (DASH) (Hudak et al., 1996) questionnaires. Barton 
found no association of moderate radial shortening with the Patient 
Rated Wrist Evaluation score at a mean of 29 months in a group of 
60 patients over 55 years of age (Barton et al., 2007). Gliatis and 
Plessas (Gliatis et al., 2000) also found no association with radial 
shortening using the Patient Evaluation Measure for Hand Surgery 
(Macey et al., 1995), but found dorsal angulation greater than 10° 
from neutral to be associated with difficulty in activities of daily 
living. 
There is lack of consistency in the findings of those studies that do 
report an effect of extra-articular malunion on clinical 
measurements and other, non-patient centred tests of function. 
Villar and colleagues (Villar et al., 1987) found range of motion was 
influenced by dorsal tilt and shortening, and grip strength 
correlated with shortening. McQueen and Caspers (McQueen and 
Caspers, 1988) found dorsal tilt and radial inclination affected 
function, activities of daily living, and grip strength. In contrast, 
Keating and colleagues (Keating et al., 1994) found dorsal tilt, but 
not loss of radial inclination or shortening, affected grip strength. 
Trumble and colleagues (Trumble et al., 1994) found radial 
inclination, but neither shortening nor dorsal tilt, affected function. 
Beumer et al. found post-traumatic ulna positive variance (>2mm) 
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to be the only radiographic factor associated with a poor outcome, 
however they used components of the  Gartland and Werley score 
to assess outcome (Beumer et al., 2013). 
The presence of an intra-articular step also has been associated 
with poor outcome (Knirk and Jupiter, 1986). But even this is now 
a topic of debate. Intra-articular malunion may predispose to the 
development of radiographic arthritic changes (Baratz, Des Jardins 
et al. 1996; Catalano, Cole et al. 1997; Kreder, Hanel et al. 2005), 
but this does not seem to correlate with a functional deficit. 
Forward et al. (Forward et al., 2008) published a study in which 
106 young adults were retrospectively reviewed at a mean of 38 
years post injury. They found that, while there was radiological 
evidence of post-traumatic osteoarthritis after an intra-articular 
fracture in 68% of patients, their DASH scores were no different 
from population norms, and function assessed by the Patient 
Evaluation measure was impaired by less than 10%. No 
radiographic parameter of extra-articular malunion affected 
outcome at a very long follow-up in this study (Forward et al., 
2008). Two further studies examined the wrists of young adults 
functionally and via computed tomography after intra-articular 
fractures treated via open reduction and internal fixation. Catalano 
et al. examined a series of 21 young adults at an average of 7.1 
years and found osteoarthritis in 76 per cent of the wrists. Despite 
this, all patients had a good or excellent functional outcome 
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(Catalano et al., 1997). Goldfarb et al. reported on the functional 
and radiographic outcomes of 21 young adults with treated intra-
articular fractures 15 years after their injury. Despite joint space 
narrowing and evidence of advanced arthrosis, patients maintained 
a high level of function (Goldfarb et al., 2006). 
Finally, there has been a distinction between low demand and 
predominately older patients and the younger high demand 
population (Young and Rayan, 2000), the assumption being 
prolonged high demand use would lead to accelerated wear in a 
less than perfect joint. It has yet to be proven that degenerative 
changes in the younger wrist are progressive and correlate with 
symptoms and functional impairment. 
1.1.5 Treatment options  
When first described, before even the advent of X-rays, distal 
radial fractures were considered rather uncomplicated. Abraham 
&ROOHVLQKLVSDSHUIDPRXVO\VWDWHGWKDW³WKHOLPEZLOODWVRPH
remote period again enjoy perfect freedom in all its motions, and 
be completely exempt from SDLQ´(Colles, 1814). 
The understanding of these fractures, techniques of radiographic 
evaluation, as well as the options for intervention have since 
progressed. The goals of treatment, however, have remained 
constant: restoration of function, cosmesis and prevention of 
associated complications. 
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As with any orthopaedic injury, decisions on management should 
not be based solely on radiographic appearance and fracture 
pattern. Factors such as handedness (dominance), patient age and 
bone quality, functional demands, co-morbidity and other injuries 
are also taken into account. Fractures of the distal radius can be 
associated with open wounds, tendon rupture, neurological or 
vascular injury and the multiply injured patient. Treatment of those 
injuries must coincide with fracture care (Kreder, Hanel et al. 
2005). 
1.1.5.1 Closed treatment 
Fractures that are undisplaced or reducible and stable are generally 
treated non-operatively, with protection in a plaster or splint. This 
avoids complications inherent to surgery, but is not without risks. 
Immobilisation in excessive wrist flexion has been associated with 
stiffness, complex regional pain and carpal tunnel syndrome 
(Cooney, Dobyns et al. 1980; Gelberman, Szabo et al. 1984). 
Patients with fractures not fulfilling the above criteria are often 
selected for surgery. Options include percutaneous pinning, 
external fixation and open reduction internal fixation with a variety 
of implants. 
1.1.5.2 Percutaneous pinning 
Percutaneous trans-osseous pinning has traditionally been an 
effective way of maintaining acceptable reduction with mostly 
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minor complications such as skin irritation, superficial pin-site 
infection, and transient nerve palsies (Botte et al., 1992, Diaz-
Garcia et al., 2011, Subramanian et al., 2012, Singh, 2005). 
It is worth noting, although percutaneous pinning has been one of 
the most widespread methods of fixation over many years, only 13 
randomised trials evaluating percutaneous pin fixation were 
included in a 2007 Cochrane review, most of these small and 
methodologically weak (Handoll, 2007b). This paucity of 
randomised studies has been a common feature of the distal radius 
literature. The Cochrane review concluded that, for dorsally 
displaced fractures, percutaneous pinning, compared with plaster 
cast immobilisation alone, helped to maintain reduction and reduce 
deformity. There was limited evidence, however, that its use 
improved function. However, most of the trials included in the 
review predated the development of validated patient functional 
assessment instruments. There was also lack of clear indications 
for fixation and evidence to support any particular wiring method. 
1.1.5.3 External fixation  
External fixation has been used extensively in the treatment of 
distal radial fractures and is also a well-established method. In a 
separate Cochrane review, it produced good results for unstable 
fractures when compared to non-operative treatment: external 
fixation reduced re-displacement, gave improved anatomical 
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results when compared to casting alone and most of the excess 
surgically-related complications were minor (Handoll 2007). 
The advantages of external fixation are ease of application, 
minimal surgical exposure and reduced surgical trauma (Chung et 
al., 2006). The disadvantages include prolonged immobilisation of 
the radiocarpal joint, pin-related complications (Ahlborg and 
Josefsson 1999; Chung, Watt et al. 2006), loss of ligamentotaxis 
over time (Bartosh and Saldana, 1990) and stiffness caused by 
excessive distraction (Kaempffe et al., 1993). 
The technique of external fixation uses ligamentotaxis to indirectly 
reduce fracture fragments. In bridging fixation, as longitudinal 
traction is applied to the carpus, tension is transmitted mostly 
through the radioscaphocapitate and long radiolunate ligaments to 
restore radial length (Slutsky, 2007). Because ligaments exhibit 
visco-elastic properties (Woo et al., 1981), there is gradual loss of 
the initial distraction applied to the fracture site through relaxation 
(Winemaker, Chinchalkar et al. 1998). This can result in partial loss 
of the initial reduction achieved (Sun et al., 2001). Ligamentotaxis 
also requires fracture fragments to have soft tissue attachment 
(capsule or ligament). Central or impacted articular fragments 
cannot be manipulated indirectly and this has been one of the 
limitations of using fixators in isolation.  Lastly, traction in isolation 
cannot correct the dorsal tilt of the distal articular fragment past 
neutral. This is because the stout volar radiocarpal ligaments are 
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shorter and pulll out to length before the thinner dorsal radiocarpal 
ligaments (Bartosh and Saldana, 1990). A dorsally directed vector 
is still necessary to restore the normal volar tilt (Slutsky, 2007). As 
a result, external fixation has often been supplemented with other 
forms of fixation, most commonly percutaneous pinning and 
sometimes even open direct elevation and bone grafting of a free 
articular segment.   
External fixation was the mainstay in the management of unstable 
fractures until the advent of volar locking plates (Wulf et al., 
2007). 
1.1.5.4 Dynamic and non-bridging external fixation 
External fixation can be static or dynamic, bridging or non-
bridging. 
Dynamic constructs with joint spanning fixators attempting to 
mobilise the wrist have been largely unsuccessful (Slutsky, 2007). 
This was due to the complex kinematics of the carpus and the 
inability to maintain ligamentotaxis throughout the entire range of 
motion (Sommerkamp, Seeman et al. 1994; Kawaguchi, Sawada et 
al. 1998). 
Non-bridging fixators have given good results in terms of range of 
motion and grip strength in extra-articular fractures, even superior 
to those of bridging fixators in some centres (McQueen 1998). But 
there have been concerns regarding rates of soft tissue 
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complications. Their use is contra-indicated when the distal 
fragment is too small for pin placement. At least 1cm of intact volar 
cortex is required for pin purchase (Slutsky, 2007). Non-bridging 
fixation can be used for intra-articular fractures in conjunction with 
intra-focal wires, but reports are sparse and the results 
unconvincing (Krishnan, Chipchase et al. 1998; Mehta, Slavotinek 
et al. 2002; Gradl, Jupiter et al. 2005). Prerequisites are good bone 
density, minimal comminution and a stable distal radio-ulnar joint 
(Slutsky, 2007). 
A 2008 Cochrane systematic review attempting a comparison of 
methods of external fixation in the setting of randomised controlled 
trials concluded that there is not enough robust evidence to 
determine the relative effects of different methods (Handoll, 2008). 
1.1.5.5 Plating  
Plates have the advantage of providing fixation without protruding 
wires or pins, which transfix soft tissues. They can allow earlier 
rehabilitation. Disadvantages include more extensive operative 
trauma, risk of fragment devascularisation through dissection, 
tendon ruptures, added scar and subsequent stiffness and, in some 
cases, the need for removal. New designs and operative strategies 
have improved the results of plate fixation. 
In 1973, Mathys designed metallic T-shaped small fragment plates 
(Synthes®), which were proportionate to the size of the distal 
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radius (Freeland and Luber, 2005). These were the first generation 
of plates fashioned specifically for distal radial fractures. Since 
then, plate design has evolved toward smaller, lower profile 
LPSODQWV7KH-plate and the low profile T-plate (Synthes®) were 
amongst early low profile designs. 
Early plates were applied through a dorsal approach. Placing 
fixation on the dorsal aspect of a dorsally angulated fracture allows 
the plate to act as a buttress, providing a biomechanical 
advantage. It is subcutaneous and easy to access surgically. It also 
allows direct visualisation of the joint surface for the reduction of 
intra-articular fractures. Studies showed excellent results of dorsal 
plating in terms of fracture reduction (Ring, 1997), but were less 
encouraging for range of motion (Green and O'Brien, 1978). Loss 
of palmar flexion due to dorsal scarring was a problem (Bassett, 
1987). There was also a high rate of soft tissue complications 
attributed to extensor tendon irritation and attrition rupture 
(Schnur, 2000, Kambouroglou, 1998, Lowry et al., 2000). Early 
removal of metalwork did not necessarily prevent these 
complications  (Fitoussi et al., 1997). Consequently, dorsal plating 
became less popular and design focused on fixed-angle constructs, 
which would be capable of supporting the metaphyseal bone 
through a volar approach. 
Another concept in distal radial plating is that of fragment-specific 
fixation. This was developed by Medoff and Kopylov in 1991 and is 
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designed to independently stabilise each major fracture element 
using an implant designed for each fragment. Increased rigidity is 
provided by using implants placed in orthogonal planes (Martineau 
et al., 2007). Fragment-specific fixation has shown good results in 
published series (Konrath and Bahler 2002; Schnall, Kim et al. 
2006), however it requires a two-incision surgical approach. It has 
increased potential for complications (Konrath and Bahler, 2002). 
In addition, though the construct is significantly more stable in four 
part fractures, it showed no biomechanical advantage over wiring 
and external-fixation in a three part fracture model (Dodds et al., 
2002). A prospective longitudinal study compared outcomes of 
volar plating with fragment-specific fixation. While the radiographic 
parameters were superior with volar locked plating and the 
complication rate was higher with fragment-specific fixation, there 
was no clinical difference (Sammer et al., 2008). 
While fragment-specific fixation is advocated by some for 
comminuted fractures not readily amenable to a standard 
approach, the technique requires expertise and experience and is 
not widespread outside specialist centres in the UK. 
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1.2 The volar locking plate for distal radial fractures  
1.2.1 The concept of locking fixed-angle plates 
Locking plates were initially developed to treat difficult fracture 
patterns in the distal femur, and later in response to the challenges 
of fixation in osteoporotic bone of an aging population. Their 
application in the management of distal radius fractures was a 
relatively new advance. 
Conventional compression plating technique, as described by 
Arbeitsgemeinschaft für Osteosynthesefragen (AO), requires 
exposure of the fracture site, anatomic reduction of fragments and 
internal fixation with the goal of achieving absolute stability and 
primary bone healing (Perren, 2001). The plate in this setting 
functions as a load-sharing device, in direct contact with the bone 
and preventing movement through compression. The periosteum is 
locally compressed by the plate across the fracture site (Figure 
1.3).  
Locking plates function as load-bearing devices. The reduction is 
maintained by screw placement held at a fixed angle to the plate 
via threaded screw heads. The plate may not need to be in direct 
contact with the bone, avoiding periosteal ischemia and reducing 
the need for soft tissue stripping (Egol et al., 2004). The plate 
HIIHFWLYHO\ IXQFWLRQV DV DQ ³LQWHUQDO´ IL[DWRU (Larson and Rizzo, 
2007). Locking plates, however, have increased stability when 
 27 
 
compared with external fixators, as the working length of the screw 
is 10 to 15 times shorter (Egol et al., 2004). 
Locking plates are considered to be more compatible with the 
biological healing response (Freeland and Luber, 2005). When used 
to bridge the fracture site, they facilitate secondary bone healing 
(Egol et al., 2004), allowing strains of between 2% and 10%. 
Primary bone healing requires absolute stability and less than 2% 
strain (Perren, 2001) whereas strain more than 10% leads to 
fibrous union or non-union (Egol et al., 2004). 
. 
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Figure 1.3 (A) Traditional compression plate. Normal force 
created between the plate and the screw prevents shearing of the 
plate-bone interface and thus stabilizes the fracture site. Soft 
tissues and periosteum are either stripped or compressed between 
the plate and cortical bone. (B) Locking plate. Stability is provided 
by threaded screw heads interfacing with the threaded holes. The 
plate acts as a second cortex. Soft tissues and periosteum may 
safely be left between the plate and bone. Unicortical fixation can 
obtain adequate stability. Locking screws will not compress the 
plate to the bone. (C) Even with comminution or gaps, a locking 
plate will maintain alignment, since screws cannot toggle in the 
plate. Axial forces will be transmitted along the length of the plate. 
(Nana et al., 2005) 
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1.2.2 Relevant anatomy of the distal radius 
The anatomy of the distal radius lends itself to a volar approach for 
internal fixation. The articular surface of the radius is triangular, 
with the apex of the triangle at the radial styloid. It slopes in a 
volar and ulnar direction with a radial inclination of 23° (range 13-
30°), a radial length of 12 mm (range 8-18 mm) and an average 
volar tilt of 12° (1-21°) (Feipel et al., 1998). The volar surface of 
the bone in the metaphyseal region is relatively flat in the 
transverse plane. The dorsal cortex is thin, which often results in 
comminution and subsequent dorsal tilt, while the volar cortex is 
thicker, stronger and typically less comminuted in dorsally 
angulated fractures. This makes restoration of rotational alignment 
easier (Orbay and Touhami, 2006) and provides an excellent 
surface to fix an implant. 
There is also more space on the volar aspect of the wrist. Flexor 
tendons are located away from the surface of the bone, while 
extensor tendons on the dorsal surface run directly under the skin 
(Orbay and Touhami, 2006). There is a volar concavity in the 
sagittal plane making a smooth curve from proximal to distal (the 
pronator fossa), allowing plenty of space for an implant. The distal 
edge of the concave surface of the volar distal radius is marked by 
a transverse ridge or watershed line. Distal to this line the bone 
slopes dorsally and gives rise to the attachment of the volar wrist 
capsule and volar carpal ligaments. The plate must not project past 
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this line to avoid irritation of, and injury to, the flexor tendons 
(Imatani et al., 2012). Another theoretical advantage to volar 
fixation is that the blood supply to the distal fracture fragment 
occurs mainly through the dorsal vascular retinaculum (Sheetz, 
Bishop et al. 1995; Shin and Bishop 2001), which remains 
undisturbed in this approach. 
1.2.3 Evolution of locking plate technology and its 
application to distal radial fractures 
The success of locking plates in the distal femur came at a time 
when open reduction and internal fixation of complex distal radial 
fractures was fraught with difficulties. Gesensway (Gesensway et 
al., 1995) was the first to design fixed-angle dorsal plates for 
dorsally displaced fractures, advocating subchondral bone support. 
Low profile dorsal locking plates were subsequently introduced, but 
still characterised by the numerous complications associated with 
the approach (Ring 1997; Kambouroglou 1998; Lowry, Gainor et 
al. 2000; Schnur 2000). These complications were not seen with 
the approach used for buttress plating of volar fracture patterns. 
Noting the anatomical advantages of this surface of the distal 
radius, the development of a volar fixed-angle device for this was 
the next step (Orbay 2000; Henry, Griggs et al. 2001; Orbay, 
Badia et al. 2001). Further refinements on the concept came from 
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a better understanding of the anatomy and biomechanics of the 
distal radius. 
Early fixed angle fixation for the wrist came in the form of non-
modular, single unit tine or blade plates (Freeland and Luber, 
2005). These were soon replaced by modular devices with 
separate, fixed-angle locking screws, initially in one and now in two 
transecting rows. The most recent advancement has been the 
introduction of multi directional fixed angle locking pegs and 
screws, which allow the surgeon more flexibility in positioning, but 
require significant expertise. 
Over the years, research into the treatment of distal radial 
fractures has focused largely on the biomechanics of different 
constructs (Raia 2007). The subset of papers discussing locking 
plates is impressive when one considers the relative paucity of 
clinical literature. Taylor et al. compared volar locking plates to 
fragment specific fixation and found the two methods to have 
similar biomechanical characteristics (Taylor et al., 2006). Knox et 
al. more recently compared stability of a volar locking plate to 
percutaneous pin fixation in a cadaveric model (Knox et al., 2007). 
They found internal fixation to be more stable. Egol et al compared 
locking plates to external fixation and found plates to be more 
stable, as the working length of the screws is 10 to 15 times 
shorter than external fixator pins (Egol et al., 2004). 
 32 
 
Osada et al. compared volar locking plates with conventional volar 
and dorsal plates and concluded that plates are superior in stability 
and ultimate strength when testing to failure under axial 
compression (Osada, Viegas et al. 2003; Osada, Fujita et al. 2004). 
A number of similar studies compared different designs of locking 
plate (though notably all with a single row of pegs) and found all to 
have comparable biomechanical characteristics (Chen, Dai et al. 
2006; Liporace, Kubiak et al. 2006). 
The clinical relevance of studies concentrating on the yield point of 
different internal fixation constructs is debatable since the forces 
which caused failure of the implants were many times over the 
estimated loads for active finger motion and thus an unlikely 
clinical scenario (McCall et al., 2007). The important message 
arising from these studies, however, is that volar fixed-angle plates 
for dorsally unstable radial fractures are strong enough to support 
the dorsal fragment and have sufficient stability to allow early 
active motion. This has been one of the main arguments for their 
exponentially increasing use. 
1.2.4 Types of volar locking plates  
The past decade has seen a shift away from percutaneous fixation 
to open reduction and internal fixation of distal; radius fractures. 
The only published quantitative data on recent trends of treatment 
originate from the United States. Chung et al. investigated the 
 33 
 
treatment of distal radius fractures in patients over the age of 65 
using Medicare data. In 2005, the last year examined, 70% of the 
Medicare claims were for closed treatment, with the remaining 
30% representing operative management. Within the operative 
group, there was an increasing trend in the use of internal fixation 
(from 3% in 1996 to 16% in 2005), which corresponded to a 
decrease in the use of closed treatment (from 82% to 70%). Even 
though they could not specify the type of plating system used, they 
stipulated that the rapid increase in internal fixation from 2002 to 
2005 is likely to represent fixation with the volar locking plating 
system (Chung et al., 2009). It is also suggested that plate fixation 
of distal radius fractures is even more widespread in younger 
populations and that the trend for volar locking plate fixation has 
been increasing (Koval et al., 2008). 
Implant manufacturers have shown great interest in developing 
and marketing volar locking plate technology. Many distal radius-
specific designs are available (Table 1.3). The most popular 
implants in terms of publications in North America and the United 
Kingdom have been the Dorsal Volar Radial or DVR® (Biomet) and 
the LCP 2.4mm Distal Radius Plate (Synthes). These implants have 
been the subject of numerous biomechanical studies which 
compare plating options (Chen, Dai et al. 2006; Koh, Andersen et 
al. 2006; Liporace, Kubiak et al. 2006; Taylor, Parks et al. 2006; 
Willis, Kutsumi et al. 2006; Knox, Ambrose et al. 2007; McCall, 
 34 
 
Conrad et al. 2007; Roberts, Grindel et al. 2007; Levin, Nelson et 
al. 2008). In terms of clinical data, the DVR® and the 2.4mm 
Synthes LCP are the most popular representatives of distal radial 
volar locking plates in the clinical literature. They feature in a 
number of longitudinal studies (Orbay and Fernandez 2002; Orbay 
2004; Arora, Lutz et al. 2005; Musgrave 2005; Chung, Watt et al. 
2006; Rozental and Blazar 2006; Murakami, Abe et al. 2007; 
Pichon and Saragaglia 2007) and comparative studies (Jubel 2005; 
Rein, Schikore et al. 2007; Egol, Walsh et al. 2008). In terms of 
volume of literature, the DVR appears to be the most widely used, 
especially in the more recent studies. 
The DVR® was the first distal radial volar locking plate. It was 
developed and patented by Orbay who introduced the concept 
WKURXJK KLV DUWLFOH LQ +DQG 6XUJHU\ HQWLWOHG ³7KH WUHDWPHQW RI
XQVWDEOHGLVWDO UDGLDO IUDFWXUHVZLWKYRODU IL[DWLRQ´ (Orbay, 2000). 
He also developed the pre-defined fixed-angle intersecting proximal 
and distal rows of locking pegs and screws, which are designed to 
provide tangential support for subchondral bone. These rapidly 
took over as a feature of newer plate design. In 2001, Orbay 
followed his original paper by publishing his modification of the 
traditional FCR approach, which quickly became popular (Orbay et 
al., 2001). 
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It is worth mentioning the more recent emergence of 
multidirectional angularly stable volar locking plates for the distal 
radius, where the screw angle for each locking hole is selected by 
the surgeon, and is not dictated by the fixed-angle drill guide. 
There has been an increase in the availability of such implants from 
different manufacturers in recent years. Current versions include 
the Medartis Artus®, the VariAx®, the PERI-LOC¸, the Synthes 
Variable Angle /&3 WKH 7UL0HG 9RODU %HDULQJ 3ODWH and the 
3UHFLVH 6' These types of volar locking plates are gaining 
popularity amongst upper limb specialists because of their 
versatility. However, their use is also technically challenging and 
requires familiarity with the three dimensional anatomy of the 
distal radius, as the positioning of screws is freehand and can 
easily penetrate the articular surface.   
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Table 1.3 Examples of available distal radial volar fixed-angle and 
multidirectional locking plates 
Company  Plate   
Biomet DVR® 
 
  
Synthes  LCP Distal Radius Plates 2.4 
 
 
 
Stryker VariAx®  
 
  
Smith & 
Nephew 
PERI-LOC¸ 
 
 
 
 
 
Wright Medical  LOCONTMVLS Distal Radius 
System  
 
  
Medartis  APTUS® 
 
 
 
Small Bone 
Innovations 
3UHFLVH6' 
 
 
 
TriMed  9RODU%HDULQJ3ODWH 
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1.2.5 Literature on outcomes of volar locking plate fixation 
Although distal radius fractures are the subject of many 
publications, the shortage of good quality, large prospective 
randomised studies is notable. In the Cochrane review on surgical 
management of distal radius IUDFWXUHV+DQGROOVWDWHV³RQO\DIHZ
and provisional conclusions relating to clinical management can be 
drawn from the available randomised trials, which do not provide 
robust nor sufficient evidence for most of the decisions necessary 
LQ WKH PDQDJHPHQW RI WKHVH IUDFWXUHV´ (Handoll, 2003). In volar 
locking plate fixation, the evidence is scarcer still. 
Many longitudinal studies have documented the advantages of, and 
shown good outcomes following volar plate fixation (Osada et al., 
2008, Pichon et al., 2007, Arora et al., 2005, Orbay and Fernandez, 
2002, Orbay et al., 2004, Musgrave, 2005, Musgrave and Idler, 
2005, Chung et al., 2006, Rozental and Blazar, 2006, Murakami et 
al., 2007, Matschke et al., 2011, Jupiter and Marent-Huber, 2010). 
Early studies consist of case series, predominately retrospective, 
with small numbers and a wide case mix. 
Nonetheless, comparative studies have not always shown that 
volar plate fixation provides better outcomes than treatment with 
potentially less expensive, less invasive implants such as 
percutaneous wires (Wright et al., 2005, Jubel, 2005, Hull et al.). It 
is important to note the potential for serious bias in uncontrolled 
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case series, retrospectively controlled studies, and prospective 
non-randomised controlled studies. 
1.2.5.1 Randomised prospective studies 
It has been over a decade since Orbay introduced the concept of 
the fixed angle device for volar fixation of dorsally displaced 
fractures of the distal radius (Orbay, 2000). The concept was 
rapidly embraced by the orthopaedic community. In sharp contrast 
was the lag in publication of randomised studies comparing this 
method of fixation with conventional established percutaneous 
techniques. When the current study started recruiting in February 
2008, there were only two published prospective randomised 
studies examining volar locking plate fixation, and many 
unanswered questions (Downing and Karantana, 2008). Koshimune 
et al. compared the effectiveness of locking and non-locking volar 
plating for unstable Colles¶ W\SH IUDFWXUHV LQ the elderly. No 
significant difference was found in radiographic parameters 
between the two groups or in range of motion apart from flexion, 
which was better by 10 º in the locking group (Koshimune, Kamano 
et al. 2005). Egol et al. compared volar locked plating with bridging 
external fixation and found no differences in outcomes after 3 
months, 6 months and one year (Egol et al., 2008). Neither study 
provided strong evidence in favour of the new technique. 
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Currently there are five published randomised trials, excluding the 
current study, which compare volar locking plate with percutaneous 
fixation (Hollevoet et al., 2011, McFadyen et al., Marcheix et al., 
Rozental et al., 2009, Goehre et al.). This is not inclusive of trials 
of plating versus external fixation, which are discussed separately. 
A further unpublished study, presented at the American 
Orthopaedic Trauma Association Meeting in 2008, was included 
recently by its investigators in a German language systematic 
review (Meier et al., 2013). Details of these studies are presented 
in Table 1.4 and their results summarized in Table 1.5. 
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Table 1.4 Summary of randomised studies of volar locking plate versus percutnaeous wire fixation 
Author  
Year  
Plate  Control 
Fracture 
Classification 
No 
 
Age  
Outcomes 
measured  
POM 
Time 
points 
Follow-
up rate 
Conclusions  
Hollevoet 
2011 
LCP Distal 
Radius 
System 
2.4mm 
(Synthes) 
k-wires  Not stated 
 
40 >50 DASH, ROM, 
grip, 
radiographic, 
complications 
Ulnar 
variance  
3 and  
>12 
months 
(range 
12-26) 
85% No difference in radiographic 
parameters , DASH, grip, 
ROM  
McFayden 
2011 
 
DVR 
(Biomet) or  
LCP T-plate 
3.5mm 
(Synthes) 
k-wires  AO Type A  56 18-
80 
QuickDASH, 
Gartland and 
Werley, 
radiographic, 
complications  
Not 
specified 
3 
weeks,  
3 and 6 
months  
100% Better QuickDASH at 3 and 6 
months,  
Better radiographic 
parameters for plate at 6 
months 
Marcheix 
2010  
Not stated  k-wires AO Type A2, 
A3, C2, C3 
110 <50 DASH, 
Herzberg, 
radiographic, 
complications 
30% loss 
of 
reduction 
6, 12 
and 26 
weeks 
94% At 26 weeks, DASH, Herzberg 
scores and grip were better 
for plate. In both groups 
overall recovery was slower 
than has been reported in 
other studies. 
Rozental  
2009 
 
VLS plate 
(Wright 
Medical) or 
DVR 
(Biomet) 
k-wires 
± 
bridging 
external 
fixation  
AO Type A2, 
A3, C1, C2 
45 19-
79 
DASH, ROM, 
grip and pinch, 
radiographic, 
complications 
DASH 6,9,12 
weeks , 
1year  
93% DASH better for plate up to 
12 weeks. No difference at 1 
year.  
Better ROM and grip to 9 
weeks.  
No radiographic differences. 
Goehre 
2013 
LCP Distal 
Radius 
System 
2.4mm 
(Synthes) 
k-wires AO Type A2, 
A3, C1 
40 >65 DASH, PRWE,  
Castaing 
ROM, grip, 
radiographic, 
complications 
Not 
stated  
3, 6 12 
months 
 No obvious differences , 
comparative statistics not 
reported  
Probst 
(unpublished) 
Aptus   
( Medartis)  
K-wires Not stated 103 18-
80 
DASH, ROM, 
grip, 
radiographic, 
complications 
Not 
stated 
1 year 91% DASH better for wire group 
ROM = range of motion  
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Table 1.5 Summary of outcome measures of randomised studies of volar locking plate versus percutnaeous wire fixation 
Author Year DASH  Other scores  
Grip 
stength 
ROM  
Ulnar 
variance  
Volar tilt  
Radial 
inclination 
Radial 
height 
Complications 
(plate/wires) 
Re-operation 
(plate/wires) 
Hollevoet  
2011 
No difference    
No 
difference  
No 
difference  
No 
difference  
No 
difference  
No 
difference  
No 
difference 
 6/11 2/3  
McFayden 
2011 
QuickDASH 
better for plate 
at 3 and 6 
months 
Gartland and 
Werley better 
for plate at 3 
and 6 months 
      
Better for 
plate  
Better for 
plate  
Better for 
plate 
   
0/8 
0/3  
Marcheix  
2010 
DASH better for 
plate at 26 
weeks, no 
difference at 12 
weeks 
Herzberg 
better for 
plate at 12 
and 26 weeks  
Better for 
plate at 26 
weeks  
No 
difference  
No 
difference  
No 
difference  
Initially 
better for k-
wires but no 
difference at 
26 weeks  
No 
difference 
1/9   
Rozental  
2009 
DASH better for 
plate up to 12 
weeks, no 
difference at 1 
year. 
  
Better for 
plate up to 
9 weeks.  
Better for 
plate up to 
9 weeks.  
  
No 
difference  
No 
difference  
No 
difference 
1/6 0/1 
Goehre  
2013 
No obvious 
differences , 
comparative 
statistics not 
done 
PRWE, 
Castaign, 
same as DASH  
No 
difference  
Better 
flexion-
extension 
arc for 
plate only 
at 12 
months  
  
Poorly reported, no great differences, 
some loss of volar tilt with k-wires at 
6 months 
 3/3 1/0 
Probst 
(unpublished) 
DASH better for 
K-wire group  
  
No 
difference  
Better 
flexion-
extension 
arc for 
plate   
  
No 
difference  
No 
difference  
No 
difference 
 3/5   
 
ROM = range of motion  
Difference = statistically significant difference as defined by the authors 
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Egol et al. compared volar plate fixation with bridging external 
fixation and found no differences in outcomes after 12 weeks (Egol 
et al., 2008). Marcheix et al. noted better functional results in the 
plate group when compared with k-wires at 26 weeks, but with a 
slower overall recovery for both treatment arms than those 
reported in other studies (Marcheix et al.).  McFayden et al. 
reported better QuickDash scores for the volar locking plate group 
at 3 and 6 months, but did not follow patients further (McFadyen et 
al., 2011). Hollevoet at al. found no functional or other difference 
between volar locking plate and percutaneous wire fixation at 3 
and > 12 months (Hollevoet et al., 2011). Rozental et al. compared 
volar locking plate fixation to percutaneous wires ± external 
fixation in a well-designed trial and found better results for the 
plate group in the first post-operative 3 months, but no differences 
at 1 year (Rozental et al., 2009). 
The main advantages of these studies are that they are prospective 
and randomised. They each have at least one functional patient-
centred outcome measure (DASH or QuickDASH), but only one 
used a questionnaire which was joint specific (Goehre et al., 2013). 
All but one report an acceptable (>85%) rate of follow-up (Goehre 
et al.). There is variation in fracture patterns included. Fractures 
are described via the AO classification (Müller ME, 1990) in three 
studies, however Hollovoet and Probst give incomplete descriptions 
of fracture inclusion characteristics, which affects the ability to 
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interpret and generalise the results (Hollevoet et al., 2011, Meier et 
al., 2013). Awareness of the CONSORT reporting style, such as the 
inclusion of a participant flow diagram is evident in three studies 
(Rozental et al., 2009, Marcheix et al., Hollevoet et al., 2011). 
However, it is of great concern that all but two studies (Hollevoet 
et al., 2011, Rozental et al., 2009) fail to clearly state their primary 
outcome measure, and of those who do, only Rozental et al. chose 
a functional outcome measure of relevance to patients. Only three 
out of five studies have a follow-up of a year. None of the studies 
used quality-of-life or economic endpoints.  
The overall conclusion of these studies, albeit their shortcomings, is 
that there may be a functional advantage to volar locking plate 
fixation, however this advantage is transient. There may be a 
statistical advantage in certain measurable clinical parameters, but 
this does not seem to correlate with the functional outcome 
measures used. Only one study reported evidence of improved 
radiographic outcomes for volar locking plate fixation (McFadyen et 
al., 2011), though two studies suggested that k-wire fixation may 
result in some collapse of the originally obtained reduction (Goehre 
et al., 2013, Marcheix et al., 2010). Finally, it is of interest to note 
that the only study reporting improved outcomes for the 
percutaneous fixation group remains unpublished. 
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1.2.5.2 External fixation versus open reduction and plate 
fixation 
External fixation has been a long established method for treating 
unstable distal radial fractures. It is simple to apply with minimal 
surgical trauma. Advances in plate technology have made plating 
increasingly popular, however plating of complex fractures can be 
technically challenging. The debate as to which of the two methods 
is superior predates the advent of volar locking plate fixation and 
generated twelve randomised trials comparing external fixation and 
plating, published in the English literature since 2000 (Williksen et 
al., 2013, Gradl et al., 2005, Jeudy et al., 2012, Grewal et al., 
2011, Wei et al., 2009, Landgren et al., 2011, Abramo et al., 2009, 
Xu et al., 2009, Egol et al., 2008, Kreder et al., 2005, Grewal et 
al., 2005, Kapoor et al., 2000). 
Three separate meta-analyses of outcomes comparing external 
fixation and plating have been published so far in 2013 (Xie et al., 
2013, Wang et al., Esposito et al.). Though showing some variation 
in the studies included, all concluded that internal fixation with 
plates provided better functional scores (DASH) and radiographic 
parameters of reduction and a lower incidence of minor 
complications, especially infection. All three meta-analyses 
attempted subgroup analysis of studies involving volar locking 
plates versus external fixation but their conclusions on this vary. 
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Six published randomised controlled studies compare volar locking 
plates with external fixation (with or without adjuvant wires) for 
distal radial fracture fixation (Williksen et al., 2013, Gradl et al., 
2005, Jeudy et al., 2012, Grewal et al., 2011, Wei et al., 2009, 
Wilcke et al., 2011). These trials are not uniform in their design. 
Some combine volar locking and other plate fixation in the plating 
arm (Wei et al., 2009, Grewal et al., 2011). One utilises non-
bridging external fixation (Gradl et al., 2005) as the comparator. 
As a result, these meta-analyses differ in their conclusions 
depending on the studies they included and the methods used to 
analyse them. 
The most robust meta-analysis methodologically is by Xie et al. 
published in Acta Orthopeadica (Xie et al., 2013). This follows 
PRISMA guidelines (Moher et al., 2009). It is arguably the most 
inclusive of uniform studies and, unlike the other two meta-
analyses discussed here, has not included data from the Rozental 
study. The later was effectively a study of percutaneous wiring, 
rather than external fixation, with only two (2/22) patients in the 
percutaneous fixation group requiring a supplemental external 
fixator (Rozental et al., 2009). Xie et al. is also the only meta-
analysis which collated data for functional outcomes at separate 
time-points (3, 6 and 12 months), which is important given the 
hypothesis that plate fixation allows for earlier rehabilitation. Xie et 
al. concluded that patients who received internal fixation using 
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volar locking plates had improved functional scores (DASH) at the 
early stage after fixation, but that the difference diminished at one 
year. The techniques were associated with similar rates of 
complications (Xie et al., 2013). 
The three most recently published trials have not yet been included 
in any meta-analyses, but are worthy of note. Williksen et al. 
originate from Norway and randomised 111 patients to external or 
volar locked plate fixation. They compared outcomes at 16, 26 and 
52 weeks and found no differences in QuickDASH scores. Both 
treatment groups had similar high rates of complications (30% and 
29%). Fifteen percent of plates had to be removed (Williksen et al., 
2013). Jeudy et al. randomised 91 but analysed 75 patients (82%). 
Their maximum follow-up was six months and they found no 
differences in Patient Rated Wrist Evaluation (PRWE) at 3 and 6 
months. Clinical measurements and radiographic reduction were 
better in the plating group throughout (Jeudy et al., 2012). It is 
interesting that, despite the lack of differences in functional 
outcome scores, both studies recommend the use of volar locking 
plates over external fixation. Finally, Gradl et al. compared non-
bridging fixation for 102 dorsally displaced fractures (intra and 
extra articular) to volar locking plate fixation and found no 
differences, though they failed to use a patient-centred validated 
functional outcome measure (Gradl et al., 2005). 
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1.2.5.3 Ongoing studies 
There are two large multicentre studies that are yet to complete or 
publish results. 
The Wrist and Radius Injury Surgical Trial (WRIST) is a multi-
centre international study, conceived in 2007 at the University of 
Michigan. Originally composed of 4 sites, the project has expanded 
over 5 years to include 21 sites in 3 countries, and is jointly funded 
by the National Institute of Arthritis and Musculoskeletal and Skin 
Diseases and the National Institute on Aging in the United States. 
The goal of WRIST is to randomize participants 60 years of age or 
older to one of three surgical procedures (percutaneous pinning, 
external fixation with or without pinning, and internal fixation with 
volar locking plates). The aim is to compare outcomes of these 
three surgical techniques in treating unstable distal radius fractures 
in the elderly. The secondary aim is to follow a cohort of elderly 
patients who choose not to have surgery to evaluate outcomes 
following treatment by closed reduction and casting alone, so 
participants who opted not to have surgical fixation will also be 
observed as a control group. The National Institute of Health (NIH) 
granted WRIST full approval in January 2012 and participant 
recruitment started in April 2012. The primary outcome measure is 
the Michigan Hand Outcomes questionnaire (Chung et al., 1998). 
Secondary outcome measures include a quality of life assessment, 
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functional and radiological measures. After enrolment, participants 
are to be observed for 2 years. This study has an estimated sample 
size of 623, aiming to complete data collection for the primary 
outcome measure in October 2014. The WRIST study group have 
recently published their reflections 1 year into the study, 
documenting their experiences of setting up and co-coordinating 
the trial. Recruitment has been a particular struggle with eligibility 
numbers lower than predicted and patients showing reluctance to 
be randomised. However, with the addition of study centres outside 
the US , the authors are confident of a successful completion of this 
highly ambitious study (WRIST_Study_Group, 2013, Chung and 
Song, 2010). 
The DRAFFT study is a UK-based pragmatic, multi-centre, 
randomised clinical trial with parallel economic analysis. The 
primary aim of this trial is to determine if there is a functional 
difference 1 year following K-wire fixation versus locking-plate 
fixation for adult patients with a dorsally-displaced fracture of the 
distal radius. The primary outcome measure for this study is the 
Patient Rated Wrist Evaluation (MacDermid et al., 1998). 
Secondary outcome measures in this trial are: the DASH score, the 
EQ-5D quality of life score (EuroQol 1990), complications, 
radiographic parameters and resource use (Costa et al., 2011).The 
study recruited their target of 390 patients in trauma units across 
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the UK. The data collection completed in 2013 and publication of 
results is awaited. 
1.2.6 Complications of volar locking plate fixation 
Though the move from dorsal plating to the volar aspect of the 
wrist reduced the number of implant related complications, the use 
of volar locking plates is not without its own problems (Rozental 
and Blazar 2006; Arora, Lutz et al. 2007; Rampoldi and Marsico 
2007). 
A comparison of published complication rates, ranging from 4.9% 
to 32%, is presented in Table 1.6 (Johnson et al., 2013). There is a 
preponderance of tendon rupture and metalwork related 
complications, often leading to re-operation. Arora et al. is the 
most cited, reporting an overall complication rate of 27% in 114 
consecutive patients treated from 2003 to 2005, in two centres 
with a single implant (Arora, Lutz et al. 2007). Johnson et al. is the 
most recent, reviewing 204 fractures in a teaching hospital from 
2009 and 2010, and reporting a 7.9% complication rate and a 
7.4% reoperation rate (Johnson et al., 2013). 
The extensor tendons are not immune from injury with volar plates 
(Benson 2006)  and irritation and rupture of the extensors form a 
significant  proportion of the reported complications (20% of 
complications reported by Arora et al ) (Arora et al., 2007). This is 
most likely the result of a failure to appreciate the three-
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dimensional shape of the distal radius which is trapezoidal. 
Consequently, screws that appear to be within the bone on the 
lateral view may be penetrating the cortex dorsally with potential 
to harm the extensors (Downing and Karantana, 2008). Flexor 
tendons are also at risk (Al-Rashid et al., 2006)  constituting 29% 
of complications reported by Arora et al.(Arora et al., 2007).The 
majority of flexor complications can be attributed to incorrect 
SODFHPHQWRIWKHLPSODQWZLWKIDLOXUHWRDSSUHFLDWHWKHµZDWHUVKHG
OLQH¶ +RZHYHU .OXJ HW DO (Klug, 2007) also reported a case of 
flexor pollicis longus rupture in a patient with normal anatomy and 
a correctly positioned implant. It seems that in many cases 
tenosynovitis precedes rupture, which timely removal of the 
implant will reverse, so high levels of suspicion are warranted. 
Because the distal radial articular surface cannot be inspected from 
the volar approach without disrupting the volar radio-carpal 
ligaments, placement of screws and pegs into the subchondral 
bone outside of the joint depends on a clear knowledge of the 
three-dimensional anatomy of the articular surface and careful 
intra-operative imaging using articular views. The use of fixed±
angle locking plates increases the risk of inadvertent joint 
penetration, especially when the optimal position for subchondral 
bone support is just millimetres from the articular surface, such as 
for fractures involving the joint (Drobetz et al., 2006). When the 
plate is placed too distally or the fracture is not reduced 
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anatomically, the predetermined direction of the screws could 
inadvertently lead to joint penetration. Intra-articular screw 
placement after volar distal radius plating has been reported (Arora 
et al., 2007). 
Sahu et al report an incidence of 10% for reoperation for 
metalwork complications following the use of volar locking plates 
for distal radius fractures in a study of 114 patients in two UK 
hospitals (Sahu et al., 2011). Gyuricza et al report on their 
experience of volar locking plate removal in 28 patients in the US 
(Gyuricza et al., 2011). Some, such as the inadvertent retention of 
angled drill guides (Bhattacharyya and Wadgaonkar, 2008) are 
implant specific. 
Early complication can be attributed to the inevitable learning curve 
encountered with a new technique. However, reported rates remain 
high in later series. It is possible that complications of this 
technique remain under-reported, in part due to publication bias, 
and also because rates are more often than not reported from 
larger centres with research interests, where the more complex 
fractures are often addressed by surgeons with a subspecialist 
interest. With the number of distal radius fractures treated with a 
plate increasing exponentially in recent years, many are also now 
treated by surgeons with less experience, such as trainees. It is 
important to track and publish the incidence of complications from 
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all settings, as this will allow a realistic framework for evaluation of 
healthcare resources, which must be balanced against the 
perceived benefits of the technique. 
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Table 1.6 Complications in the published literature, modified from Johnson et al. (Johnson et al., 2013) 
Study N 
Complication 
rate 
CRPS Wound Nerve 
Tendon 
(rupture) 
Metalwork Fracture 
Johnson 
(2013) 
206 7.9 % 1.9 % 0.5 % 0.5 % 3.4 % (1.9 %) 1.9 % 1.5 % 
Phadnis 
(2012) 
180 15 % 9 % 1.1 % 2.2 % 1.7 % (1.7 %) 
  
Lattmann 
(2011) 
245 15 % 3.7 % 0.4 % 3.7 % 3.7 % (1.6 %) 
 
0.8 % 
Sahu 
(2011) 
114 10.5 % 
   
1.8 % (0.9 %) 10.5 % 
 
Arora 
(2007) 
141 27 % 3.5 % 0 2.1 % 12 % (2.8 %) 2.1 % 2.1 % 
Chung 
(2006) 
161 4.9 % 
 
3.1 % 0.6 % 
   
Rozental 
(2006) 
41 22 % 0 2.4 % 
 
7.3 % 
 
9.8 % 
Al-Rashid 
(2006) 
35 8.6 % 
   
8.6 % (8.6 %) 
  
Drobetz 
(2003) 
50 32 % 6 % 4 % 2 % 16 % (14 %) 2 % 2 % 
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1.3  Summary  
Distal radius fractures are common injuries that have a substantial 
impact on health care systems. There is no consensus view on their 
management (Karantana and Davis, 2012). This is partially because of 
the failure of clinical studies to demonstrate overall superiority of one 
treatment technique over the other (Handoll, 2007a, Handoll, 2007b, 
Handoll, 2003).  
In the past few years, the rate of non-operative treatment of these 
injuries has declined, just as the rate of internal fixation, and 
particularly of volar locking plate fixation, has increased exponentially 
(Chung et al., 2009). Early studies documented a number of theoretical 
advantages of volar locking plate fixation (Larson and Rizzo, 2007) and 
many retrospective studies demonstrated good outcomes (Chung et al., 
2006, Rozental and Blazar, 2006, Beaton et al., 2005, Orbay et al., 
2004). However, the few published prospective randomized studies 
have failed to demonstrate a consistent and lasting benefit of volar 
plate fixation over percutaneous techniques (Hollevoet et al., 2011, 
McFadyen et al., 2011, Marcheix et al., 2010, Rozental et al., 2009, 
Goehre et al., 2013). These studies suffer from methodological 
shortfalls. In addition, there has been no attempt so far to establish the 
cost-effectiveness of volar locking plate fixation, which is considered to 
be a more expensive and more invasive technique (Shyamalan et al., 
2009, Karantana and Davis, 2012). 
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1.4 Thesis Aims 
The aim of this study was to perform a randomised controlled trial 
comparing the outcome of displaced distal radial fractures treated with 
a volar locking plate (the DVR®), to percutaneous fixation with wire 
fixation and/or supplemental stabilisation via bridging external fixator 
as required.  
Primary objective 
To determine whether the use of volar locking plates improved 
functional outcome, as experienced by the patient, at one year post 
intervention. 
Secondary objectives  
To ascertain whether the use of volar locking plates resulted in: 
x improved measurable clinical outcomes, such as range of motion 
and grip strength, 
x improved radiographic parameters or  
x earlier return to normal activities and work 
In addition, to determine the type and rate of complications associated 
with each fixation method.  
Finally, to determine the additional costs of volar locking plate fixation 
compared with the potential additional benefits that this method 
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delivers over percutaneous fixation. This was achieved via a cost-
effectiveness analysis of the interventions, from the perspective of the 
NHS.   
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Chapter 2 ± Methods 
2.1 Study design 
This study was a single-centre, randomised controlled trial of pragmatic 
design with a parallel-group structure, accompanied by an economic 
evaluation. The conduct and reporting of the trial followed the 
CONSORT recommendations (Schulz et al.). 
The current study was classified as a parallel-group trial, which is the 
most common RCT design. In this, patients are randomised to either 
WKH³QHZ´RUWKHVWDQGDUGWUHDWPHQWDQGIROORZHG-up to determine the 
effect of each in parallel groups (Grindel, 2007).  
The study was designed to reflect routine surgical management of distal 
radius fractures in an NHS setting and so incorporates pragmatic 
features in the design. Exploratory trials generally measure efficacy ± 
this is the benefit a treatment produces under ideal conditions, for 
example using carefully defined subjects in a research clinic. Pragmatic 
trials measure effectiveness ± the benefit a treatment produces in 
routine clinical practice (Roland and Torgerson, 1998). The distinction 
between exploratory and pragmatic design is a continuum, not a binary 
system and most trials, like this one, have both exploratory and 
pragmatic aspects (Patsopoulos, 2011).  
From an economic viewpoint, the study was primarily a cost-utility 
analysis of the interventions from the perspective of the NHS, modelled 
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around the RCT in line with NICE guidance on the methodology of 
technology appraisals (NICE, 2008). The preferred measure of health 
related utility in this approach is the EQ-5D. The NICE technology 
appraisal programme follows the QALY approach, so the units of 
effectiveness were expressed in QALYs. 
A cost analysis of each treatment method was performed from the 
SURYLGHU¶V SHUVSHFWLYH WKH SURYLGHU EHLQJ WKH 1+6 7Ke analysis was 
based on a model pathway for each arm of the trial and was informed 
by real patient data collected, making it the most pragmatic and 
detailed estimation of real total cost for the described interventions 
available to date.  
In addition to the EQ-5D, data were also collected via the SF-6D health 
state index (Brazier et al., 2002). The SF-6D represented a possible 
alternative to the EQ-5D, as utility weights generated from a UK 
population sample exist for both instruments. The rationale was to 
compare the two scores, and to explore whether the SF-6D could be a 
more sensitive utility measure in the setting of distal radius fracture. 
Finally, the effectiveness of the interventions at reducing days off work 
was examined. The hypothesis was tested that volar locking plate 
fixation provides indirect economic benefit by returning people to work 
soonerµ7LPHWRUHWXUQWRGULYLQJ¶ZDValso determined. 
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2.2 Study approval and registration 
The study was approved by the regional Research Ethics Committee, 
the institutional Research and Development Unit and registered under 
Current Controlled Trials (ISRCTN27396017). The trial protocol, as 
approved by the local Research Ethics Committee and institutional 
Research and Development Unit, is presented in Chapter 6, along with 
evidence of board approval. 
2.3 Participants and setting  
All adult (skeletally mature) patients presenting to the orthopaedic 
trauma service were eligible for inclusion in the study. Participants had 
to satisfy the inclusion and exclusion criteria (Table 2.1), and be 
referred to the research team by their attending surgical team. 
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Table 2.1  Inclusion and Exclusion Criteria 
Inclusion Criteria 
Fractures which the referring physician considers require operative 
intervention 
Adults (skeletally mature) with high demand requirements of their wrist 
in whom the radiological appearance of the bone suggests that it is 
robust enough to tolerate internal fixation 
Fractures of the distal radius which are:   
x 'RUVDOO\GLVSODFHGq) extra-articular fractures (with or without 
an undisplaced intra-articular component) with dorsal cortical 
comminution as seen on the lateral radiograph. 
x Displaced intra-articular fractures with an articular step or gap in 
the radio carpal joint surface. 
Configuration is such that the fracture would be amenable to stabilisation 
via volar locking plate (not unreconstructable) 
Exclusion Criteria 
Patients with concomitant systemic diseases  
(diabetes with vascular or neurological complications, advanced cardiac, 
pulmonary or neurological disease) 
Proximal metaphyseal fractures  
(more than 2.5 centimetres from the articular surface)  
Open fractures 
6PLWK¶VDQGYRODU%DUWRQ¶VFRQILJXUDWLRQ 
Significant pre-existing radiological abnormality 
Multiply injured 
Bilateral injuries 
Previous fractures of the distal radius of the same or contra-lateral limb  
Patients who may have difficulties in adequate understanding of English 
Patients who are unable to consent for themselves to treatment 
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The setting was an acute teaching urban NHS trust (Nottingham 
University Hospitals, Queen's Medical Centre Campus, Nottingham). 
Patients were recruited through fracture clinic and the acute 
orthopaedic take and treated on the orthopaedic wards and trauma 
theatres. 
While distal radial fracture classification systems generally fall short in 
terms of repeatability and reliability, a description of the fracture 
distribution in our study was required. Fractures were classified 
according to the AO classification system (Müller ME, 1990). There is no 
gold standard classification with prognostic value. The AO system is 
commonly used in the literature and will allow for direct comparisons in 
future meta-analysis. The AO was also the classification requested by 
the target journal for this study.  
There is no well justified precedent as to whether fracture severity 
should be treated as a nominal or ordinal variable. Categories of 
fracture classification in the study were treated as nominal.  
2.4 Methods: Clinical Trial 
2.4.1 Clinical intervention 
Open reduction and internal fixation with the volar locking plate was 
performed via a volar approach through the flexor carpi radialis flexor 
sheath, under fluoroscopic guidance. Fracture stabilisation was achieved 
with the use of the Distal Volar Radius (DVR®) plate (DePuy, Warsaw, 
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Indiana, USA), which was selected on the advice of our Hand Surgery 
and Trauma Units (Figure 2.1). It is in common use across the United 
Kingdom, widely represented in the published literature and is an 
implant with which our surgeons had significant prior experience. Bone 
grafting was not performed. The wrist was immobilised post-operatively 
in either a plaster splint or a removable Velcro splint. Patients were 
instructed in active and passive finger motion. Splints were removed 2 
weeks after surgery when patients were seen by a physiotherapist and 
instructed on standard range-of-motion exercises. 
 
Figure 2.1 Example of a distal radius fracture treated via volar locking 
plate DVR® fixation 
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Instrumentation in the conventional arm of the trial included smooth 
1.6mm Kirschner wires with a supplemental standard AO-ASIF external 
fixator (Synthes, Paoli, Pennsylvania, USA), if required. The surgical 
technique involved closed reduction with ligamentotaxis under 
fluoroscopic control and stabilisation with 1.6mm Kirschner wires 
passed through small stab incisions. Where additional stability, beyond 
that provided by k-wire fixation was necessary to maintain reduction, 
bridging external fixation was added to increase stability via 
ligamentotaxis (Figure 2.2). The decision was made based on the 
judgement of the operating surgeon at the time. Post-operatively the 
wrist was immobilised in a plaster splint for 6 weeks and patients were 
instructed in active and passive finger motion exercises. Patients with a 
supplemental external fixator did not require plaster cast support. The 
wires and external fixators were removed at 6 weeks. Patients were 
seen by a physiotherapist to be instructed on standard range-of-motion 
exercises. 
All surgery was performed by one of six consultant surgeons, with a 
subspecialty interest in either hand and upper extremity or trauma 
surgery (N.D.D, D.P.F., M.H., C.G.M., A.M.T. and T.R.D). 
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Figure 2.2 Example of a distal radius fracture treated via Kirschner 
wires with a supplemental standard AO-ASIF external fixator  
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2.4.2 Outcome assessments 
Outcome assessments were patient-reported, clinical and radiological 
and were performed at 6 weeks, 12 weeks and 1 year in a designated 
room in the Outpatient Fracture Clinic. Clinical assessments were 
performed by the main investigator and an independent research 
assistant, who had received extensive training on how to perform the 
range-of-motion and grip strength measurements.  
2.4.2.1 Primary outcome measure  
The primary endpoint of the current study was function of the limb 
following a surgically treated distal radius fracture. As an endpoint, 
function is clinically relevant and meaningful to the patient, more so 
than radiographic criteria of reduction or degeneration, which have not 
been shown to correlate with disability in the case of the radiocarpal 
joint (Karantana and Davis, 2012, Diaz-Garcia and Chung, 2012). 
Outcome assessment in the wrist has traditionally largely relied on 
measurements such as grip strength and range of motion. However, 
function of the upper limb is complex and these measurements do not 
DOZD\VUHIOHFWWKHSDWLHQW¶VH[SHULHQFH7KHLPSRUWDQFHRIWKHSDWLHQW¶V
own assessment of outcome in this setting is now widely recognized 
(Amadio, 1994). 
We selected the Hand Health Profile of the Patient Evaluation Measure 
(PEM) (Macey et al., 1995) as the primary measure of function. This is a 
standardized self- administered patient questionnaire proposed by the 
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first Derby consensus meeting for measuring outcomes of hand surgery 
as a practical means of recording outcomes in hand surgery (Hobby et 
al., 2005). It consists of ten questions relating to subjective hand 
function. They are rated by the patient on a scale of 1 to 7 and assess 
feeling, cold intolerance, pain, dexterity, movement, subjective grip 
strength, daily activities, work, appearance and a general assessment. 
The answers are expressed as a percentage disability ranging from zero 
to 100. 
The PEM is short, uncluttered and easy to understand and score. 
Because of this, its use has gained ground in routine clinical practice. It 
has been shown to be comparable with other well established upper 
limb questionnaires such as the DASH and the Michigan Hand Outcome 
Questionnaire in terms of validity and reliability (Dias et al., 2008). It is 
a measure specifically assessed in the setting of distal radius fractures 
and shown to be valid in terms of content (Henry, 2007). Forward et al. 
assessed the internal consistency and validity of the PEM in the setting 
of medium and long term outcome (6 to 42 years) after distal radius 
fracture (Forward et al., 2007). We also know that, in a more general 
setting, the PEM has been shown to be reproducible and responsive 
(Sharma and Dias, 2000, Dias et al., 2001). It is also the only validated 
measure to have a question on cosmesis of the limb. As a final point, an 
additional benefit to choosing the PEM as the primary outcome measure 
for this study is the availability of comparable data which allowed a 
sample size calculation for the trial. 
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2.4.2.2 Secondary outcome measures  
Our secondary endpoints consisted of objective measurements such as 
grip strength, range of motion and radiographic parameters, as well as 
two quality of life scores. The objective measures allowed comparisons 
to our functional measurements, in addition to producing data for future 
comparisons with other studies, which traditionally report these 
measures. The quality of life scores were required for determining 
health economic end-points.  Patients were also asked at each 
attendance if they had returned to driving, if they drive, and to their 
work, if employed. 
Range of motion of the wrist was assessed by recording flexion-
extension and pronation-supination with a standard goniometer. Grip 
strength was measured with a calibrated dynamometer (Jamar®, 
Sammons Preston Rolyan, Bollingbrook, Illinois, USA). Values were 
compared with those of the contra lateral limb for each individual and 
expressed as the percentage values. 
As part of what were defined as secondary endpoints in this trial, we 
also collected data in the form of the QuickDASH (Beaton et al., 2005) 
and Patient Rated Wrist Evaluation Questionnaires (PRWE) (MacDermid 
et al., 2003). 
The QuickDASH is a shortened version of the Disability of the Arm, 
Shoulder and Hand (DASH) Outcome Measure. In a 2006 study, 
Gummesson et al determined that the QuickDASH can be used in place 
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of the DASH without sacrificing any precision for upper extremity 
disorders (Gummesson et al., 2006). It represents a regional evaluation 
of the whole upper limb and is not specific to the wrist, however has 
been widely used in the distal radius fracture literature. The DASH 
(Goehre et al., 2013, Hollevoet et al., 2011, Egol et al., 2008, Probst, 
2008, Rozental et al., 2009, Marcheix et al., 2010, McFadyen et al., 
2011) and QuickDASH (McFadyen et al., 2011) have been used in many 
RCTs of volar locking plates versus conventional fixation, allowing for a 
comparison of results across studies. 
The PRWE was originally described by MacDermid et al. in 1998 
(MacDermid et al., 1998). This score was used as it is specific for the 
outcome of one joint, the wrist.  It is a 15-item questionnaire which 
allows patients to rate their levels of wrist pain and disability from 0 to 
10 and a total score is computed on a scale of 100 (0 = no disability). 
Macdermid et al. (MacDermid et al., 2000) compared the 
responsiveness of the DASH, PRWE and SF-36 scores in evaluating 
recovery after distal radius fractures. The PRWE score was the most 
responsive of the three in this particular group of patients. There are 
however some concerns about the correlation of the score with 
objective clinical variables (Karnezis and Fragkiadakis, 2002). 
Radiographic assessment included a standardised series comprising of 
dorsi-palmar, 45 degree pronated dorsi-palmar oblique and lateral 
views of the wrist, taken at presentation and at 6 weeks and 1 year 
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post injury. The contra lateral wrist was X-rayed at 6 weeks and acted 
as a standard for the assessment of palmar tilt, radial height, radial 
inclination and the presence of an intra-articular step or gap of 2mm or 
more. All radiographic measurements were performed by an 
independent assessor (S.C.), blinded to patient outcome. Measurement 
of radiographic angles was made using TraumaCad® software 
2UWKRFUDW /WG ,VUDHO ZKLFK ZDV DYDLODEOH DV SDUW RI RXU 7UXVW¶V
software package. This allows users to perform measurements of digital 
images on-screen, using angle and length measurement tools. The 
software enables the import and export of all picture archiving 
communication system (PACS) files. An example of radiographic 
parameters measured using this system is presented in Figure 2.3. 
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Figure 2.3 Example of measurement of radiographic parameters using 
electronic measurement tools 
    Radial inclination 
 
 
       Radial height 
 
 
    Palmar inclination 
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Reliability of the radiographic measurements was validated by a second 
observer (N.D.D). A sample, consisting of 45 anonymised and blinded 
radiographs, was selected at random from the trial x-ray database. 
Measurements of radial height, radial inclination and palmar inclination 
were made independently by the main independent assessor (S.C.) and 
a second observer (N.D.D), using the same approach and software. The 
second observer measurements were performed to assess inter-
observer variation and to give an estimate of the accuracy of 
radiographic assessments. Data was analysed via the Bland-Altman 
method for comparing measurements of continuous variables using 
limits of agreement (Altman, 1999, Bland and Altman, 1986). 
The number of complications was tabulated. Patients requiring 
additional interventions were identified and recorded. 
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2.4.3 Addressing sources of bias 
In clinical research, bias is defined as systematic distortion of the 
HVWLPDWHG LQWHUYHQWLRQ HIIHFW DZD\ IURP WKH ³WUXWK´ FDXVHG E\
inadequacies in the design, conduct or analysis of a trial (Altman et al., 
2001). It is impossible to completely eliminate bias. However, bias can 
be reduced through careful study design.  
2.4.3.1 Selection bias  
Wide, pragmatic inclusion criteria were employed in an attempt to 
capture a representative study population. 
There will always be an element of selection bias in enrolment of any 
study, even with adherence to carefully designed inclusion and 
exclusion criteria. First of all, this is because potential participants must 
somehow be identified and referred to the trial and this introduces bias 
from their original treating team. Second, because participation in any 
study is voluntary and this introduces an element of bias due to the 
personal beliefs of the potential recruit.   
The personal belief of the referring surgeon that a certain fracture 
should be fixed by a certain method could prohibit referral to the trial. 
This is enhanced by the rules of research governance, which prohibit 
the study team from directly approaching suitable recruits. Participants 
must first be introduced to the investigators by their treating physician. 
In addition, non-trial personnel could express a biased personal opinion 
 73 
 
to a potential patient, who subsequently refuses to enter the trial 
believing that they are likely not to get WKH³EHVW´WUHDWPHQW 
In order to minimise this, we: 
(1) disseminated detailed information of the study to all orthopaedic 
teams treating acute fractures prior to the onset; 
(2) made every opportunity to discuss the published literature; 
(3) REWDLQHGHDFKWHDP¶VRSLnion on study design. 
We achieved the cooperation of the entire Orthopaedic unit at our 
hospital, with all consultants agreeing to refer their patients to the trial 
if they satisfied the inclusion criteria. In addition, we encouraged 
discussion with the junior staff as to the nature of the study question 
and the difference between personal preference and good quality 
published evidence. 
2.4.3.2 Observer or ascertainment bias 
Ascertainment bias is the systematic distortion of the results of a trial, 
which occurs when the person assessing outcome (whether an 
investigator or the participant) knows the group assignment (Altman et 
al., 2001). The best way of dealing with this is blinding or masking. This 
is the practice of keeping the trial participants, care providers, data 
collectors and sometimes those that analyze the data unaware of 
treatment allocation.  
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Blinding was not considered realistic due to the nature of the surgical 
procedures, differing hardware and their distinctive scars which are 
difficult to conceal during clinical examination of the area. Radiographic 
blinding was not feasible due to the presence of different hardware in 
the two arms of the study. Also, the principal investigator was at times 
both collecting and managing the data. 
The choice of primary outcome measure reduced ascertainment bias.  
The Patient Evaluation Measure (PEM) (Macey et al., 1995) is a patient-
centred validated functional assessment questionnaire, which is 
completed at each time point solely by the patient, prior to the 
encounter at which clinical data is collected, and with no input from 
study personnel. 
2.4.4 Analysis 
2.4.4.1 Intention-to-treat analysis 
Analysis was intention-to-treat (ITT). This is a strategy in which all 
participants are analysed in the group to which they were originally 
assigned, regardless of whether they completed the intervention given 
to that group (Altman et al., 2001). It maintains the benefits of 
randomisation and prevents bias caused by non-adherence to protocol 
whether this is due to the patients or their clinicians. Intention-to-treat 
is the optimal way of analysing a pragmatic study. The benefit is that 
most types of deviation from protocol would continue to occur in routine 
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clinical practice and so should be included in the estimated benefit of a 
change in treatment policy (Hollis and Campbell, 1999) 
However, intention-to-WUHDW DQDO\VLV DVVXPHV DQ HTXDO ³ULVN´ RI QRQ-
compliance in all treatment groups. If there is an imbalance in drop 
outs, this must be taken into account when interpreting results. It is 
noted in the literature that rarely, in 5% to 10% of cases, acceptable 
reduction of distal radius fractures cannot be achieved by closed 
reduction and percutaneous techniques and the surgeon must consider 
converting to open reduction and internal fixation (Kreder, Hanel et al. 
2005; Wulf, Ackerman et al. 2007). 
It was anticipated that, in a small number of cases, a trial participant 
could be randomised to percutaneous treatment but converted intra-
operatively to volar locking plate fixation. Therefore, non-compliance 
GHILQHGDV WKHVXUJHRQ¶V LQWUD-operative decision to convert from one 
method of fixation to the other) carried an inherent risk of imbalance 
which was not due to failure of randomisation, but due to unpredictably 
difficult fracture configurations.  In the present study, per protocol (PP) 
analysis was planned, in addition to intention to treat analysis. This was 
in order to address the risk of potential imbalance between intention-to-
treat randomisation arms, as a result of the number of cases of non-
compliance being considerable. The combined results were interpreted 
with the aid of the grid demonstrated in Table 2.2.  
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Table 2.2 Interpretation of combined results from ITT and PP analysis. 
'HULYHG IURP WKH LQWHUSUHWDWLRQ RI &KDSWHU  RI :DQJ¶V WH[WERRN
HQWLWOHG³$3UDFWLFDO*XLGHWR'HVLJQ$QDO\VLVDQG5HSRUWLQJRI&OLQLFDO
7ULDOV´(Grindel, 2007) 
Per Protocol 
(PP) 
Intention-to-treat 
(ITT) 
Interpretation 
- - 
Non-compliant cases 
equally distributed 
or minimal  
- + 
Presence of 
unidentified / 
unadjusted 
confounder 
+ - 
High crossover* in 
one direction 
++ + 
High rates of non-
compliance 
Key 
³+´ indicates the presence of a statistically significant difference in 
outcome between the two treatment groups.  
³++´ indicates a higher level of statistical significance. The  
³±´ indicates no statistically significant difference in outcome 
between treatment groups  
³´ crossover is the rate of participants switching treatments.  
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2.4.4.2 Addressing sources of confounding  
In the context of a surgical trial, a confounder is best described as a 
variable which we would expect to have a significant impact on 
outcome, but is not the result of allocation. The most effective way to 
prevent confounding is through randomisation. Randomisation of over 
100 participants in a trial is usually able to balance the main 
confounders in a study. 
Though statistical tests comparing baseline group characteristics are 
often reported in published trials, this is not the correct way to address 
potential imbalance. The 2010 CONSORT statement recommends 
avoiding such blanket comparisons, stating that such hypothesis testing 
is superfluous and can mislead investigators and their readers. 
Significance tests assess the probability that observed baseline 
differences could have occurred by chance. However, providing 
randomisation was adhered to, any potential differences are, by 
definition, caused by chance (Schulz et al., 2010). 
The landmark paper on this topic is by Altman (Altman, 1985) which 
states: 
³,IVLJQLILFDQFHWHVWVDUHLQDSSURSULDWHIRUFRPSDULQJEDVHOLQHYDULDEOHV
in randomised clinical trials, how should the comparability of the 
treatment groups be established? An initial comparison may be made 
non-statistically using a combination of clinical knowledge and common 
sense. In any trial most variables examined will either differ only very 
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slightly between groups or will be felt, on the basis of previous 
knowledge, to have no direct bearing upon the outcome of the trial, be 
it survival, cure, or whatever´. 
The alternative approach is to compare the results from analyses of the 
trial both with and without allowance being made for the variable(s) in 
question. If the two results are essentially the same, this indicates that 
the simple comparison of treatment groups is reasonable. If they differ 
then the imbalance was important and adjustment beneficial. 
CONSORT recommends presenting baseline data in a table, with mean 
and standard deviation given for continuous variables, and proportions 
for categorical variables (Schulz et al., 2010). 
Potential confounders in this study, as well as the strategy that can be 
employed to address each, if not balanced by randomisation, are shown 
in Table 2.3.  
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Table 2.3 Potential confounders in our study and the strategy which 
can be employed to address each, if not balanced by randomisation 
Confounding factor Strategy 
Fracture classification 
Nominal logistic regression 
Employment category 
Age Linear regression 
Sex 
Binary logistic regression 
Hand Dominance 
 
 
Linear regression to control for age can only be used if values are 
normally distributed. If they are not, log transformation will be 
attempted to normalize the data. If the data remains non-parametric 
after transformation, then the option of non-parametric regression will 
be explored. The main disadvantage of non-parametric regression is 
that it is computationally intensive and requires a large number of 
observations, which surgical trials rarely achieve. 
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2.4.4.3 Dealing with missing data 
There will inevitably be participants who are either lost to follow-up or 
miss a particular data entry point in a study. Dealing with missing data 
is a much more complex issue than non-compliance with protocol. No 
golden standard method exists and strategies vary from simply 
analysing only the completely observed data (complete-case analysis) 
to using complex statistics or ad hoc methods to arbitrarily replace 
missing data (multiple imputation). 
Statistical software packages also deal with missing data in different 
wD\V67$7$XVHV³OLVWZLVHGHOHWLRQ´E\GHIDXOW/LVWZLVHGHOHWLRQPHDQV
that only cases with available data on each variable are analysed and is 
another term for complete-case analysis. The main advantages of this 
approach are its simplicity and that it allows comparability across 
analyses. The disadvantages are that it may reduce statistical power 
(because it lowers n) and it does not use all information. 
We examined the number of data entry points in the study. All missing 
data was tagged at the point of insertion in the data base. This allowed 
XV WR UHDGLO\ GLIIHUHQWLDWH GDWD WKDW ZDV ³PLVVLQJ´ UDWKHU WKDQ ³QRW
DSSOLFDEOH´ WR D SDUWLFXODU SDWLHQW We also examined absence from 
follow-up at each time point in the study. 
Given the resources available, the decision was made that, unless the 
overall data missing at any time point in the study exceeded 10% of 
total values, a complete-case analysis would be performed. The sample 
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size was adjusted upwards accordingly to allow for potential loss to 
follow-up and improve power. If missing data was to exceed 10%, then 
specialist input would be sought for multiple imputation analysis. 
If imputation analysis were required, analysis would be as follows:  
1. First analyse only the completely observed data. 
2. Then perform multiple imputation on the assumption that missing 
data is MAR (missing at random).  
3. If the above two analyses give similar results (and there is no 
reason to believe that the missing values are not MAR) then it is 
reasonable to assume that these missing observations do not alter 
the conclusions of the trial. 
4. If results of two analyses differ, then sensitivity analysis should be 
undertaken.  
2.4.4.4 Randomisation 
Randomisation is the process of assigning participants to groups such 
that each participant has a known probability of receiving each 
treatment before it is assigned, but the actual treatment is determined 
by a chance process and cannot be predicted (Altman et al., 2001). It 
should be determined by someone independent to the trial, ideally a 
statistician, using a computer-generated random sequence or random-
number tables. 
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The size of the current study meant that simple randomisation was 
likely to produce imbalances in numbers between the two treatment 
groups. We therefore opted for restricted randomisation in the form of 
random permuted blocks of randomly varying size. This would ensure a 
good balance of numbers, even if the trial was to be stopped early or 
went on to recruit larger numbers than first anticipated. Furthermore, it 
made it impossible for anyone in the team to predict what treatment 
was coming up next in any particular block. 
:H DOVR KDG WR GHDO ZLWK WKH ³VXUJLFDO´ DVSHFW RI RXU VWXG\ ,W LV D
known fact that varying levels of experience of a surgeon, as well as 
conscious or unconscious preference of a particular technique, are 
sources of bias in surgical RCTs (Lilford, 2004, McCulloch et al., 2002). 
It is not possible to completely eliminate this in a surgical trial. The bias 
is larger with smaller numbers of surgeons in a study, even more so in 
a single-surgeon trial. Conversely, the more surgeons involved, the 
larger the likely variation in technique. 
We decided to address this, as well as practical issues to do with 
resources, through the inclusion of six surgeons, experienced in both 
treatment techniques. In order to ensure each individual performed a 
balanced number of both treatment methods (thus addressing surgeon 
bias) each participating surgeon had their own series. The 
UDQGRPLVDWLRQLV³VWUDWLILHGE\VXUJHRQ´ 
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To ensure indisputable pre-allocation concealment and avoid selection 
bias, we use a computer generated random code, created by the 
Nottingham Clinical Trials Support Unit (CTSU) and held on a secure 
server. Access to the sequence was confined to the CTSU Data 
Manager. The trial coordinator accessed the treatment allocation for 
each participant by means of a remote, internet-based randomisation 
system, which was developed and maintained by the CTSU. 
2.4.4.5 Sample size calculation 
In order to determine appropriate sample size the following must be 
considered: 
x Whether treatment groups are to be of equal size 
x The primary outcome measure and its form  
x What are the values of the primary endpoint in previous studies of 
standard treatment?  
x The standard deviation (SD) of these measurements.  
x How large a difference in treatment outcome is considered 
clinically important? 
x What is the acceptable Type I error rate (a)? 
x :KDWLVWKHDFFHSWDEOH7\SH,,HUURUUDWHǃ" 
x The rate of potential drop outs 
The above information is entered into a mathematical equation or 
statistical software. 
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One of the most difficult tasks in the current study was identifying 
published outcome data for the primary outcome measure (PEM) at one 
year. Given that studies of distal radius fractures have only recently 
employed validated functional outcome measures such as the PEM or 
DASH, and these are almost exclusively studies of plates, such data for 
the conventional treatment of wires +/- ex-fix was not readily available 
at the onset of the current study in 2008. In addition, many studies 
failed to give the standard deviation or standard error of their means 
and had variable follow-up lengths. 
Data was identified from a historical cohort of distal radial fractures 
examined in 2001, on average 3-9 years following distal radial fracture. 
This cohort received what was considered standard treatment (including 
manipulation, wiring, external fixator and plating) between 1989 and 
1996. The cohort originated from the same geographic area as the 
current study sample (Forward et al., 2007). 
These data were selected as a reference for our sample size calculation, 
as the patient group was deemed the most relevant and comparable. In 
terms of management, patients had what was considered conventional 
treatment of their wrist fracture at the time. They were of similar level 
of function as the patients we aimed to recruit. In addition, they were 
treated in the same institution, in some cases by the same surgical 
teams. 
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The PEM does not have a published minimally clinical important 
difference (MCID). An arbitrary 10% difference was used. This 
represents a minimum one point drop in score in each of the 10 items 
comprising the score.  
It is also important to consider that the number of patients required for 
a clinical trial (sample size) refers to the number of patients who finish 
a trial rather than the number that enter. The expected drop out rate 
was considered at the recruitment stage. A frequently quoted estimate 
is 10%, but in some studies of certain conditions this can be higher. 
One would expect a higher dropout rate when treating trauma, such as 
distal radius fracture, which is acute and the result of opportunistic 
exposure. Patients typically fail to return for long term follow-up if they 
have good results aQG FRQVLGHU WKHPVHOYHV ³FXUHG´ A proportion of 
patients may be young, otherwise fit and more likely to be 
geographically mobile, making them difficult to track. We therefore 
assumed a maximum loss to follow-up of 20%, adjusting our sample 
size upwards accordingly.  
The size of a trial is determined by the power needed to detect a 
difference in the primary endpoint. Calculating sample size on the basis 
of a single primary outcome measure is a well-established method 
which features in most surgical RCT publications. However, it does not 
guarantee that secondary outcome measures will not be underpowered, 
nor does it take into account loss of significance due to multiple testing. 
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The Bonferroni correction (Altman, 1999) was used to adjust the study 
sample size for multiple comparisons. This involved dividing the alpha 
level by the number of tested hypotheses. This gave an adjusted alpha 
value of 0.01 for the five main outcome categories: function, grip 
strength, range of movement, quality of life and quality of radiographic 
reduction.   
STATA® VRIWZDUHDQGWKH³VDPSVL´FRPPDQGwere used for a two 
sample test. PRZHU ǃ was set at 80%, as this is the level 
recommended by Cohen  and it is the most common for non-critical 
studies (Cohen, 1988). Higher power of 90% is used predominately for 
critical studies with life-or-death outcomes. We set our alpha at an 
original 0.05, which was dropped to 0.01 following Bonferroni 
correction.  
A sample size calculation for a two-sample comparison of the means 
was performed, based on the following: 
Primary outcome measure:  PEM 
Test Ho:  m1 = m2, where m1 is the mean in 
population 1 and m2 is the mean in population 
2 
Assumptions: 
Minimum clinically important difference in PEM score: 10% 
Standard deviation is the same in both groups 
 87 
 
Alpha = 0.01 (two-sided) 
Power = 0.8000 
m1 = 21 
m2 =31  
sd1 = 15 
sd2 = 15 
n2/n1 = 1.00 
Estimated required sample sizes 
n1 = 53 
n2 = 53 
Assuming a maximum loss to follow-up of 20% (22 patients), the total 
sample size to reach significance in this study would be 106+22= 128 
patients. 
2.4.4.6 Statistical methods 
STATA® 10.0 software was used. The characteristics of the groups were 
compared with use of the Pearson chi-square test for categorical 
variables and the Student t-test for continuous variables. For non-
parametric data we used the Mann-Whitney test.  
It is now recognised that post-hoc subgroup analysis in the form of 
significance testing should not be reported (Oxman and Guyatt, 1992, 
Pocock et al., 1987, Rothwell, 2005b). This is because rates of false 
positive and false negative results are extremely high. The accepted 
analysis is not the significance of the treatment effect in one group or 
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the other, but whether the effect differed significantly between the 
subgroups ± the test of subgroup-treatment effect interaction (Rothwell, 
2005b). This test can be applied to continuous data, such as age. In the 
current study, to answer the question whether the treatments behaved 
differently in patients of differing age, a two-way ANOVA test with effect 
modification was used in order to examine treatment interaction effect 
for age. 
The overall level of significance for the study was set at p<0.01. 
2.5 Methods: Economic Evaluation   
2.5.1 Derivation of costs   
To calculate the cost of interventions comprising the two arms of the 
randomised controlled trial, resource use was modelled and translated 
into monetary values using unit resource costs. All costs were 
expressed in UK pounds sterling (£). The base year for all cost figures 
was 2011/12. 
In economic evaluation, the choice of perspective influences the range 
of costs to be identified, measured and valued (Brazier, 2007). The 
cost-utility study was performed from the perspective of the NHS. 
Therefore, direct healthcare costs were identified and estimated 
including implants, consumables, labour costs, investigations, pharmacy 
supplies and hospital resources. The sources of unit cost figures used to 
convert resource usage into costs are detailed in Table 2.4. 
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No protocol driven costs were incurred during the RCT. None of the 
costs incurred in the randomised control trial were associated with the 
trial per se rather than the costs of providing healthcare.   
This analysis considered the trial period of 12 months follow-up. As the 
analysis used a one year time horizon over which cost and benefits 
were incurred, discounting was not required (Drummond, 2005). 
According to NICE guidance, value added tax (VAT) should be excluded 
from all economic evaluations, but included in budget impact calculation 
when the resources in question all liable for this tax (NICE, 2008). Our 
costs are therefore exclusive of VAT. 
Economists have generally advocated the mean average as the 
theoretically correct way to aggregate individual values, irrespective of 
WKHQDWXUHRIWKHGLVWULEXWLRQ7KLVLVEHFDXVHWKHPHDQUHIOHFWVSHRSOH¶V
intensity of preference and addresses whether the total benefit of those 
who gain are greater than the total benefits of those who lose form a 
policy change (Brazier, 2007). However, if you look at the issue from 
the public policy point of view, the median value seems to be a fairer 
choice as WKH PHGLDQ WUHDWV HDFK SHUVRQ¶V YDOXDWLRQ as equal in the 
voting context. 
When calculating cost in a randomised controlled trial, the distribution is 
rarely normal. This is because: 
x cost cannot be negative 
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x there is often a fraction of study participants that require more 
medical services than the norm 
x there is usually a small number of participants among whom a 
catastrophic event occurs that is several standard deviations 
above the mean 
As a result, cost distribution is usually right skewed with a long right 
tail, with a median smaller than the arithmetic mean. Though the 
median may be useful in describing the data, it does not provide 
information about the total cost that will be incurred by treating all 
patients, nor the amount saved by treating with one therapy versus 
another. For this reason Glick concludes that the arithmetic mean and 
the difference in the means of the treatments are the measures we 
should use for cost-effectiveness analysis in clinical trials (Glick, 2007). 
NICE guidelines to the methods of technology appraisals also state that, 
for continuous variables, mean (rather than median) values are used in 
the analysis (NICE, 2008). 
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Table 2.4 Cost data sources 
Cost categories  Source  
Implants and hardware  Manufacturer public list  
Consumables  
(dressings, casting materials, splints and slings) 
NHS Supply Chain National 
Catalogue 2011 
Pharmacy items and medication  British National Formulary 2011 
NHS staff costs  
Unit Costs of Health and Social 
Care 2011 
Local resource hospital costs  
(theatre, ward cost and investigations) 
Finance Department Nottingham 
University Hospitals NHS Trust 
(NUH) 
GP practice and A&E attendance 
costs 
Unit Costs of Health and Social 
Care 2011 
Productivity costs 
Office of National Statistics (ONS) 
Bulletin Annual Survey of Hours 
and Earnings 2011 
HRG4 Tariffs 
NHS Payment by Results 2010-
2011  
National Tariff Information  
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2.5.1.1 Consumables 
According to NICE guidance (NICE, 2008), costs should relate to 
resources that are under the control of the NHS and these resources 
should be valued using prices relevant to the NHS. When the acquisition 
price paid for a resource differs from the public list price (for example, 
pharmaceuticals and medical devices sold at reduced prices to NHS 
institutions), the public list price should be used. The exception to this 
are prices of consumables supplied via the NHS Purchasing and Supply 
Agency (PASA), in which case the reduced prices are transparent and 
can be consistently available across the NHS. In the absence of a 
published list price and price agreed by a national institution, the price 
submitted by the manufacturer may be used, provided that it is 
nationally and publicly available. 
In the current study, the cost of consumables was calculated based on 
prices supplied by the NHS Purchasing and Supply Agency (PASA) 
(Appendix 6.5) and public list price for those items not available in the 
NHS supply chain catalogue. For the price of the implants, we contacted 
the manufacturers directly and were provided with the list price, 
excluding all hospital discounts.  Net prices of drugs were sourced from 
the 2011 BNF (BNF, 2011) (Appendix 6.6). 
Biomet UK Healthcare Limited, the company which at the time of the 
trial marketed and supplied the DVR® implant, provided legal permission 
for use of the price data provided by them for economic evaluation 
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purposes, provided that the following footnote was expressly contained 
in the evaluation paper as follows: ³7KH SULFHV TXRWHG IRU WKH%LRPHW
DVR trauma plate and accessories are an indicative price only and may 
YDU\ GHSHQGLQJ RQ D KRVSLWDO¶V XVDJH´ ,Q DGGLWLRQ, the principal 
investigator would have to provide Biomet with a copy of the evaluation 
paper after submission, to show compliance with this condition. 
Synthes, the company which markets the K-wire and external fixator 
implants, provided implant cost data without requiring a signed 
permission letter. 
When undertaking economic evaluation, it is important to ensure 
transparency from the onset and the agreement of all parties 
concerned. This is especially important when aspects of pricing may be 
confidential and could vary between institutions. Lack of relevant 
permissions could preclude publication. 
2.5.1.2 Costing of re-usable external fixator components  
Costing of reusable components, such as the external fixator clamps 
and bars, is controversial. These devices are very expensive. The 
rationale used in this study is outlined below.   
In the United States, external fixators are sold as single use devices. 
This creates liability issues with re-use. If not licensed as a re-usable 
component, the liability for failure of such a device lies with the doctor 
who applied it. As the use of external fixators in trauma grew, hospitals 
sought to rationalise their costs and a profitable new industry of 
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reprocessing components flourished. The Food and Drug Administration 
Agency responded by introducing regulations for third party processors 
and hospitals (Sikka et al., 2005). They defined the term ³UHSURFHVVHG
VLQJOHXVHGHYLFH´DV³DQRULJLQDOGHYLFHWKDWKDVEHHQSUHYLRXVO\XVHG
on a patient and has been subjected to additional reprocessing and 
PDQXIDFWXULQJIRUWKHSXUSRVHRIDQDGGLWLRQDOVLQJOHXVHRQDSDWLHQW´
(2006). The regulations required re-processors to comply with a set of 
approved processes for the non-implantable components known as the 
510(k) pathway, and an industry worth 1.4 billion dollars in 2003 (Sung 
et al., 2008) with huge potential for growth was born.  Such 
refurbishment programmes can, on average, reduce the cost of non-
implantable external fixator devices by 25% (Dirschl and Smith, 1998, 
Horwitz et al., 2007, Dirschl, 2006). 
In the UK, many companies also market non implantable external-
fixator and circular frame components as single use. This would make 
the use of these devices in the NHS impracticable. Hospitals and 
departments can - and do- get around this problem through local risk 
assessment processes. 
Synthes, the company which manufactures the fixators used in this 
study, is a notable exception, licensing non implantable components as 
re-usable. However, they offer no specific recommendations regarding 
how many times and/or by what standards components can be safely 
re-used. 
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The evidence on the subject of safety is scarce and originates from the 
American literature. Although not all external fixator brands have been 
tested, available biomechanical data suggest that many external 
IL[DWRUV DUH ³RYHU-HQJLQHHUHG´ (Dirschl, 2006) and can withstand at 
least 3 clinical uses (Horwitz et al., 2007), without compromise of their 
ability to stabilise. 
While a cost reduction of 25% via the reprocessing industry is 
achievable in the American market, the current study is aimed at a UK 
audience, where such reprocessing facilities do not exist. In the current 
study, our approach was based on the biomechanical published data 
suggesting a minimum of three safe uses of each component. In 
practice records of use are not kept and most components are likely re-
used many more than three times, until they fail or exhibit significant 
macroscopic wear. This was considered a rational approach. It was a 
generous estimate of price, however, in practice, would also cover the 
cost of any lost components.  
2.5.1.3 Costing of resource use 
According to the NICE guide to the methods of technology appraisal 
(NICE, 2008), national data based on Healthcare Resource Groups 
(HRG), such as the Payment by Results tariff, are a valuable source of 
information and should be considered for use when they are appropriate 
and available. However, data based on HRGs may not be appropriate in 
all circumstances, for example, when the definition of the HRG is broad 
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or the mean cost probably does not reflect resource use in relation to 
the technology under appraisal. This was the case in the current study, 
where the HRG code for inpatient operative treatment of an isolated 
distal radius fracture in an uncomplicated patient is identical for the two 
arms of the trial. As a result, it does not allow for differential costing. 
Consequently, a micro-costing study of the trial treatment pathway was 
performed, YLDDGHWDLOHGµERWWRP-XS¶DSSURDFK 
Nevertheless, in the costing of complications requiring formal surgical 
intervention (such as carpal tunnel decompression, removal of 
metalwork in theatre and extensor pollicis longus reconstruction), 
certain HRG codes were used. These events were rare and data for 
micro-costing in this setting were not readily available. Market Force 
Factor Index adjustments were not applied to any HRG code. 
In costing fracture clinic appointments, a combination approach was 
used. When an outpatient fracture clinic appointment involved no 
procedure, the HRG codes "WF01B First Attendance - Single 
Professional (£)" and "WF01A Follow Up Attendance - Single 
Professional (£)" were used (Table 2.5). A fracture clinic appointment 
differs from a standard hospital consultation, in that it is fast-paced and 
involves input from a great number of personnel of differing grades and 
professions, as well as periods of waiting, which are variable and 
extremely difficult to track. Therefore the standard HRG codes were 
considered to be the best approximation of this cost, including 
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overheads. However, when a procedure was performed during the 
course of fracture clinic appointment (either in the treatment or plaster 
URRPWKH+5*FRGHXVHGIRU³RXWSDWLHQWSURFHGXUHV´was felt to be too 
broad and did not reflect the differences in aftercare of the technologies 
under review. For example, the cost of a wound check for the plate 
group is not expected to be the same as a K-wire wound check for the 
control group, the later requiring the additional removal and then re-
application of a plaster cast. As a result, the cost of individual 
SURFHGXUHV ZDV FDOFXODWHG YLD D GHWDLOHG µERWWRP-XS¶ PLFUR-costing 
technique, in an attempt to accurately reflect the two differing 
treatment pathways and minimise bias. The cost of the outpatient 
procedure was then added to the standard appointment cost. 
In terms of physiotherapy input, all patients in the study had three 
physiotherapy contacts as part of the protocol: post-operatively whilst 
an inpatient, at the two week wound check and at the 6 week 
outpatient appointment. Any further physiotherapy input was classed as 
³H[WUD´ DQG FRVW  D ILJXUH SURYLGHG E\ WKH SK\VLRWKHUDS\
department which reflected what the department charged the 
commissioning body per appointment contact. 
 
  
 98 
 
Table 2.5 Payment by Results tariffs used  (DOH, 2010) 
HRG name   Code Tariff (£) 
Outpatient Attendance Trauma and Orthopaedics 
Consultant-led 
First Attendance - Single 
Professional  
WF01B 143 
Follow Up Attendance - 
Single Professional 
WF01A 86 
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2.5.1.4 Tracking inpatient and outpatient resource use  
Data regarding inpatient length of stay and any readmission were 
collected prospectively. 
Data on operative times were obtained via the ORMIS theatre 
management system. ORMIS is the name of the Operating Room 
Management Information System supplied by EHR software vendor 
iSoft, used in the study institution. 
Data on outpatient resource usage (fracture clinic, accident and 
emergency attendances relating to the treatment of the wrist fracture) 
were collected prospectively via review of the electronic patient health 
record on hospital attendances (PAS). All plaster room attendances at 
the study institution, as well as the reason for attendance and the 
intervention performed, are manually recorded in the plaster room log. 
Data on outpatient physiotherapy attendance was collected via review 
of the electronic patient records and physiotherapy notes. 
This data was validated by confirming attendances with the patient. 
Patients were also asked to report their time to return to work, if they 
worked, and the time to return to driving, if they drove. 
Data on complications, the management of such and the outcome were 
collected prospectively on the database, which was updated at each 
clinic attendance. 
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2.5.1.5 Health personnel labour costs 
Health personnel labour costs were derived from national estimates 
which include salaries, insurance and pension contributions, labour 
related hospital overheads and capital development costs. Hourly costs 
for nursing time were based on patient contact time. Hourly rates for 
junior medical staff were based on a 48 hour week. Rates for 
consultants were calculated per contract hour (Curtis, 2011). 
2.5.1.6 Overheads 
Overhead costs were calculated based on adding 20% to direct costs, as 
advised by the financial directorate of the host Trust. This percentage 
has previously been published in economic evaluations from the same 
trust (Whynes et al., 2012) and it follows closely the proportion of 
expenditure devoted to areas other than personnel, clinical services and 
supplies in our own hospital (NUH, 2010). 
2.5.1.7 Productivity loss 
The rehabilitation days off work were calculated for each patient in 
gainful employment at the time of their injury.  In valuing production 
gains and losses, the issue of what to include or exclude has been a 
source of debate, particularly when the role of the government is 
included.  The most common means of valuation, and the means 
adopted in this study, is the human capital approach. According to this, 
the output lost if an individual is unable to work is generally estimated 
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E\ XVLQJ WKH LQGLYLGXDO¶V JURVV HDUQLQJV 7KH XQGHUO\LQJ MXVWLILFDWLRQ
assumes that employers go on hiring labour until the value of the 
marginal contribution to output by an additional worker is just matched 
by the cost of employing them (Fox-Rushby and Cairns, 2009). 
Labour costs were sourced from the Office of National Statistics 2011 
Bulletin Annual Survey of Hours and Earnings (ONS, 2011). Our 
randomisation groups were balanced for age, sex, and employment 
category. Therefore, for the calculation of labour costs, we used the 
figure of £400 per week representing median gross earning for all 
employee jobs in the United Kingdom, regardless of age, sex, and 
employment type (ONS, 2011)  
Whether production gains should be used or not is controversial. One 
implication of taking them into account when informing health policy is 
that more productive groups could tend to be given more priority over 
less productive groups. The treatment of diseases which have a more 
marked impact on those of working age could receive more resources 
than those affecting the elderly. It has been argued that to the extent 
that these production gains result in increased private consumption 
rather than a contribution to the rest of society, they are of less 
significance (Fox-Rushby and Cairns, 2009). 
It should be considered that not every person works, and of those who 
do, only part of their time is spent at work. It remains very difficult to 
measure time devoWHG WRZKDW LV WHUPHG µQRQ-PDUNHW DFWLYLWLHV¶  7KH
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standard approach is to use diary cards or interviews. The resources to 
do this were not available in this study. It is also likely that the 
compliance rate would be low due to the acute nature of the injury and 
the length of the study. Furthermore, it is generally proposed that 
changes in leisure time should be reflected in quality of life 
measurements, rather than measured in monetary terms (Drummond 
and McGuire, 2001). 
)LQDOO\ D YDOXDWLRQ RI FDUHU¶V WLPH was not required, as the study 
population was selected to include active individuals with no significant 
medical co-PRUELGLWLHV:KLOHUHVWULFWLRQRIWKHXVHRIRQH¶VXSSHUOLPE
does impair self-care to a degree and impedes driving, the participants 
did not require formal care input as would be supplied by Personal 
Social Services.  Informal care giving can only be estimated by the use 
of diary cards or interviews, resources not at the disposal of the study. 
2.5.1.8 Cost of complications 
Complications which required medical intervention and could be 
converted to NHS monetary and/or productivity costs, were itemised. 
Self-resolving complications, requiring no additional follow-up 
appointments and no intervention were not included as part of the 
costing exercise. The indirect cost of these complications, if any, was 
reflected via the condition-specific and HRQL scores.  
Complications which were treated on an outpatient basis were costed 
via a micro-costing approach detailed in Appendix 6.7. Selected HRG 
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codes were used to cost complications which required formal surgical 
intervention, such as carpal tunnel decompression, removal of 
metalwork in theatre and extensor pollicis longus reconstruction. These 
events were rare and data for micro-costing in this setting were not 
readily available. 
2.5.2 Health related quality of life outcome measures 
The EuroQol health related-quality of life instrument (EuroQol, 1990) 
was used to quantify the effects of the compared technologies on HRQL.  
The EQ-5D-3L version of the EQ-5D questionnaire was used. It has five 
domains, mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. Each domain is defined by three levels of function 
from good to poor. The three levels for each of the five domains can be 
used to define 243 (35) health states (Glick, 2007). 
Responses were obtained directly from participants at baseline, 6 
weeks, 12 weeks and 12 months.  
The EQ-5D a widely used, standardised generic instrument, validated in 
many different patient populations (Brazier, 2008) and the preferred 
measure of health related utility used by NICE, in order to ensure 
consistency across their appraisals. The valuation of changes in HRQL 
reported by patients should be based on public preferences elicited 
using a choice-based method (the time trade-off method) (NICE, 2008). 
A set of preference values elicited from a large UK population study 
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using the time trade-off method is available for the EQ-5D classification 
system (Dolan, 1997). The Standard Gamble and the Visual Analogue 
Scale (VAS) approach were also presented. 
The standard tariff values (Dolan, 1997) were applied to responses at 
each time point to provide EQ-5D-3L quality of life values. QALYs were 
FDOFXODWHGDVDQµDUHDXQGHUWKHFXUYH¶YLDDVXLWDEOHDOJRULWKP 
In addition to the EQ-5D, the SF-6D health state index was calculated. 
This was derived from the SF-12 Health Survey, a 12-item short form 
self-administered health survey which measures functional health and 
well-EHLQJ IURP WKH SDWLHQW¶V SRLQW RI YLHZ (Ware, 2007). The SF-12 
was obtained via QualityMetric, who hold the licence for its use, for a 
charge. The SF-6D algorithms were provided by the University of 
Sheffield Health Economics and Decision Science Unit, free of charge for 
the purposes of the study. 
The SF-12 generates eight dimension scores and two summary scores 
for each of physical and mental health. Whilst such scores provide an 
excellent means for judging the effectiveness of health care 
interventions, they cannot be applied directly in economic evaluation 
because they are not based on preferences. The SF-6D comes with a set 
of preference weights obtained from a sample of the general population 
using the valuation technique of standard gamble. The SF-6D provides a 
means for using SF-12 data in economic evaluation by estimating a 
preference-based single index measure for health from these data using 
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general population values, allowing us to obtain quality adjusted life 
years (QALYs) for use in the cost utility analysis. This technique is 
described by Brazier et al. (Brazier et al., 2002).  
Validation of EQ-5D scores 
In order to demonstrate that the study sample was also a good 
representation of the population as a whole, each participant was asked 
to complete the Quality of Life scores at the point of recruitment, as if 
they had not just injured their wrist. These measurements were collated 
with the purpose of acting as a baseline to which patients return when 
they have fully recovered from their injury. Given the potential of some 
bias due to recall (the period of recall was typically less than a week), 
compounded by the distress of just having sustained a painful injury, 
the measurements were validated. This was achieved by comparison 
with published population norms, which also served to confirm that the 
study sample was representative of the general population. 
The EQ-5D recruitment TTO index and health state scores were 
compared with UK population norms published by the University of York 
Centre for Health Economics (Kind et al., 1999), after a survey of 3395 
individuals selected using a strategy designed to generate a sample 
representative of the general population with respect to age, gender 
and social class. The survey collected data on health state evaluations 
using a time-trade-off procedure and reports on the TTO index and VAS 
health state scores in the form of tables providing population norms and 
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standard deviation. There are many ways of classifying the data. The 
current study participants were matched to their respective population 
norms by age/sex and standard region (East Midlands). 
The comparisons were made using the methodology described in the 
discussion paper by Kind et al (Kind et al., 1999). Individual scores 
were compared to the group means presented in the tables by 
transforming the individual score to a z score (or standard score) which 
indicates where the score stands in relation to all other scores. A z score 
is a measure of how many standard deviations an individual score is 
from the mean of the distribution. The formula for calculating a z score 
is as follows: 
ݖ ൌ  െ Ɋɐ  
X = the individual score to be transformed 
ǋ SRSXODWLRQPHDQ 
ı SRSXODWLRQVWDQGDUGGHYLDWLRQ 
A z score of ±2 is considered to be an extremely high or low score.  
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2.5.3 Analysis  
2.5.3.1 Base-case analysis 
Cost-effectiveness derives from the analysis of economic efficiency, 
where one alternative is preferred to another if it provides greater 
benefit at the same or lower cost, or lower cost for the same or greater 
benefit (Parkin, 2009).  
In order to allow direct comparisons, an incremental cost-effectiveness 
ratio (ICER) was introduced between the intervention under 
investigation (volar locking plate) and the alternative (percutaneous 
methods of fixation) in the form of:  
           Cost of new intervention ± Cost of old intervention   
     Outcome of new intervention ± Outcome of old intervention 
or 
ICER =  
The ICER shows the cost of obtaining a unit of benefit. For the cost-
utility analysis, benefit was expressed in QALYs.   
The concept of the cost-effectiveness plane, including how it relates to 
the ICER of a new intervention and the NICE cost-effectiveness 
threshold are detailed in Appendix 6.8.  
  Cost A ± Cost B 
Effect A ± Effect B 
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When the acquisition price paid for a resource differs from the public list 
price (for example, pharmaceuticals and medical devices sold at 
reduced prices to NHS institutions), the public list price should be used 
in the reference or base-case analysis. In the absence of a published list 
price and price agreed by a national institution, the price submitted by 
the manufacturer may be used, provided that it is nationally and 
publicly available (NICE, 2008). 
The base-case scenario was constructed using public list price provided 
by the manufacturers of all implants used, with no hospital discounts 
applied. This price was sought directly from the companies involved for 
express use in the study. For re-usable implant components, as no 
formal guidelines exist, we calculated cost based on three safe uses of 
components, an approach based on published biomechanical data and 
detailed previously. 
2.5.3.2 One-way sensitivity analysis 
There are large uncertainties regarding much of the information 
required in order to estimate ICERs. These may pertain to the 
methodology, the data collected, the assumptions made and /or the 
generalisability of the results (Briggs, 2000b). In response to these 
uncertainties, economic evaluation must include some form of 
sensitivity analysis (NICE, 2008). 
 109 
 
Sensitivity analysis is a set of techniques that analyse how sensitive the 
results are to changes in the model, for example in the data that are 
contained within it or the way that the data are combined.  
One-way or univariate sensitivity analysis involves examining the 
impact on the ICER of changing one parameter at a time. After 
calculating the base-case scenario, the ICER is re-calculated holding all 
parameters constant, apart from the parameter selected to vary over a 
specified and justified range. NICE requires the uncertainly around the 
appropriate selection of data sources to be dealt with through sensitivity 
analysis. In particular, guidelines specify it should be performed when 
there is variability between hospitals in the acquisition price of a 
technology (NICE, 2008). 
In the current study, we performed one-way sensitivity analysis based 
on possible differing costs of the volar locking plate construct. The base-
case analysis used public list price for all implants, as per NICE 
guidance. The one-way sensitivity analysis included a 20% hospital 
discount.   
Most, if not, all hospitals receive discounts on implants and other 
consumables, which are usually volume-based and vary depending on 
the particulars of a contract. The discounts are confidential and are not 
disclosed. Subsequently, the cost of implants will vary in different 
environments. 20% was chosen as a representative discount for a large 
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volume hospital environment, which is an indicative figure. It is not 
meant to represent the discount given to the host trust. 
Threshold analysis allows us to determine the price range for the volar 
locking plate and its accessories, which would result in the technology 
becoming potentially cost effective. 
2.5.3.3 Probabilistic sensitivity analysis 
Simple sensitivity analysis deals predominately with issues of construct, 
such as the accuracy of the model selected and decisions around the 
origin of values for the key resources like cost and utilities. Probabilistic 
sensitivity analysis addresses the uncertainty arising from parameter 
imprecision, once the most appropriate sources of information have 
been identified. This reflects the uncertainty around mean health and 
cost values used in the calculation of the ICER. 
NICE states in their Guidance for technology appraisal (NICE, 2008). 
³All inputs used in the analysis will be estimated with a degree of 
imprecision. Probabilistic sensitivity analysis is preferred for translating 
the imprecision in all input variables into a measure of decision 
uncertainty in the cost effectiveness of the options bHLQJFRPSDUHG´ 
This translates to the need to present confidence intervals for the ICER. 
The mathematics used to generate confidence intervals when non-linear 
distributions are involved are extremely complicated. The statistical 
methodology was based on the use of non-parametric boot-strap. Boot-
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strap methods are founded on the generation of multiple replications of 
the parameter of interest, by sampling with replacement from the 
original data (Glick, 2007). 
Monte Carlo simulation was used to produce the cost±effectiveness 
plane and cost-effectiveness acceptability curve (CEAC). The statistical 
technique of calculating ICERs by simulation, including the generation 
and interpretation of the cost-effectiveness plane and CEAC are detailed 
in Appendix 6.9. 
2.5.3.4 Comparison of EQ-5D TTO and SF-6D 
As the SF-6D describes 18,000 health states, as opposed to 243 for the 
EQ-5D, and has a summary score specifically for physical health, we 
sought to investigate if the SF-6D could be a more responsive 
instrument, with the possibility of being better able to discriminate 
between small, particularly marginal, changes in randomised trials (Fox-
Rushby and Cairns, 2009). The responsiveness of the EQ-5D and the 
SF-6D were assessed by use of effect size (ES) and the standardised 
response mean (SRM) (Kazis et al., 1989).  
2.5.3.5 General statistical methods 
Data were stored in Microsoft Access, coded in Excel, Windows 2000 
(Microsoft Corp., Redmond, Washington, USA) and analysed using SPSS 
(IBM, Armonk, USA) and STATA version 10.1 software (StataCorp LP, 
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College Station, Texas, USA). Risk 4.5 software (Palisade, Ithaca, USA) 
was used for the probabilistic analysis. 
The characteristics of the groups were compared with use of the 
Pearson chi-square test for categorical variables and the Student t-test 
for continuous variables. For non-parametric data we used the Mann-
Whitney test. The level of significance was set at p<0.01. 
Cost distributions and utility distributions were summarised by their 
mean, confidence intervals and standard deviation. All confidence 
intervals reported are at 95 per cent. Evidence suggests that it is the 
arithmetic mean cost that is most useful to NHS decision makers 
(Thompson and Barber, 2000). 
All outcomes were analysed according to intention-to-treat principles, 
whereby patients are analysed in the group they were initially assigned.  
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Chapter 3 ± Results 
 
3.1 Participant flow 
Between February 2008 and August 2009, 180 patients were referred to 
the research team and assessed for eligibility. Twenty-nine of these did 
not meet the inclusion criteria and 16 refused to participate. Thus 135 
patients, aged 18 to 73 years met the inclusion criteria and were 
randomised to either Group One (open reduction and internal fixation 
using a volar locking plate) or Group Two (conventional treatment 
group consisting of closed reduction with percutaneous Kirschner wire 
fixation with/without external fixation). Eleven patients within the 
percutaneous fixation group required an external fixator for added 
stability (11/64, 17%).  
Five participants were excluded. One patient withdrew from the trial 
after randomisation. In a further four cases, due to sickness and 
unforeseen scheduling issues, the operating surgeon was a not a 
participating trial senior surgeon. This resulted in deviation in the 
surgical device(s) used in one case, the treatment randomisation in two 
others, and the procedure being performed by a registrar in four cases. 
These five patients were therefore not included in the analysis. 
Follow-up was for one year and completed in August 2010. Follow up at 
1 year was 95% (124/130), with four patients lost to follow-up from 
Group One and two patients from Group Two. All outcomes were 
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analysed according to intention-to-treat principals, whereby patients are 
analysed in the group they were initially assigned to via randomisation, 
regardless of the final treatment received. This is demonstrated 
graphically in Figure 3.1. The Consort flow chart (Moher et al.) is 
summarized in Figure 3.2. 
 
Figure 3.1 Diagram demonstrating allocation according to intention-to-
treat principles 
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Figure 3.2 Consort flow chart for Enrolment and Analysis 
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3.2 Missing data 
Absence from follow-up was examined at each time point in the study. 
This is presented in Table 3.1. The total number of data entry points in 
the study was also examined. All missing data was tagged at the point 
of insertion in the data base. This allowed GDWD WKDW ZDV ³PLVVLQJ´
rather than ³QRW DSSOLFDEOH´ WR D SDUWLFXODU SDWLHQW to be readily 
differentiated. The trial clinical database included 29,510 data entry 
points in total (100%). The rates of missing data points pertaining to 
each study time point are presented in Table 3.2. Given that the overall 
data missing at any time point in the study did not exceed 10% of total 
values, multiple imputation was not required. 
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Table 3.1 Participant numbers absent from follow-up at each study 
time point 
 
Volar Locking 
Plate (n) 
Percutaneous 
(n) 
Total per time 
point (n, %) 
6 weeks 3 5 8 (6.2%) 
12 weeks 7 3 10 (7.7%) 
1 year 4 2 6 (4.6%) 
 
 
Table 3.2 Rates of missing data points at each study time point 
 
Missing data 
points (n) 
Total data 
points (N) 
% 
Recruitment 124 4550 2.7 
6 weeks 828 12090 6.9 
12 weeks 977 12090 8.1 
1 year 740 12870 5.8 
Total 2669 41600 6.4 
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3.3 Participant demographics  
The demographic characteristics for the participant groups are 
summarized in Table 3.3. Characteristics of relevance to an economic 
viewpoint are presented in Table 3.4. All calculations on time to work 
and productivity pertain to those patients who were in employment at 
the time of their injury.  
Randomisation groups were balanced for baseline characteristics. In 
addition, there was no difference in the age distribution between 
groups, which is demonstrated graphically in Figure 3.3 (p=0.210).  
Patients with a low energy mechanism of injury were older than those 
with a high energy mechanism (mean age 55, SD 13 versus 42, SD 15, 
p<0.001). 
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Table 3.3 Participant demographic characteristics 
 VLP Group 
Percutaneous 
Group 
Age in years 48 ± 15 51 ± 16 
Gender  
           Women  47 (71%) 50 (78%) 
Men 19 (29%) 14 (22%) 
Dominance  
           Right  61 (92%) 60 (94%) 
Side Injured   
Dominant 32 (49%) 28 (44%) 
Mechanism  
           Low energy  41 (62%) 41 (64%) 
           High energy  25 (38%) 23 (36%) 
Smokers 15 (23%) 15 (23%) 
Regular prescription 
medication 
27 (41%) 25 (39%) 
Low energy = fall from standing height  
High energy = fall from above standing height, sport, road traffic 
accident  
 The values are given as the mean and the standard deviation. 
 
Taking regular prescription medication was used as an indicator of the 
presence or absence of significant past medical history.  
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Table 3.4  Participant employment characteristics 
 VLP Group 
Percutaneous 
Group 
In employment 48 (73%) 35 (55%) 
Self-employed 3 (6%) 2 (6%) 
Occupation category 
     Clerical 24 (36%) 20 (31%) 
     Light manual  13 (20%) 11 (18%) 
     Heavy manual 10 (15%) 4 (6%) 
     Fine skill  1 (1%) 0 
     Retired 11 (17%) 18 (28%) 
     Unemployed  3 (5%) 4 (6%) 
     Homemaker 4 (6%) 7 (11%) 
Drives 40 (61%) 47 (73%) 
Injured at work  5 (8%) 2 (3%) 
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Figure 3.3 Age distribution of participants within the two randomisation 
groups 
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3.4 Clinical results 
3.4.1 Functional and measurable clinical outcomes 
At 6 weeks PEM functional scores were significantly better in the volar 
locking plate group (p<0.001, 95% CI -15.44 to -6.28), but there was 
no significant difference at 12 weeks and 1 year. This was corroborated 
by significant differences in the QuickDASH (p=0.002, 95% CI -19.44 to 
-4.31) and PRWE (p<0.001, 95% CI -26.32 to -9.89) scores at 6 
weeks, but no differences at 12 weeks and 1 year (Table 3.5). There 
was no significant functional treatment effect-interaction between age 
and method of fixation at 6, 12 weeks or 1 year for the PEM (p=0.780, 
p=0.973, p=0.175), Quick DASH (p=0.475, p=0.827, p=0.662) or 
PRWE (p=0.06, p=0.145, p=0.399). 
The mean values for range of motion (ROM) and grip strength, 
expressed as percentage of the ROM and grip strength of the uninjured 
contra-lateral limb are summarized in Table 3.5. Patients in the volar 
locking plate group had greater ROM than the conventional group at 6 
ZHHNV S ZLWK QR GLIIHUHQFH DW  ZHHNV DQG  \HDU *ULS
strength was greater for the plate group at 6 (p<0.001, 95% CI 0.64 to 
1.13), 12 weeks (p=0.002, 95% CI 0.11 to 0.50) and 1 year (p=0.005, 
95% CI 3.4 to 18.30). 
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Table 3.5  Functional and clinical outcomes 
 
Volar 
Locking 
Plate 
Percutaneous P value 
PEM questionnaire 
 6 weeks  34 ± 13 45 ± 12    0.000 * 
 12 weeks 24 ± 11 27 ± 12 0.116 
 1 year   17 ± 9 18 ± 10 0.703 
QuickDASH questionnaire 
 6 weeks   41 ± 21 52 ± 20    0.002 * 
 12 weeks 21 ± 17 27 ± 20 0.069 
 1 year     9 ± 12 12 ± 15 0.313 
PRWE questionnaire 
 6 weeks   43 ± 23 61 ± 22    0.000 * 
 12 weeks 23 ± 19 29 ± 22 0.150 
 1 year   13 ± 14 13 ± 16 0.412 
Grip strength  
(as percentage % of grip strength of uninjured contra lateral limb) 
 6 weeks   40 ± 23 10 ± 12  0.000 * 
 12 weeks 65 ± 26 45 ± 22  0.002 * 
 1 year   95 ± 22 84 ± 19  0.005 * 
Range of movement  
(as percentage % of range of movement of uninjured contra lateral 
limb) 
6 weeks  Flexion 59 ± 18 47 ± 22   0.001 * 
 Extension 57 ± 22 17 ± 30   0.000 * 
 Pronation 80 ± 17 65 ± 28   0.001 * 
 Supination   73 ± 23 37 ± 26   0.000 * 
12 weeks  Flexion 73 ± 19 72 ± 18 0.786 
 Extension 79 ± 17 78 ± 20 0.593 
 Pronation 91 ± 13 91 ± 14 0.971 
 Supination   91 ± 16 89 ± 15 0.394 
1 year  Flexion 88 ± 19 87 ± 16 0.893 
 Extension 93 ± 17 93 ± 18 0.885 
 Pronation 95 ± 8 98 ± 6 0.115 
 Supination   95 ± 10 96 ± 7 0.524 
 
* Statistically significant values.  
 The values are given as the mean and the standard deviation. 
 124 
 
3.4.2 Per protocol analysis  
In the present study, per protocol analysis (PP) of functional and clinical 
outcomes was undertaken, in addition to intention-to-treat analysis. The 
treatment groups compared included only those patients who completed 
the treatment originally allocated. This acted as a sensitivity analysis, 
and enabled the effect of cross-over between the groups to be 
investigated. A total of six participants cross over from their original 
randomisation groups, three each way, as demonstrated by the Consort 
Flow Chart (Figure 3.2). 
The results of the per protocol analysis of clinical and functional 
outcomes are presented in Table 3.6 below.  As demonstrated, the 
results of PP analysis were no different to intention-to-treat analysis.  
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Table 3.6  Functional and clinical results of per protocol analysis 
 
Volar 
Locking Plate 
Percutaneous P value 
PEM questionnaire 
 6 weeks  34 ± 13 46 ± 12    0.000 * 
 12 weeks 24 ± 11 28 ± 13 0.060 
 1 year   17± 9 18 ± 11 0.404 
QuickDASH questionnaire 
 6 weeks   40 ± 20 53 ± 20    0.000 * 
 12 weeks 21 ± 17 28 ± 20 0.036 
 1 year   9 ± 12 12 ± 15 0.180 
PRWE questionnaire 
 6 weeks   42 ± 23 63 ± 22    0.000 * 
 12 weeks 24 ± 19 30 ± 22 0.085 
 1 year   12 ± 14 13 ± 17 0.704 
Grip strength  
(as percentage % of grip strength of uninjured contra lateral limb) 
 6 weeks   42 ± 23 9 ± 12    0.000 * 
 12 weeks 65 ± 26 49 ± 22    0.003 * 
 1 year   95 ± 21 84 ± 19    0.006 * 
Range of movement  
(as percentage % of range of movement of uninjured contra lateral limb) 
6 weeks  Flexion 60 ± 18  46 ± 23    0.000 * 
 Extension 59 ± 21 15 ± 29    0.000 * 
 Pronation 80 ± 17 64 ± 28    0.000 * 
 Supination   76 ± 21 34 ± 24    0.000 * 
12 weeks  Flexion 73 ± 20 73 ± 18 0.838 
 Extension 80 ± 17 78  ± 20 0.567 
 Pronation 91 ± 14 91 ± 14 0.914 
 Supination   92 ± 15 89 ± 15 0.276 
1 year  Flexion 88 ± 19 87 ± 17 0.873 
 Extension 93 ± 17 93 ± 19 0.935 
 Pronation 95 ± 9 97 ± 6 0.161 
 Supination   96 ± 10 96 ± 7 0.713 
 
* Statistically significant values.  
 The values are given as the mean and the standard deviation. 
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3.4.3 Radiographic outcomes 
The radiographic fracture characteristics are presented in Table 3.7. 
Positive values indicate a palmar angulation and negative values 
indicate angulation dorsally beyond neutral.  
The randomisation groups at presentation were comparable in terms of 
fracture characteristics and anatomy of the contra-lateral uninjured 
wrist. Fractures in the study fell into one of three AO classification 
groups (23-A3 extra-articular multi-fragmentary, 23-C2 complete 
articular simple, metaphyseal multi-fragmentary or 23-C3 complete 
articular, multi-fragmentary). The randomisation groups were balanced 
in their distribution of fracture classification groups. 
All fractures united radiographically. Reduction achieved via the fixation 
was expressed as the percentage of radiographic reduction, when 
compared to the contra-lateral normal limb for each patient at 1 year, 
with 100% reduction corresponding to full anatomical alignment.  
The volar locking plate group achieved significantly better restoration of 
palmar tilt (8° versus 2°, p<0.001, 95%CI 4 to 9 at 6 weeks and 3 to 9 
at 1 year). When expressed as percentage reduction, radial height was 
also better restored in the plate group (p=0.004, 95%CI 4 to 23) 
though the difference in absolute values did not reach statistical 
significance. There were no significant differences between the 
radiographic measurements at 6 weeks and 1 year within each 
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treatment group, which demonstrates that there was no significant loss 
of reduction with either treatment after week 6. 
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Table 3.7 Radiographic data and fracture classification 
 
Volar 
Locking 
Plate 
Percutaneous p value 
AO classification 
A3                        27/66 (41%) 28/64 (44%) 
p=0.257 C2                        37/66 (56%) 30/64 (47%) 
C3                        2/66 (3%) 6/64 (9%) 
Injured wrist at presentation 
3DOPDUWLOWÛIURP
neutral)  
-27 ± 10 -25 ± 11 
p=0.373 
Radial height (mm)  4 ± 5 4 ± 4 p=0.508 
Radial inclination (Û 15 ± 8 16 ± 8 p=0.336 
Contra-lateral uninjured wrist  
3DOPDUWLOWÛIURP
neutral)  
12 ± 6 12 ± 5 
p=0.815 
Radial height (mm)  11 ± 2 11 ± 2 p=0.280 
Radial inclination (Û 25 ± 2 25 ± 3 p=0.445 
6 weeks post-operatively 
3DOPDUWLOWÛIURP
neutral)  
8 ± 6 2 ± 8 
  p<0.001* 
Radial height (mm)  10 ± 2 9 ± 3 p=0.010 
Radial inclination (Û 23 ± 4 23 ± 4 p=0.887 
1 year post-operatively  
3DOPDUWLOWÛIURP
neutral)  
8 ± 6 2 ± 10 
  p<0.001* 
Radial height (mm)  10 ± 2 9 ± 3 p=0.029 
Radial inclination (Û 24 ± 4 23 ± 4 p=0.636 
Reduction achieved at 1 year  
(as % of measurements of contra-lateral uninjured limb)    
3DOPDUWLOWÛIURP
neutral)  
71 ± 73 12 ± 86 
  p<0.001* 
Radial height (mm)  96 ± 20 82 ± 31   p=0.004* 
Radial inclination (Û 95 ± 15 89 ± 25 p=0.121 
Significance set at p<0.01 
* Statistically significant values 
 The values are given as the mean and the standard deviation 
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Reliability of radiographic measurements 
Three radiographic variables were compared between 45 sets of 
radiographs. Data were analysed via the Bland-Altman method for 
comparing measurements of continuous variables using limits of 
agreement (Altman, 1999, Bland and Altman, 1986).  
In a Bland-Altman plot, the difference between the two measurements 
per observer is plotted against the mean of the two measurements. The 
lack of agreement can be summarised by calculating the relative bias, 
which is the mean difference (Ņ), and the standard deviation of the 
differences (s). If the observers tend to agree, the differences between 
WKHREVHUYHUV¶REVHUYDWLRQVZLOOEHQHDU]HUR,IRQHREVHUYHULVXVXDOO\
higher or lower than the other by a consistent amount, the relative bias 
(mean of differences) will be different from zero. The standard deviation 
(s) of the differences is the estimate of error. Differences within 
Ņ±1.96s DUH WHUPHG WKH ³ OLPLWV RI DJUHHPHQW´ 3URYLGLQJ
differences within the limits of agreement are not considered clinically 
important, then the observers show acceptable agreement. 
Table 3.8 includes the indicators of reliability of the radiographic 
measurements. Positive values indicate a palmar angulation and 
negative values indicate angulation dorsally beyond neutral. The 
resulting Bland-Altman plots for radial height, radial inclination and 
palmar inclination are shown in Figure 3.4. The patterns of the plots 
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show no obvious relationship between the measurement differences and 
the absolute values.   
 131 
 
Table 3.8 Indicators of reliability 
 Ņ Range  LA  95% tolerance limits 
 (Kreder et al., 1996b) 
Radial height -0.7mm 0mm to 14.6mm -2.4mm to 1.1mm ±10mm 
Radial inclination -0.4° 6° to 30° -3.7° to 2.9° ±11° 
Palmar inclination 0.4° -40° to 19.5° -6.7° to 7.4° ±15° 
Key  
Ņ  mean difference (degrees) 
LA  95% limits of agreement  
Range  range of the observer measurements 
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Figure 3.4 Bland-Altman plots of radiographic parameters 
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3.4.4 Complications 
Complications are summarized in Table 3.9. There were more 
complications in the percutaneous fixation group, but the difference 
was not statistically significant (p=0.047) for the level of 
significance set in this study. The participant complication rate was 
15/66 (23%) for the volar locking plate group and 26/64 (39%) for 
the percutaneous fixation group (p=0.057).  
In the percutaneous fixation group, transient nerve palsies 
consisted of superficial radial nerve palsies. The percutaneous k-
wires became buried in six occasions, requiring removal under local 
anaesthetic on an outpatient basis. One patient, who developed 
carpal tunnel syndrome 3 months following her injury, required 
decompression. One patient suffered an extensor pollicis longus 
(EPL) rupture and proceeded to later reconstruction. This patient 
was randomised to the percutaneous group, but underwent volar 
ORFNLQJ SODWH IL[DWLRQ DW KLV VXUJHRQ¶V GLVFUHWLRQ DIWHU failure to 
achieve an acceptable intra-operative result with K-wires. This 
complication was analysed in the original randomisation group, 
according to intention to treat principles. 
In the volar locking plate group, two plates required removal due 
to malposition. This presented as flexor pollicis longus crepitus in 
one case and restriction of wrist flexion in the second. Both 
recovered fully after removal of the plates. In one patient, it was 
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observed 4 months after the injury that some of the pegs appeared 
intra-articular at the border of the joint, whereas the intra-
operative films showed them to be clearly outside the joint. A CT 
scan was obtained which confirmed that there had been some bone 
collapse and the pegs where prominent in the subchondral bone. 
The patient remained asymptomatic with no restriction and 
declined plate removal. 
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Table 3.9 Complications 
Volar Locking Plate Percutaneous Fixation  
 
N=16 N=27 p=0.047 
Superficial infections 2 Superficial infections 5  
Transient nerve 
palsies 
4 
Transient nerve 
palsies 
10  
Carpal tunnel 
syndrome  
4 
Carpal tunnel 
syndrome  
2  
Plate impingement  2 Buried k-wires   6  
Migration of pegs 
into the joint 
1 EPL rupture  1  
Ulnar styloid pain 2 Ulnar styloid pain 2  
Non-specific wrist 
pain  
1 
Non-specific wrist 
pain  
1  
Further procedures Further procedures  
n=2 n=8 p=0.090 
Removal of plate  2 
Carpal tunnel 
decompression 
1  
EPL reconstruction 1  
Removal of buried k-
wires  
6  
 
N = Number of complications 
EPL = Extensor Pollicis Longus  
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3.5 Economic evaluation results 
3.5.1 Health related quality of life scores  
The health related quality of life (HRQL) scores achieved are 
presented in tabular (Table 3.10) and graphic form (Figure 3.5). 
Table 3.11 summarises comparative statistics at the time points of 
the study. 
There were no significant differences in any parameter of the EQ-
5D or the SF-6D scores from recruitment to one year. All returned 
to baseline quality of life at the end of trial follow-up (Table 3.12a-
b). EQ-5D and SF-6D index scores showed similar patterns of 
recovery. 
Non-parametric distributions are identifiable. Non-parametric 
distributions (and those that cannot be log-transformed into 
parametric distributions), were compared via the Mann Whitney 
test. This is a test of shift in distribution and the confidence 
intervals are not easily calculated. SPSS does not provide 
confidence intervals, though STATA does. The method is based on 
jack-knifed estimates (similar to bootstrapping) and the command 
LV ³FHQGLI´ (Newson, 2002). Confidence intervals produced by this 
method represent the difference in the median and are used to 
summarize or estimate the shift of the distributions. They are 
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derived by a method which is different from the original test and 
are not a measure of significance.  
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Figure 3.5 Quality of Life Scores (EQ-5D and SF-6D) 
 
 
 
KEY 
EQ-5D TTO EQ-5D index score with UK time trade-off weightings 
EQ-5D VAS  EQ-5D index score with UK VAS weightings 
EQ-5D Health State EQ-5D Health state thermometer score 
SF-6D SF-6D   index score 
1 Volar locking plate group 
2 Percutaneous fixation group 
 
  
0.60
0.70
0.80
0.90
Base 6W 3M 1Y
EQ-5D VAS 1
EQ-5D VAS 2
EQ-5D TTO 1
EQ-5D TTO 2
EQ-5D Health State 1
EQ-5D Health State 2
SF-6D 1
SF-6D 2
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Table 3.10 Quality of Life Utility Index Scores (EQ-5D and SF-6D) 
 
Randomisation group N Mean SD 
 
Recr EQ-5D VAS score 
1 63 0.89 0.17 
2 63 0.89 0.18 
 
Recr EQ-5D TTO score 
1 63 0.90 0.20 
2 63 0.89 0.19 
 
Recr EQ-5D Health 
State 
1 62 82.74 18.51 
2 61 84.54 12.98 
 
Recr SF-6D  
1 62 0.82 0.09 
2 61 0.80 0.08 
 
6W EQ-5D VAS Score 
1 64 0.70 0.18 
2 60 0.66 0.19 
 
6W EQ-5D TTO Score 
1 64 0.71 0.22 
2 60 0.66 0.23 
 
6W EQ-5D Health State 
1 64 76.89 16.59 
2 60 75.85 16.98 
 
6W SF-6D 
1 63 0.66 0.13 
2 60 0.63 0.13 
 
3M EQ-5D VAS Score 
1 58 0.79 0.13 
2 61 0.76 0.16 
 
3M EQ-5D TTO Score 
1 58 0.81 0.12 
2 61 0.77 0.18 
 
3M EQ-5D Health State 
1 58 83.76 13.41 
2 59 78.58 19.92 
 
3M SF-6D 
1 58 0.77 0.12 
2 61 0.76 0.11 
 
1Y EQ-5D VAS Score 
1 62 0.87 0.18 
2 60 0.88 0.16 
 
1Y EQ-5D TTO Score 
1 62 0.87 0.20 
2 60 0.89 0.17 
 
1Y EQ-5D Health State 
1 62 85.16 16.57 
2 59 84.49 11.93 
 
1Y SF-6D 
1 62 0.79 0.11 
2 60 0.81 0.09 
Recr = recruitment 
6W = 6 week 
3M = 3 month 
1Y = 1 year
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Table 3.11 Comparative statistics for HRQL measures at data collection time points 
 
Volar Locking 
Plate 
Percutaneous 
Fixation 
 
 
Mean SD Mean SD 
95% CI Sig.  
(2-tailed) Upper Lower 
EQ-5D questionnaire 
6 weeks TTO score 0.71  0.22 0.66  0.23 0.15 0.38 0.04 
 VAS score 0.70 0.18 0.66 0.19 -0.02 0.11 0.19 
 Health State   77  17 76 17 -4.93 7.01 0.73 
12 weeks TTO score 0.81  0.12 0.77  0.18 -0.01 0.17 0.09 
 VAS score 0.79 0.13 0.76 0.16 -0.02 0.09 0.23 
 Health 
State   
84   13 79 20 0 9 0.22 
1 year  772VFRUH 0.87  0.20 0.89  0.16 0 0 0.73 
 9$6VFRUH 0.86 0.18 0.88 0.16 0 0 0.70 
 Health State 85  17 84 12 -4.55 5.89 0.80 
SF-6D utility index  
6 weeks 0.66 0.13 0.63 0.13 -0.02 0.07 0.24 
12 weeks 0.77 0.12 0.76 0.11 -0.03 0.05 0.60 
1 year 0.79 0.11 0.81 0.09 -0.06 0.01 0.19 
Significance set at p<0.01 
1RQ-parametric distributions that could not be log-transformed to parametric. 
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Tables 3.12 a and b Paired sample t-tests comparing recruitment and one year HRQL scores for the two 
treatment groups, demonstrating return to baseline at one year 
a. Volar locking plate group 
Paired samples Mean of diff SD 
95% Confidence Interval Sig.  
(2-tailed) 
 Upper Lower 
1Y EQ-5D VAS - Recr EQ-5D VAS -0.03 0.19 -0.08 0.02 0.30 
1Y EQ-5D TTO - Recr EQ-5D TTO -0.03 0.22 -0.08 0.03 0.36 
1Y EQ-5D HS - Recr EQ-5D HS 2.20 15.94 -1.95 6.36 0.29 
1Y SF-6D - RECR SF-6D -0.03 0.12 -0.06 0.00 0.08 
 
b. Percutaneous fixation group 
Paired samples Mean of diff  SD 
95% Confidence Interval Sig.  
(2-tailed) 
 Upper Lower 
1Y EQ-5D VAS - Recr EQ-5D VAS 0.00 0.18 -0.05 0.04 0.84 
1Y EQ-5D TTO - Recr EQ-5D TTO 0.00 0.17 -0.05 0.04 0.98 
1Y EQ-5D HS - Recr EQ-5D HS -0.16 11.21 -3.16 2.84 0.92 
1Y SF-6D - RECR SF-6D 0.00 0.08 -0.02 0.03 0.72 
Significance set at p<0.01 
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QALY Gain 
A QALY is effectively the area under a curve, when plotting the 
selected HRQL measurements against time. An algorithm was 
created to calculate the QALYs reported by trial participants over 
the time period of the study and, subsequently by comparison, the 
differential QALY gain of volar locking plate fixation over 
conventional percutaneous methods. This is represented 
graphically as the surface area between the two curves or lines in 
Figure 3.6. This is a graphic representation of a more complex 
statistical algorithm which compared a distribution of values rather 
than the mean values between randomisation groups. 
The QALY gain achieved by volar locking plate fixation over 
percutaneous methods in this study was ¨Q = 0.0178 (SE 0.025). 
This represented the denominator of the ICER. The gain was not 
statistically significant (p= 0.47, 95% CI-0.03 to 0.07). 
The results were similar for the EQ-5D VAS and Health State, 
scores, which are not used by NICE to inform cost-effectiveness. 
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Figure 3.6 EQ-5D TTO scores over time for the randomisation 
groups. The surface area between the lines graphically represents 
the QALY gain achieved by volar locking plate fixation over 
percutaneous methods. Note that the y axis represents the top 
range of the TTO scale and so the gain appears magnified. 
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Validation of EQ-5D scores 
All trial patients questioned (126/130, 97%) had TTO recruitment 
index scores ranging from 0.53 to -1 standard deviation (SD) from 
their respective UK population norms, matched for age, sex and 
standard geographic region. There were 4 missing TTO recruitment 
index score values (4/130, 3%). 
The vast majority of patients (115/123, 93.5%) had health state 
recruitment scores ranging from 1.63 to -1.96 SD of their 
respective UK population norm matched for age, sex and standard 
geographic region.  Eight patients (8/123, 6.5%) had a health state 
recruitment score that was >2 or <-2 SD from their respective UK 
population norm. There were 7 missing recruitment health state 
score values (7/130, 5.4%). 
Overall, the study population was comparable to the norm in terms 
of EQ-5D scores, with an average z score of -0.16 for TTO and -
0.14 for health state and no discernable differences in matching 
between the randomisation groups. 
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3.5.2  Costs 
3.5.2.1 Model cost analysis 
A model cost analysis of each intervention from the perspective of 
the NHS was performed, based on individual patient data collected 
prospectively during the trial.  The model, detailed in Table 3.13, 
identifies and lists incremental costs between treatment options. It 
was derived based on the management options: 
x volar locking plate fixation 
x k-wire fixation 
x k-wires with supplemental external fixation 
Resource use was translated into monetary values using unit costs 
as per the methodology described previously. The itemised cost per 
differential intervention is also detailed in Table 3.13. This was 
used to inform the main cost-utility analysis. 
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Table 3.13 Itemised model cost per intervention 
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With reference to Table 3.13, the following should be noted: 
x New and follow-up fracture clinic attendance costs were 
based on the 2010-11 HRG tariffs for Trauma & Orthopaedic 
Outpatient Attendances (Market Forces Factor not applied) 
x Consumable costs were exclusive of VAT, as per NICE 
guidelines (NICE, 2008). 
x Operative time was calculated by subtracting the procedure 
start and end time, as recorded by theatre staff in ORMIS 
and included preparation, draping and the application of 
dressings, splints or plasters. Times reported in this model 
are not intention-to-treat. 
x Different departments have different policies regarding 
disinfectant preparation solutions. We have estimated a 
minimum of one bottle used or discarded over 24 hours and 
average use of 125mls per patient. 
x Consumable and implant prices were list prices. No hospital 
discounts were applied. The capital cost of purchasing 
equipment, such as re-usable operating sets and surgical 
instruments, was included in the non-pay element theatre 
overheads. Theatre Sterile Supply Unit (TSSU) costs were 
included in pay element and non-pay element overheads and 
were considered to be the same for each procedure. 
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x The costs of anaesthetic and resuscitation equipment which 
was not single use, as well as oxygen and other anaesthetic 
gases, were incorporated in overhead costs. 
x Prophylactic antibiotics used were as per hospital protocol 
and are detailed in Appendix 6.6.1. Post op and discharge 
analgesics are also detailed in Appendix 6.6.2. 
x The total cost figures do not include potential complications 
or above-average use of resources. Complication costs are 
presented separately in Appendix 6.7. 
A model cost analysis, such as the one presented in Table 3.13, is 
a pre-requisite to, but separate from the main cost-utility analysis.  
Costing tables are itemised in great detail and consequently busy. 
The aim was to provide the greatest methodological transparency 
and allow reproducible use of the bottom-up costing methodology 
in this study for future economic evaluations.   
3.5.2.2 Incremental treatment costs 
Cost-utility analyses consider the incremental differences between 
two treatment alternatives. Incremental cost becomes the 
numerator of the ICER, which informs cost-effectiveness. In Table 
3.13, the blue boxes highlight incremental costs i.e. costs that can 
differ between treatment interventions. 
Figure 3.7 UHSUHVHQWVDQ³LQFUHPHQWDOFRVWIORZFKDUW´RIDSDWLHQW¶V
journey through the study. When applied to each trial participant, 
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this allowed us to conceptually convert our data to columns in a 
workable excel spreadsheet.  
Table 3.14 itemises the typical cost of a plaster room attendance. 
Tables 3.15 and 3.16 itemise the costs of a dressing change for the 
volar locking plate and a K-wire pin-site check as part of the 
percutaneous arm of the study.  
The number of complications affecting cost per randomisation 
group is listed in Table 3.17. Details of cost per complication are 
presented in Table 3.18. 
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Figure 3.7 Incremental costs flow chart 
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Table 3.14 Costing of plaster room attendance (removal and re-
application of a below elbow cast with simple dressing change for 
k-wire inspection) 
Cost category  Unit Cost (£) 
Staff  
Staff Nurse Band 5 (25 min) 40.50 
Change of dressing  
Dressing pack sterile wound care with 
forceps  
0.28 
20ml water for injection  0.68 
Swab non-woven in 5s sterile  0.03 
Dressing primary knitted polyester 
impregnated with neutral triglycerides 
(n=3) 
0.39 
Application of cast 
Stockinette 7.5 x 40cms 0.09 
Under cast padding synthetic non-sterile 
7.5cm 
0.32 
Non fibreglass casting tape 7.5cm x 3.6m 
White (n=1.5) 
5.97 
Overheads  1.55 
Total 49.81 
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Table 3.15 Costing of dressing changes for the plate group 
Dressing change  plate  Cost (£) 
Staff Nurse Band 5 (15 min) 24.30 
Dressing pack sterile wound care with 
forceps  
0.28 
20ml water for injection  0.68 
Sterile gloves (one pair) 0.60 
Swab non-woven in 5s sterile  0.03 
Dressing paraffin gauze sterile 0.29 
Bandage crepe non-sterile 0.36 
Overheads  0.45 
Total 26.99 
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Table 3.16 Costing of dressing changes, which incorporate a cast 
exchange, for the K-wire patients 
Dressing change  wires  Cost (£) 
Staff Nurse Band 5 (30 min) 48.60 
Dressing pack sterile wound care with 
forceps  
0.28 
20ml water for injection  0.68 
Sterile gloves (one pair) 0.60 
Swab non-woven in 5s sterile  0.03 
Dressing paraffin gauze sterile 0.29 
Dressing primary knitted polyester 
impregnated with neutral triglycerides 
(n=2) 
0.26 
Cast change 
Stockinette 7.5 x 40cms 0.09 
Undercast padding synthetic non-sterile 
7.5cm 
0.32 
Non fibreglass casting tape 7.5cm x 3.6m 
White 9n=1.5) 
5.97 
Overheads  1.70 
Total 58.82 
1 First dressing change at diagnosis, second at review. 
2 Based on an approximate amount; some institutions use other 
skin preparations; Hydrex® is the cheapest. 
3 This is the internal (in-house) charge. External charge to a 
different NHS provider is £11.55  
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Table 3.17 Complications requiring intervention per randomisation 
group  
Locking Plate Group Percutaneous Group 
 N  N 
Superficial infection 2 
Superficial 
infection 
5 
Removal of plate  2 EPL reconstruction 1 
  
Carpal tunnel 
decompression 
1 
  
Removal of buried 
k-wires  
6 
 
EPL = Extensor Pollicis Longus  
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Table 3.18 Cost of complications 
Complication A (£) B (£) 
Removal of buried k-wires 
(outpatient procedure) 
91.78 663.18 
Removal of buried k-wires 
(day-case theatres) 
934.2 1505.6 
Superficial infection± plate 67.75 67.75 
Superficial infection± control 135.33 135.33 
Carpal tunnel decompression 934.2 2534.2 
Removal of plate  1300 2900 
EPL reconstruction 1310.2 3710.2 
 
A = Cost from an NHS perspective 
B = Cost from societal perspective (this also includes productivity loss) 
  
 157 
 
3.5.2.3 True treatment costs  
We present the total cost per treatment intervention, along with 
measures of spread and distribution. This cost is calculated from 
patient clinical data, taking into account the variability between 
individuals, potential complications, above or below average use of 
resources. The results are presented below as distributions (Figure 
3.8). Total NHS cost, especially for the control group, is a positive 
skew. 
  
Figure 3.8 Total NHS treatment cost per randomisation group 
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Descriptive statistics for NHS treatment costs in our study are 
summarized in Table 3.19. The volar locking plate option was 
significantly more expensive (p<0.001, 95% CI 496.9 to 929.5). 
The differential cost for the two arms of the trial was £713.42 (SE 
109.3). This represents the numerator of the ICER. 
 
Table 3.19 Total NHS treatment costs per randomisation group 
Cost (£) Mean SD Min Max 
Volar locking 
plate 
2928.9 424.5 1912.6 4543.7 
Percutaneous 
fixation 
2215.7 776.5 1231.3 5212.5 
 
This trial was not powered for subgroup comparative analysis. 
However, we can present the descriptive statistics of mean cost per 
non-intention to treat treatment category: £2995 (SD 486) for 
patients who underwent VPL fixation, £ 1915 (SD 426) for those 
who underwent simple K-wire fixation and £3169 (SD 550) for 
those who requiring supplemental external fixation. These figures 
are not used in the generation of the cost-effectiveness ratio. 
There were no lost external fixation components.  
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3.5.3 Base-case analysis  
The ICER for the base-case scenario, based on a differential 
treatment cost of £713.2 (SE 109.3) and the QALY gain achieved 
by volar locking plate fixation over percutaneous methods of  
0.0178 (SE 0.025), was £40,080. 
or 
ICER =      = 40,080  
 
3.5.4 Resource use 
As part of the trial protocol, each patient was allocated as standard 
one overnight inpatient stay and four follow-up fracture clinic 
appointments (two, six, twelve weeks and one year), incorporating 
dressing room or plaster room attendances according to the 
treatment arm. Any hospital contacts above this were considered 
extra.  In addition, operative time in minutes and number of 
physiotherapy sessions are presented in Table 3.20. 
There were significantly more extra plaster room visits, as well as 
overall number of extra hospital contacts for the percutaneous 
IL[DWLRQ DUP 7KLV UHSUHVHQWV WKH ³KLGGHQ FRVW´ RI SHUFXWDQHRXV
fixation. Percutaneous fixation in this study was also no faster in 
terms of operative time. 
713.42 
0.0178 
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Table 3.20 Resource use by randomisation group 
 
Locking Plate 
Group 
Control 
Group 
 
Mean SD Mean SD p  
Operative time 
(min) 
64 22 66 32 0.693 
Extra inpatient 
days  
0.39 0.74 0.61 1.50 0.265 
Extra fracture 
clinic visits  
0.42 0.88 0.72 1.23 0.117 
Extra plaster room 
visits  
0.07 0.32 0.48 0.89 <0.001 
Extra emergency 
room visits 
0.07 0.27 0.05 0.21 0.497 
Extra overall 
hospital contacts*  
0.52 1.07 1.56 2.22 <0.001 
Extra 
physiotherapy 
sessions 
3.90 4.75 3.47 4.88 0.643 
* Extra overall hospital contacts = fracture clinic + plaster room + 
A&E visits  
 
Descriptive statistics of the three subgroups are detailed in Table 
3.21. Patients with supplemental external fixation required a longer 
inpatient stay, more fracture clinic follow-up visits and almost 
double the number of physiotherapy sessions. The study was not 
powered for subgroup analysis, so comparative analyses were not 
performed. 
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Table 3.21 Resource use by treatment subgroup (not intention-to-treat)  
 
Volar Locking 
Plate  
Percutaneous 
Wires  
External 
fixator 
 n=67 n=52 n=11 
 
Mean SD Mean SD Mean SD 
Operative time 
(min) 
66 26 63 29 69 28 
Extra inpatient 
days  
0.42 0.80 0.33 1.0 1.72 2.5 
Extra fracture 
clinic visits  
0.46 0.97 0.61 1.22 1 0.77 
Extra plaster room 
visits  
0.07 0.32 0.58 0.96 0.09 0.30 
Extra emergency 
room visits 
0.06 0.24 0.08 0.27 0 0 
Extra overall 
hospital contacts*  
0.62 1.21 1.33 1.91 2.09 3.33 
Extra 
physiotherapy 
sessions 
3.64 4.18 3.16 5.13 6.3 6.24 
* Extra overall hospital contacts = fracture clinic + plaster room + 
A&E visits 
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Time taken to return to work and income lost (value in lost 
productivity) per randomisation group are reported in Tables 
3.22a-b. The data distributions, as shown in Figures 3.9 and 3.10 
were not normal and represented a positive skew. Though the 
median is useful in describing the data, for reasons described 
previously in the methods, it is broadly accepted that the 
arithmetic mean and the difference in the mean are the measures 
used for cost-effectiveness analysis (Glick, 2007). The results of 
the between-group comparisons are the same, either way. 
Patients who underwent volar locking plate fixation did not return 
to work earlier, and there was no significant productivity gain by 
using this treatment. However, they did return to driving sooner. 
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Figure 3.9 Days off work per randomisation group 
 
Figure 3.10 Lost productivity per randomisation group 
0 50 100 150 200 0 50 100 150 200
Volar Locking Plate Control
Days taken to return to work
0 5000 10000 15000 20000 0 5000 10000 15000 20000
Volar locking plate Control
Lost income in pounds
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Table 3.22a and b Time of work, driving and value of lost productivity 
 
Locking Plate Group Control Group  
Median Range Median Range  p 
Days of work  43 3-181 63 2-174 0.877 
Days off driving  37 6-242 46 8-272 <0.001 
Value in lost productivity (£) 2086 0-10,343 2400 0-22,286 0.537 
 
 
 
Locking Plate Group Control Group  
Mean SD Mean SD p 
Days of work  50.58 40.81 47.17 36.19 0.679 
Days off driving  50.98 7.36 68.82 7.112 0.006 
Value in lost productivity (£) 2827 2345 3400 5050 0.497 
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3.5.5 One-way sensitivity analysis 
In this study, sensitivity analysis was performed to vary 
assumptions about the cost of implants. A 20% discount, before 
VAT, was applied to all orthopaedic implants (see methods). Given 
that the original cost of the volar locking plate implant was 
substantially higher (£930) compared to that of Kirschner wires 
(£16.8) and higher even to that of the components of supplemental 
external fixation (£763), the proportional savings were also larger. 
The ICER for this scenario was £31,898 (Table 3.23). 
Threshold analysis allowed the indicative price to be determined for 
the volar locking plate implant, which would potentially bring the 
technology into the cost-effective range according to NICE 
thresholds. Assuming all other costs remain the same and an 
indicative hospital discount of 20% is applied to the control arm to 
simulate a realistic hospital environment, an implant cost of £621 
for the volar locking plate would produce an ICER of £25,000 and 
an implant cost of £532 pounds an ICER of £20,000 (Table 4.18). 
The implications are debated in the discussion. Prices are exclusive 
of VAT and discount percentages are based on the public list price 
of the DVR® implant, which was the implant used in this study. 
There are a great number of volar locking plate implants, available 
from a variety of manufacturers, for differing prices.  
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Table 3.23 Results of one-way and threshold sensitivity analyses 
 
 
3.5.6 Probabilistic sensitivity analysis 
Cost and QALY data typically are not normally distributed. Cost 
data are often highly right skewed because of a few cases that 
incur extremely high costs, while QALY data are usually left skewed 
because of the ceiling effect (Willan and Briggs, 2006) (Thompson 
and Barber, 2000). 
In the current study, probabilistic sensitivity analysis in the form of 
a Monte Carlo simulation was used to explore the calculated ICER. 
The results from the simulation were used to plot the cost-
effectiveness plane (CEP) of the study (Figure 3.11) and the cost-
effectiveness acceptability curve (CEAC) (Figure 3.12) to 
demonstrate decision uncertainty. The CEAC presents the 
 ICER  
Cost of volar 
locking plate 
implant  
Percentage 
discount on list 
price 
Base-case 
analysis  
£40,080 £930 0% 
20% hospital 
discount  
£31,898 £744 20% 
ICER £25,000 £25,000 £621 33% 
ICER £20,000 £20,000 £532 43% 
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probability that fixation via volar locking plate is the preferred 
WUHDWPHQW RSWLRQ DW GLIIHUHQW YDOXHV IRU D GHFLVLRQ PDNHU¶V
willingness-to-pay (WTP) (Fenwick et al., 2001)  
The illustrations show that, on the majority of occasions, the volar 
locking plate was more costly than the control method of 
percutaneous fixation. The likelihood of it being cost-effective for 
any given threshold was 50% or less. On a small number of 
occasions, VLP fixation was more expensive and less effective 
compared with percutaneous fixation and vice versa. 
At no point was the new treatment (plate) associated with 100% 
probability of being cost-effective. This was because there were a 
number of simulations that suggested it produces fewer QALYs at 
greater cost compared to the alternative. Note also that the 
average ICER was found at a willingness to pay threshold of 
approximately 50% (Fox-Rushby and Cairns, 2009). 
The simulation also allowed the calculation of the confidence 
interval for the ICER (95% CI -100,123 to 95,833), which spanned 
zero, and similarly reflected the uncertainty associated with the 
results. The confidence interval was driven by HRQL accuracy 
rather than costs (there was much less variation in incremental 
cost rather than in incremental QALYs). 
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Figure 3.11 Cost-effectiveness plane showing bootstrapped 
replicates of the ICER 
Each point represents an estimate of the ICER based on dual 
bootstrap of cost and efficacy. The diagonal red line represents a 
cost-effectiveness threshold of £25,000. Estimates of the ICER 
below this benchmark would be considered cost-effective. 
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Figure 3.12 Cost-effectiveness acceptability curve showing the 
probability that the intervention is cost-effective at different 
willingness-to-pay thresholds 
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3.5.7 Comparison of the EQ-5D TTO and SF-6D 
For the health states described in our study, the EQ-5D appears 
consistently to assign a higher utility score than the SF-6D (Table 
3.10). Figure 3.13 graphically compares EQ-5D TTO and the SF-6D 
utility index scores for the randomisation groups at each time point 
in the study. 
Table 3.24 demonstrates summary statistics for the QALY gain 
calculated using the SF-6D and the EQ-5D TTO index scores for 
each intervention.   
 
Figure 3.13 EQ-5D and SF-6D utility index scores for the 
randomisation groups at each study time point. 
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Table 3.24 QALYs calculated using the EQ-5D TTO and SF-6D 
utility measures  
 
 
We found utility scores to be higher with the EQ-5D than with the 
SF-6D. Utility scores on the SF-6D have a narrower range (0.296 
to 1.00) (Brazier et al., 2004), compared to the EQ-5D (-0.594 to 
1.00) (Dolan, 1997). This is because both scales have 1.00 for 
perfect health, but the worst utility score for the EQ-5D is below 
zero, whereas the utility of the worst health state for the SF-6D is 
well above zero. In other words, the SF-6D and the EQ-5D are not 
perfect linear analogues of each other. Additionally, time trade-off 
valuation scores (the technique used with the EQ-5D) tend to be 
higher for milder states, but lower for more severe states, 
compared with standard gamble scores (which are used with the 
SF-6D) (Sach et al., 2009). As a result, it has been proposed that 
 Mean 
Diff in 
means 
SED 95% CI Sign. 
QALYs using EQ-5D TTO 
VPL  0.828 
0.0178 0.025 
-0.031 to 
0.067 
p=0.47 
Control 0.811 
QALYs using SF-6D 
VPL  0.766 
0.0032 0.016 
-0.028 to 
0.035 
p=0.84 
Control 0.763 
 172 
 
estimated utility gains will tend to be higher according to the EQ-
5D, compared with the SF-6D (Conner-Spady and Suarez-Almazor, 
2003, Tsuchiya et al., 2006). This has been shown in different 
patient populations (Longworth and Bryan, 2003, Lamers et al., 
2006, van Stel and Buskens, 2006). Our results support this 
conclusion, as the QALY gain was estimated to be higher according 
to the EQ-5D. 
We examined whether the SF-6D could be a more sensitive utility 
score in our setting of the operative management of distal radius 
fractures. At 12 months the EQ-5D TTO standardised responses 
mean (SRM) 0.09 versus 0.03 for the SF-6D.  It could therefore be 
considered the more sensitive measure in this population group. 
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Chapter 4 ± Discussion 
4.1 Statement of principal findings 
This work compared the outcome of displaced distal radius 
fractures when treated with a volar locking plate or closed 
reduction and percutaneous wire fixation, with supplemental 
bridging external fixation when required. The study showed that 
the use of a volar locking resulted in better early post-operative 
function.  However, there was no significant difference at, or after 
12 weeks (Table 3.5). Despite the early functional advantage, 
participants did not return to work sooner (mean difference 3 days, 
SE 9 days, p=0.72). The volar locking plate achieved better 
radiographic reduction (Table 3.7) and grip strength throughout 
(Table 3.5). However this did not translate to a difference in 
function at 12 weeks and 1 year. There were more complications in 
the percutaneous fixation arm of the study (26/64, 39% vs 15/66, 
23%, p = 0.057). 
NHS costs for the volar locking plate group were significantly 
higher (£713.2, SE 109, p<0,001). Quality of life scores for this 
group were slightly, but not significantly better at early follow-up 
(¨Q = 0.0178, SE 0.025, p=0.47). Both groups returned to 
baseline at one year (Table 3.12). Based on the results of cost-
effectiveness analysis from the perspective of the NHS, volar 
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locking plate fixation for distal radius fractures in this study was 
not found to be cost-effective according to NICE threshold criteria 
(ICER = £40,080). 
4.2 Discussion of results in the context of the 
literature  
4.2.1 Discussion of clinical results  
Distal radius fractures are common injuries that have a substantial 
impact on health care systems (Cummings et al., 1985). In recent 
years, the rate of non-operative treatment has declined, just as the 
rate of internal fixation and particularly of volar locking plate 
fixation, has increased exponentially (Chung et al., 2009). 
Early biomechanical studies documented a number of theoretical 
advantages of volar locking plate fixation (Larson and Rizzo, 2007) 
and subsequent longitudinal  clinical studies demonstrated good 
outcomes (Chung et al., 2006, Rozental and Blazar, 2006, Beaton 
et al., 2005, Orbay et al., 2004). More recently, prospective 
randomised studies have emerged, comparing treatment with volar 
locking plates and less invasive, percutaneous methods of fixation 
(Goehre et al., 2013, Egol et al., 2008, Rozental et al., 2009, Wei 
et al., 2009, Marcheix et al., 2010, McFadyen et al., 2011, 
Hollevoet et al., 2011). These studies are reported in detail in 
Chapter 1.2.5.1. Overall, they advocated the use of volar locking 
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plate fixation over percutaneous methods, despite failure to 
identify a long-lasting functional advantage of the new technique.  
The benefit of volar locking plate fixation in terms of functional 
outcome in the short term has been challenged by the current 
study. Previously, it was suggested that the functional benefit of 
volar locked plating may last from 3 up to 6 months (Rozental et 
al., 2009, McFadyen et al., 2011, Marcheix et al., 2010). However, 
we found this short-term benefit was smaller and lasted for 
between six and twelve weeks after surgery. As such, and given 
the large prevalence of distal radial fractures (Wulf et al., 2007), 
the results of this and similar studies can be seen in a different 
light: if patients experience only an additional maximum six weeks 
of functional advantage from the use of the technique, it should be 
considered if these outcomes justify the cost of treatment with a 
volar plate. 
Measured grip strength was significantly greater for the plate group 
at all study time points, in contrast to the functional patient-
centred outcome measures, which showed no difference at, or 
beyond, 12 weeks (Table 3.5). This could be explained if the 
observed differences in grip strength were statistically, but not 
clinically important.  There is no published Minimally Clinically 
Important Difference (MCID) for grip strength relevant to the 
population in this study. MCID for grip strength varies according to 
 176 
 
the condition and the population studied. For example, in a study 
of stroke patients, the reported MCID was 22% for the non-
dominant limb (Lang et al., 2008). In a health population 
differences between dominant and non-dominant hand are in the 
range of 10-15% for right handed people (Petersen et al., 1989, 
Nitschke et al., 1999). 
Per protocol analysis (PP) of functional and clinical outcomes was 
undertaken, in addition to intention-to-treat analysis. The results of 
the PP analysis results were no different to the intention-to-treat 
analysis (Tables 3.5 and 3.6). The combined results were 
interpreted as per the grid demonstrated in Table 2.2 of the 
methods. This demonstrated that the effect of the equally 
distributed, non-compliant cases was minimal. 
Radiographic outcomes demonstrated that better restoration of 
palmar tilt and radial height was achieved with plating (Table 3.7). 
This did not translate to a difference in function past 6 weeks. 
Radiographic parameters reflect the accuracy of surgical reduction, 
however the link between malunion and patient-related function 
has long been under debate (Downing and Karantana, 2008, 
Forward et al., 2008, Brogren et al., 2013, Finsen et al., 2013). 
While many studies have investigated the relationship between 
extra-articular malunion and outcome after fractures of the distal 
radius, there is little consensus on the amount of malunion that can 
be tolerated without loss of function (Karantana and Davis, 2012). 
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The uncertainty about the long term relevance of varying degrees 
of extra-articular malunion is unlikely to be resolved in the near 
future. Large prospective studies of long-term outcome, with 
appropriate outcome measures including cosmesis, and a clear, 
stratified and clinically relevant definition of malunion, are 
required. 
Limits of agreement for radiographic parameters in this study 
(Table 3.8) were narrower than the intra-observer tolerance limits 
set by Kreder et al. in their paper on standardising x-ray film 
measurements for healed distal radius fractures (Kreder et al., 
1996b). This is likely attributable to good quality, standardised 
radiographs obtained as part of the trial protocol, the experience of 
the observers in techniques of radiographic assessment and the 
accuracy of the electronic software measurement tools. Kreder et 
al. used the interclass correlation coefficient (ICC), a statistical 
method which according to Altman is inappropriate for the problem 
of judging agreement. This could have had an additional effect on 
the variance of their measurements (Bland and Altman, 1986) and 
is a commonly occurring error in the medical literature. The 
correlation coefficient is not a valid measure of agreement, as it is 
influenced not only by the measurement variation between 
observers, but also the values being measured. So, if the variation 
between individuals (i.e. patients, not observers) is high compared 
to the measurement error, the correlation will be high, whereas if 
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the variation between individuals is low the correlation will be low 
(Altman and Bland, 1983). The Bland-Altman method eliminates 
this problem.  
Deciding what is good and poor agreement also depends on what is 
considered to be clinically important. Given the lack of correlation 
between radiographic parameters and function (as discussed in 
Chapter 2.1.4), this type of analysis can only show the level of 
precision of our measurements in relation to those made by others. 
It cannot help define what level of agreement is clinically relevant. 
Though there were more complications in the percutaneous arm, 
the difference did not reach statistical significance (Table 3.9). 
Overall, most complications were transient. However, two plates 
required removal and a third patient, who received a plate but was 
analysed in the percutaneous group as per intention-to treat, 
required extensor pollicis longus tendon reconstruction. The 
number of implant specific complications for volar locking plate 
fixation (3/66, 4.5%) was lower than that reported by other 
studies (Table 1.6)  (Johnson et al., 2013, Sahu et al., 2011, Arora 
et al., 2011, Rozental et al., 2009). This can be explained by the 
fact that surgery was consultant led, performed in a tertiary centre.  
4.2.2  Discussion of economic evaluation results  
There is, at present, no published evidence of the cost-
effectiveness of volar locking plate fixation for distal radius 
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fractures. None of the existing trials have been accompanied by 
economic evaluations. Given that comparative studies have not 
proven a long-term benefit, one of the driving factors for the 
continued use of the technique has been the perception that it 
provides a fiscal advantage, with implant costs offset by a shorter 
period of immobilisation, a lower use of resources and an earlier 
return to work. The current study found no evidence to support 
these propositions. 
Based on the results of the cost-effectiveness analysis, and 
according to NICE threshold criteria, volar locking plate fixation for 
distal radius fractures was not cost-effective at the current list price 
for the DVR® implant: the ICER for the base-case scenario was 
£40,080. However, as hospitals do not pay list price for implants, it 
is more realistic scenario to apply a hospital discount. With an 
indicative 20% hospital discount, the ICER was reduced to 
£31,898, which remained overly expensive. 
This study used a specific implant, selected on the basis of surgeon 
preference, familiarly, popularity and widespread use. This plate is 
one of many implants available on the market, and at the more 
expensive end of the range. Though one would not want to select a 
particular implant based on price alone, the volume of volar locking 
plate implants utilised in the health service necessitates that 
pricing be, at least, a consideration. Sensitivity analysis showed 
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that, providing all other parameters remained the same, an implant 
cost of £621 plus VAT would generate an ICER of £25,000 and an 
implant cost of £532 plus VAT would generate an ICER of £20,000, 
within the approved cost effectiveness range. It should be 
emphasised that these figures are not absolute. They carry 
uncertainly and require specific assumptions. However, they 
provide a guide on what could be expected from a lower priced 
implant in the described context of use. This univariate sensitivity 
analysis based on price is fairly robust, as there are no 
assumptions made about resource use or patient preference-based 
scores, and only a single, constant parameter is altered in a 
transparent way. 
The differential cost of the two treatments ¨& ZDV ORZHU
than the cost-GLIIHUHQFHRIWKH LPSODQWV LQYROYHG¨& 7KLV
reflected the higher use of certain resources by patients in the 
percutaneous treatment arm and the high cost of the infrequently 
used supplemental external-fixator components (£688.8). The 
study design focused on capturing what could be considered the 
³KLGGHQ´UHVRXUFH-use of the percutaneous fixation group, such as 
plaster changes, wound checks secondary to troublesome pin sites, 
inadvertently buried wires etc. 
Unexpectedly, percutaneous fixation was no quicker than open 
reduction internal fixation in terms of operative time. This 
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remained the case, even when resource use was depicted 
separately for each subgroup: K-wire fixation was no quicker than 
plate fixation (Table 3.21). This could possibly be explained in part 
by delays in awaiting radiographers.  However, the data to support 
this was not available as part of this study. 
Patients with supplemental external fixation had high costs 
associated with expensive implants. They also required on average 
a longer inpatient stay, at least one additional fracture clinic visit 
and increased use of physiotherapy services. The study was not 
powered for subgroup analysis, so we cannot draw statistical 
conclusions. However, the figures suggest that the few patients 
with supplemental external fixation required more resources and a 
longer recovery period. 
In terms of implant costing, published evidence was used to 
support the safe re-use of non-single use external fixator 
components three times. In practice, most re-usable external 
fixator components continue in use for longer, until they appear 
macroscopically worn or cease to function. This could represent a 
small potential bias in favour of the volar locking plate. 
Nevertheless, this would not alter the conclusion of the study. 
The study showed that volar locking plate fixation was definitely a 
more expensive treatment (SED of costs was very narrow). Despite 
this, it was not more effective than percutaneous fixation, in terms 
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of quality of life scores. The SED of the QALY gain was very wide. 
As a result, the confidence interval for the ICER was also very wide 
and spanned zero. The confidence interval was calculated using 
stochastic probabilistic methods, a special type of modelling (Glick, 
2007, Briggs, 2000b). This is a valid method which uses a 
computer algorithm and the data from the trial to carry out circa 
25,000 calculations, in order to model what would happen if the 
trial had 25,000 participants. Confidence intervals cannot be 
produced with standard techniques, such as when comparing 
normal distributions. There are other methods of expressing 
uncertainty in cost-effectiveness analysis. In effect, calculating a 
confidence interval for the ICER in economic evaluation is, in itself, 
a subject of debate for health economists, as is the issue of power 
in economic evaluation (Polsky et al., 1997, Briggs, 2000a). 
According to the analysis, there was no evidence to support volar 
locking plate fixation offering value-for-money in the setting of 
distal radius fractures. There was less than 50% chance of cost-
effectiveness at current willingness-to-pay thresholds, as 
demonstrated by the cost-effectiveness curve (Figure 3.12). This 
probability represents less than the toss of a coin. 
The study also examined the effectiveness of the interventions at 
reducing days taken off work. The expectation of a speedier 
recovery and potential earlier return to work has been one of the 
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driving forces for the increasing use of volar locking plate fixation 
in an active population (Diaz-Garcia and Chung, 2012). Patients 
who underwent volar locking plate fixation and were in 
employment at the time of injury, did not return to work 
significantly earlier in our study (mean difference 3 days, SE 9 
days, p=0.72). There was therefore no significant productivity gain 
by using this treatment (Table 3.22). It is worth noting however, 
that only 6% (5/83) of working patients in the study were self-
employed. It is conceivable that some patients returned to work 
later than they could physically have done so. To that end, we also 
examined as a soft surrogate outcome measure, the self-reported 
time from injury to return to driving. Patients who underwent volar 
locking plate fixation returned to driving earlier (mean difference 
18 days, SE 10 days, p<0.01) than those undergoing percutaneous 
fixation. In a setting where compensation is offered, in the form of 
sick pay, for short term disability and illness, time taken off work 
reduces productivity, but not always personal income. 
Nevertheless, this does not alter the main study conclusion from a 
societal perspective.  Finally, 5% (7/135) of injuries were sustained 
at work and, to our knowledge there was one compensation claim, 
which was in the volar locking plate group. 
Baseline compatibility of the randomisation groups was very good. 
In addition tKHSDUWLFLSDQWV¶DJHDQGVH[ distribution was consistent 
with published age and sex-specific incidence rates for distal radius 
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fractures (Larsen and Lauritsen, 1993), demonstrating that the 
study sample was representative of the demographics of the injury.  
The study population was also comparable, in term of baseline EQ-
5D recruitment scores, with published UK population norms 
matched for age, sex and standard region (TTO z score = -0.16, 
HS TTO z score = -0.14), with no discernable differences in 
matching between the randomisation groups. Length of follow-up 
was adequate and appropriate. There were no significant 
differences in HRQL scores from recruitment to one year. Scores 
returned to baseline at the end of trial follow-up, and all showed 
similar patterns of recovery (Table 3.12). 
Finally, we examined whether the SF-6D could be a more sensitive 
utility score in our setting of the operative management of distal 
radius fractures. A purported advantage of the SF-6D is its larger 
descriptive system (i.e. 18,000 unique health states can be 
described by SF-6D, compared to only 243 by EQ-5D). Therefore it 
potentially had greater ability to identify small health changes 
(Bryan and Longworth, 2005). Also, compared to the EQ-5D, the 
SF-6D has more dimensions and more levels. This leads to the 
suggestion that for patients with relatively high levels of health of 
baseline health, such as those in our study, the SF-6D could have 
been more sensitive to utility gain (Grieve et al., 2009). We found 
no evidence to support this in the current study (Table 3.24). 
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Even so, this does not prove that the EQ-5D is also the preferred 
measure, as this could represent an overestimation of the true gain 
in utility associated with the particular change in health. Due to the 
complexity of the methodology involved and the range of issues 
that need to be considered when choosing between HRQL 
measures, simple comparisons of data collected using the two 
instruments cannot effectively be used to uncover the main drivers 
of disagreement between utility measures (Bryan and Longworth, 
2005). It was beyond the scope of the thesis to explore this 
complex and controversial issue. The main conclusion is that the 
SF-6D and the EQ-5D are not interchangeable in economic 
evaluation. In light of this, and to ensure a consistency in its 
approach, NICE developed its reference case, which includes use of 
the EQ-5D TTO score only, in order to estimate adult utility scores 
(NICE, 2008). 
4.3 Study caveats 
The present study has limitations.  
Study time points 
The postoperative immobilization period differed between the two 
surgical techniques.  Patients in the volar locking plate group were 
allowed to start moving their wrist two weeks after surgery (though 
not everyone would mobilise to the same degree, and some 
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patients required longer periods of immobilisation), whereas 
patients in the percutaneous fixation group had the wrist 
immobilized in plaster for six weeks as standard. When the first 
functional outcome scores were determined at six weeks, the plate 
group demonstrated better results. It could be argued that the 
difference in outcomes at six weeks could be attributed to the 
longer immobilization period following percutaneous fixation, rather 
than the result of a difference in initial fixation techniques (Day et 
al., 2013). The implication would be that a slightly later follow-up 
time point, for example at seven or eight weeks, would have 
perhaps eliminated this potential advantage for the plate.  
Perhaps in retrospect, an 8 week time point could have provided 
more precise information about the pattern of early functional 
recovery. However, the study was designed on pragmatic principles 
to reflect usual practice. Patients were routinely seen at six weeks 
as part of the treatment pathway. An additional follow-up 
appointment solely for the purpose of data collection would have 
increased cost and resources required to run the study. 
Furthermore, more follow-up points generally reflect a more 
exploratory approach, with implications on the external validity of 
other aspects of the study design, such as the economic 
evaluation. 
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Blinding and ascertainment bias  
Blinding is very important in maintaining the integrity and validity 
of results. Failure to blind tends to influence results in favour of 
newer or more expensive treatments. In a review of 250 RCTs 
identified from 33 meta-analyses, researchers observed that lack of 
double-blinding led to a significant overestimate of treatment 
effect, with odds ratios being exaggerated by as much as 17% in 
un-blinded studies (Schulz et al., 1995). 
The current study was not blinded. This is because the nature of 
the surgical procedures, the scars and the differences in the related 
post-operative care are difficult, if not impossible to realistically 
mask. Simply wearing a bandage or glove to cover scars during 
assessment was not judged adequate in our setting. Radiographic 
blinding was also not possible due to the presence of differing 
hardware.  
In addition, organisational issues, lack of monetary and personnel 
resources, as well as time restraints introduced elements of 
ascertainment bias to the study.  The chief investigator (CI) both 
designed and implemented the study. This included participation in 
recruitment, data collection, patient assessment, information 
management and analysis, but not operative management. As an 
assessor, she therefore could not be FODVVHGDVIXOO\³LQGHSHQGHQW´ 
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The choice of a patient-reported outcome measure as primary 
outcome measure, completed independently by the participants, 
reduced the risk of ascertainment bias. The PEM (Macey et al., 
1995) is a patient-centred questionnaire,  completed at each time 
point solely by the patient, with no input from study personnel, 
prior to the encounter at which clinical data was collected.  
Age range 
The study examined a large age range, with younger and older 
patients in each group. Based on their age, some of the older 
patients were more likely to be osteopaenic.  While plain 
radiographs may suggest reduced bone stock, a 35-50% reduction 
in mineral density must occur before bone density appears 
decreased on x-ray (Jensen et al., 2004, Jergas et al., 1994).  
Furthermore plain X-rays are not quantitative and cannot be used 
for an objective measurement of bone mineral density. This would 
require Dual energy X-ray absorptiometry (DXA) scanning or 
computed tomography (CT), for which there was neither funding 
nor ethical approval. 
However, the randomisation groups were balanced for age (no 
difference in age distributions between groups) with a sample size 
large enough to allow for this balance.  If there had been a 
statistically significant difference in age between the groups, age as 
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a confounder would have been controlled for with regression 
analysis. This was not required. 
It is a logical question to ask if one treatment fairs better in a 
particular age group. Despite the balanced nature of the 
randomisation groups, this trial was not set up to answer this 
question. A much larger sample size would be required. Even in a 
large multi-centre surgical study, one could not provide answers to 
FRYHU LQGLYLGXDOGHFDGHV$ OLPLWHGQXPEHURIDJH³JURXSV´ZRXOG
have to be defined, for example a cut-RII EHWZHHQ ³\RXQJ´ DQG
³ROG´DQGDVXEJURXSDQDO\VLVso pre-defined. The point where this 
cut-off lies is debatable and depends on which factor one takes to 
be the confounder: is it the quality of the bone that is likely to 
affect outcome, or the level of activity, or even the ability to self-
care? The DRAFFT study suggested tactic to tackle this issue (Costa 
et al., 2011). The investigators stratified on the basis of age, using 
age as a surrogate of bone mineral density and mechanism of 
injury. They chose to stratify by age above or below 50.  This 
approach was based on a study from Norway that demonstrated 
that forearm bone mineral density remained stable until the age of 
50 years, before declining steadily in males and more abruptly in 
females (Berntsen et al., 2001).  This is a reasonably justified way 
to ensure balance across groups and eliminate a potential 
confounder, providing the sample size calculation a priori allows for 
such a comparison. 
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Supplemental external fixation 
The choice to include supplemental external fixation in the 
percutaneous arm could also be questioned. Percutaneous 
Kirschner-wiring supplemented by external fixation is a recognised 
treatment modality and the established treatment prior to the 
introduction of angularly stable, volar locking plate devices. The 
decision for an external fixator to supplement k-wire fixation is 
generally made at the time of surgery and cannot always be 
predicted. It is based on the stability of the achieved wire fixation 
and the intra-operative images.   
The option of supplemental external fixation was included, when 
the surgeon felt this was indicated, as it was considered unethical 
to assign additional external fixation to all patients in the 
percutaneous group, or alternatively to under-treat fractures for 
which an acceptable fixation was not achieved with k-wires alone. 
This represents a pragmatic aspect of study design and reflects 
clinical practice for percutaneous fixation. 
It could be argued that patients with an external fixator were likely 
to have a slower recovery in the short term. Subgroup analysis in 
this setting would involve direct comparisons using the extremely 
small number of patients with external fixators. This comparison 
would be underpowered, non-randomised, and not predetermined, 
and therefore contra-indicated (Moher et al., 2010). In addition, 
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participants requiring supplemental external fixation would 
potentially be the patients with the most unstable fracture patters 
within the percutaneous fixation group. It could equally be argued 
that their potentially slower recovery was the result of the original 
injury, rather than the treatment modality.  
Finally, excluding the patients with external fixation from the 
analysis would not have changed the results of the study. Such a 
practice of exclusion is methodologically flawed as it would 
LQWURGXFHDGLIIHUHQW IRUPRIELDVQDPHO\³ELDVGXHWRH[FOXVLRQV
DIWHUUDQGRPLVDWLRQ´7KLV LVWKHVDPHW\SHRIELDVWKDW LQWHQWLRQ-
to-treat-analysis is aimed to address (Moher et al., 2010).  Any 
potential bias introduced by the slower recovery in the small 
number of patients with external fixators would be in favour of the 
RULJLQDO K\SRWKHVLV ZKLFK LV WKDW ³WKH XVH RI YRlar locking plates 
LPSURYHVIXQFWLRQDORXWFRPH´ 7KLVZRXOG LQFUHDVHWKHSRVVLELOLW\
that the trial could have produced a spurious result in favour of the 
plate, which it did not.  Hence, this does not compromise the 
conclusion. 
Fracture types 
There has been some discussion about the use of pragmatic trials 
with wide inclusion criteria to inform individual clinical practice 
(Rothwell, 2005a, Patsopoulos, 2011, Summerskill, 2005). In 
particular, there could be criticism regarding the inability to power 
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trials similar to this for subgroup analysis according to fracture 
type. The current study has dealt mostly with AO type A3 and C2 
fractures, with these comprising over 90% of the fracture 
population (Table 3.7). Only a small number of AO C3 fractures 
were represented in each group. Though the current study provides 
answers for the most common fracture types treated via locking 
plate fixation, it is possible that a study of selected AO C3 
fractures, performed by experts in the technique, and within a 
specific population, would give different results. 
Power of economic evaluation 
If the goal of a study is to show that the ICER is significantly below 
some upper limit on the maximum society is willing to pay for 
health gain, then it is very likely that sample size requirements for 
economic evaluation will be many times those required to show a 
clinical effect (Briggs, 2000a). As a result, cost-utility analyses 
alongside clinical trials are almost always underpowered, especially 
in surgery. 
Some may argue that it is unethical to power a trial based on 
economic endpoints, as the numbers required are extremely high, 
many times those required to power a clinical outcome. In other 
words, this would require further randomisation of patients to a 
treatment which has already been proven to be clinically 
ineffective, merely to prove beyond doubt whether it is cost-
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effective (Briggs, 2000a). On the other hand, most funding bodies 
now require economic evaluations to be performed alongside 
clinical trials. However, given finite budgets, the NHS is faced with 
funding either only a few very large trials based on economic 
endpoints or many more comparatively smaller ones powered for 
clinical endpoints, which can provide only estimates of cost-
effectiveness.  
Briggs et al. from Oxford have produced the main guidance to date 
on power and sample size calculations for stochastic cost-
effectiveness analysis (Briggs and Gray, 1998). They explored the 
issues associated with sample size calculation for economic 
evaluation alongside RCTs and developed a formula for determining 
sample size that can be used for cost-effectiveness analysis. In 
their landmark paper, they give a numerical example. This 
suggests that in order to detect a 40% difference in outcome of a 
new surgical intervention compared to conventional treatment, for 
an ICER of circa £21,000-£25,000, with power of 90% at a 5% 
level of significance, a sample size of 750 is required.  For a smaller 
difference in outcome, the number required is in the thousands. 
This is an unrealistic target for surgical trials, even for large multi-
centre studies.  
  
 194 
 
Confidence interval for the ICER  
The ICER is accompanied by a very wide 95% confidence interval, 
due mostly to the large variation (SED) in EQ-5D scores. This is a 
common occurrence in economic evaluations which run alongside 
trials, and has to do predominately with the issues of power 
mentioned above. As a result, many cost-effectiveness studies do 
not present confidence intervals at all. When they do, very little 
can be inferred by a wide 95% CI for the ICER which spans zero in 
the context of an economic evaluation powered for the clinical trial 
it accompanies.  This does not render a study valueless, it merely 
sets the context in which the results can be interpreted. As the 
ICER for an intervention increases within the acceptable NICE 
threshold cost-effectiveness range, the degree of uncertainty 
associated with it weighs more heavily in the decision-making 
process, making it less likely for an intervention to be approved 
(see Appendix 6.8). 
We cannot prove with absolute certainty that the results are due to 
the volar locking plate being cost-ineffective, rather than the study 
being underpowered. However, when validated patient-centred 
functional outcome measures, for which the clinical study was 
sufficiently powered, fail to demonstrate improved outcomes for 
the plate over the year, there is, in our opinion, no reason to 
expect this from the more generic HRQL scores. 
 195 
 
External validity  
Single-centre studies are easier to organise and run, and allow for 
tighter quality control in both the intervention and the assessment. 
Multi-centre trials, however, may be a more efficient way of 
accruing sufficient participants over a shorter period of time, and 
also provide a better basis for generalisation of findings. 
This was a single centre study performed in a United Kingdom 
centre, which may affect the external validity of findings. The 
structure of the treatment pathways represents practice within the 
NHS, where distal radius fractures are treated within a specific 
hospital environment and a particular specialty. Result of a similar 
comparison could be different in other healthcare settings, for 
example if presentation for treatment was regularly delayed 
making indirect reduction of fractures more challenging, availability 
of follow-up and access to fracture clinics was limited, or there 
were differing levels of resources and expertise with each 
technique. 
Furthermore, it is a study reflecting practice in a tertiary centre, 
with surgery performed at the expert consultant level. It is 
plausible that, in a more generalist environment, volar locking plate 
fixation, as a more interventional technique, could be associated 
with a greater number of complications and revision surgery. For 
example, there was no flexor pollicis longus (FPL) tendon rupture 
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following plating in this study. This is an increasingly occurring 
complication, associated with plate mal-positioning and tendon 
attrition (Asadollahi and Keith). It requires subsequent plate 
removal and tendon reconstruction, which is major surgery with 
substantial costs and a long period of recovery. In addition, plate 
removal in the setting of malposition and/or poorly locked screws, 
is an increasingly reported problem (Sahu et al., 2011, Gyuricza et 
al., 2011), which was infrequent in the setting of the current study. 
4.4 Study Strengths 
This study also has several strengths.  
It is currently the largest single-centre published RCT comparing 
volar locking plate fixation with percutaneous techniques for distal 
radius fractures. It is the also the first and only cost-effectiveness 
study of volar locking plate fixation. The economic evaluation was 
executed prospectively. The study design  complied with NICE 
guidance on the methodology of technology appraisal criteria 
(NICE, 2008). 
The conduct and reporting of the trial have followed the CONSORT 
recommendations (Schulz et al.). 
The primary outcome measure was an appropriate validated 
patient-centred functional outcome measure. In addition, 
secondary outcomes measures could allow for direct comparison 
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with other published studies, making this trial suitable for inclusion 
in future meta-analyses. 
The study was adequately powered and strictly executed. 
Significance criteria were stringent, and the sample size calculation 
transparent and based on a comparable population. 
The follow-up rate achieved at one year was 95%. High retention 
rates throughout the duration of the study meant that there was no 
need to imputate missing data.  
Costing for the economic study included detailed data collection 
EDVHGRQD³ERWWRP-XS´PLFUR-costing technique. This technique is 
particularly resource and time intensive. Most published economical 
evaluations are based on estimated costs referenced from the 
literature, department of health figures and national tariffs and do 
not attempt a bottom-up approach. Though large multi-centre 
trials have the benefits of larger patient numbers and potentially 
greater external validity, a single-centre study can be much more 
exacting in costing, and can provide useful reference for future 
studies. The costing model in this study was transparent and 
transferable and can be referenced in future distal radius fracture 
economic evaluation studies. 
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4.5 Future work  
The next stage is for the ongoing, large UK multi-centre study 
comparing volar locking plate and Kirschner wire fixation (DRAFFT), 
to complete and publish results (Costa et al., 2011). This will 
enhance what we have learned from the current study, and add 
power to meta-analyses and systematic reviews. 
The work in this thesis covers the short to medium term. Long 
term outcomes are also important. Though there is no funding in 
place, we hope to be able to approach this group of patients at 10 
years and 20 years from their injury. Ideally both a functional and 
radiographic assessment would be sought, but this would depend 
on ethical and institutional approval, as well as the availability of 
funds. With such a long interval from the original intervention, we 
would expect a high drop-out with reduced rates of follow-up, as is 
often the case with trauma, higher even if patients remain 
asymptomatic and thus less incentivised to volunteer their time. 
One of the advantages of large, centrally funded studies is that 
long-term follow-up, when indicated, is typically planned for at the 
onset, making full use of the original resources. 
Fractures of the distal radius are common and account for a 
considerable proportion of all attendances at fracture clinics.  
Although they have been the subject of much research, the paucity 
of large, prospective outcome trials of the different methods of 
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treatment is surprising, given the number of patients available for 
study. There remain unanswered questions regarding the optimal 
management of this very common fracture. These are mostly 
driven by the uncertainty about the long-term relevance of varying 
degrees of extra-articular malunion. Collating data on truly long 
term follow-up of younger patients will take decades. 
In the meantime, the next step should perhaps be a return to 
basics: large randomised studies to compare operative and non-
operative management of distal radius fractures. Given the 
increasing trend for operative intervention (Chung et al., 2009), 
there has been little interest in such studies in the recent past. 
However, the debate surrounding volar plate fixation has refuelled 
interest in outcomes of non-operative management.  
Arora et al. in 2011 published a prospective randomised trial of 73 
patients comparing non-operative cast treatment with volar locking 
plate fixation for displaced and unstable distal radial fractures in 
patients sixty-five years of age and older (Arora et al., 2011). At 
the twelve-month follow-up, the range of motion, the level of pain, 
and the PRWE and DASH scores were no different between the 
treatment groups. There were significantly more complications in 
the operative group. Improved radiographic reduction in the 
operative group did not convey any advantage in terms of the 
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range of motion or the ability to perform daily living activities, 
though cosmesis was not assessed when considering outcome. 
An ambitious multi-centre trial (the ORCHID study) (Bartl et al., 
2011) was attempted in Germany. ORCHID (Open reduction and 
internal fixation versus casting for highly comminuted intra-
articular fractures of the distal radius) was funded by the German 
research council and planned to recruit 504 patients over a three 
year period. The primary objective was to determine differences in 
the Short Form 36 (SF-36) Physical Component Score (PCS) 
between volar locked plating and closed reduction and casting of 
intra-articular, comminuted (AO C3) distal radius fractures in 
patients over 65 years of age. Secondary outcomes included 
differences in other SF-36 dimensions, the EuroQol-5D 
questionnaire, the DASH score as well as clinical measurements 
and complications. Recruitment started in 2008 and unfortunately 
prematurely terminated in early 2012 due to low recruitment. 
Nevertheless, they report having randomised 183 patients up to 
that point, making it the largest study on the topic to date, and 
also the only study to randomise exclusively AO C3 fractures. The 
results have not so far been published, but would perhaps help 
provide answers to questions our the present and the DRAFFT 
multicentre studies were not designed to answer i.e. how far do we 
go in treating intra-articular comminuted fractures in the elderly? 
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Lastly, more focus on techniques of economic evaluation is 
required.  Health practitioners are required to operate within a 
framework where budgets are limited and funds are allocated in 
ways not always under their control. Developments in the structure 
of health policy processes emphasise the importance of ensuring 
that the results of economic analyses are robust. Decision making 
therefore requires not only sound clinical evidence that treatments 
work, but also, good quality evidence that they provide value for 
money for the NHS and for society in general. More economic 
evaluations alongside prospective clinical studies in upper limb 
surgery are required.  
The methodology that determines cost effectiveness through the 
guidance of bodies such as NICE is not without controversy. Topics 
relevant to the context of the current study are questions regarding 
the ability of HRQL measures to capture short-term benefits gained 
from the treatment of acute conditions and non-systemic 
conditions limited to the upper limb; also how the innovative 
nature of particular technologies adds distinctive benefits not 
adequately captured by the QALY measure.  
A body of work is required which aims to map validated patient-
centred functional outcome measures to generic quality-of-life 
scores. Or perhaps the development of a disease-specific measure 
of health related quality-of life (HRQL) for trauma. Disease-specific 
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measures of HRQL are increasingly being used to evaluate medical 
treatments, to make therapeutic decisions, and to allocate 
treatments (Bowling, 2001, Shumaker et al., 1994, Barber et al., 
2001). In addition, we should invest in larger studies that can limit 
the degree of uncertainty associated with outcomes. Multi-centre 
collaborative long term studies are required. They are possible if a) 
adequate funds are allocated b) patients are willing to participate 
and c) individual practicing surgeons are willing to enter patients.  
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Chapter 6 - Appendix 
 
6.1 List of common abbreviations 
x A&E  Accident and Emergency  
x CBA  Cost Benefit Analysis 
x CEAC  Cost±effectiveness Acceptability Curve 
x CI  Confidence interval  
x CQG  Cost per QALY Gained 
x CUA  Cost Utility Analysis 
x EPL  Extensor Pollicis Longus  
x GP  General Practitioner 
x HRG4  Health Resource Group Version 4 
x HRQL  Health Related Quality of Life  
x ICER   Incremental Cost Effectiveness Ratio 
x MSD  Minimally Significant Difference 
x NHS  National Health Service 
x NICE  National Institute for Health and Clinical Excellence  
x NUH   Nottingham University Hospitals NHS Trust  
x ONS  Office of National Statistics  
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x PASA  NHS Purchasing and Supply Agency  
x PP  Per Protocol  
x QALY  Quality Adjusted Life Years  
x RCT  Randomised Controlled Trial 
x SG  Standard Gamble 
x TSSU  Theatre Sterile Supply Unit  
x TTO  Time Trade-Off 
x VAS  Visual Analogue Scale 
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6.2 Trial Protocol 
This is the trial protocol, in the form that was approved by the local 
Research Ethics Committee and institutional Research and 
Development Unit (September 2007). 
Project Design 
This study is a pragmatic surgical randomised controlled trial 
aiming to compare the outcome of fractures of the distal radius 
when treated with a volar plate with locking screws, or the 
established conventional method typically involving percutaneous 
wires and/or an external fixator. 
A diagram demonstrating participant flow through each stage is 
demonstrated in Figure 6.1. 
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Figure 6.1 Diagram demonstrating participant flow 
  
 235 
 
Objectives 
Our research objectives are: 
x To determine whether the use of volar locking plates 
improves clinical and functional outcome, and allows for an 
earlier return to normal activities and work. 
x To undertake an Economical Evaluation from the point of 
view of the NHS and Personal Social Services as follows: 
o Cost Utility Analysis of the interventions, using the EQ-
5D to calculate QALYs. 
o Clinical Effectiveness Analysis to determine 
effectiveness of the interventions at reducing the 
duration of rehabilitation. For this purpose we will 
calculate the incremental cost of rehabilitation days 
avoided for each intervention. 
Setting 
Acute teaching urban NHS trust (Nottingham University Hospitals, 
Queen's Medical Centre Campus, Nottingham). Patients are 
recruited through fracture clinic and the acute orthopaedic take and 
treated on the orthopaedic wards and trauma theatres. 
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Target Population 
Adults (skeletally mature) with a fracture of the distal radius 
suitable for surgical treatment with a volar locking plate.  
Participants must satisfy the study inclusion and exclusion criteria 
and be referred to the research team by their treating consultant. 
Recruitment and Consent 
Potential participants will be identified as suitable for the study by 
their treating consultant through attendance at fracture clinic, 
which runs on a daily basis. 
Suitable participants will be approached by their treating surgeon 
in fracture clinic and informed of the existence of the project. The 
chief investigator will be contacted, to ensure all inclusion criteria 
are met. Should the patient agree they will be introduced to the 
chief investigator who will discuss the nature of the study in more 
detail. Written information will be provided in the form of the 
Patient Information Sheet. 
This will be done in the clinic room to ensure confidentiality. 
Patients will be allowed to ask questions and consider their decision 
in private. It will be reinforced that their decision will in no way 
affect the quality of their care. 
It is aimed that recruitment occurs at this stage. This is due to the 
acute nature of the injury and the need to organise operative 
intervention as soon as possible by the appropriate surgical team 
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and in available theatre time, as would happen during routine 
clinical care. 
Written consent will be obtained by the chief investigator. The 
investigator will retain the original consent form in the Trial Master 
File. A copy will be given to the participant and a copy will be 
placed in the medical notes. Patients will be admitted as 
appropriate. It will be reinforced that participants are free to 
withdraw at any point and consent is not binding. However, it is 
our aim whenever possible to allow at least 24 hours for the 
participant to decide if they wish to remain within the trial or 
withdraw. The participant will thus not be randomised at 
recruitment, but on the morning or afternoon of surgery. Should 
they decide to withdraw, surgery will take place as scheduled but 
the patient will not be randomised into the trial. 
If a patient declines to participate, we will record the reason why. 
No other data will be collected. They will remain under the care of 
their admitting consultant team. 
A patient can withdraw from the study at any time by informing a 
member of the medical team. Treatment will proceed as planned, 
but no further information will be collected nor retained for the 
purposes of the study. 
  
 238 
 
Intervention 
Patients will undergo their surgery on a dedicated orthopaedic 
trauma list, and the surgery performed by one of the five senior 
surgeon members of the study team, who are fully trained and 
experienced in the treatment of these fractures with both the DVR® 
plate and the alternative options. Each must perform a minimum of 
16 fracture fixations. 
The plate chosen for this trial is the Distal Volar Radius or DVR® 
plate, manufactured by Biomet. This has been selected on the 
advice of our Hand Surgery and Trauma Unit as representative of 
volar locking plates. It is in common use across the UK and widely 
represented in the published literature. It is an implant with which 
our surgeons already have significant prior experience. 
Instrumentation in the conventional arm of the trial will include 
smooth 1.6mm Kirschner wires and the standard AO external 
fixator, as appropriate. All the above devices are in current use 
within the NHS, CME licensed and will not require MHRA 
authorisation. 
There is no expected difference in the type or the duration of the 
anaesthetic for the two techniques. Both treatments may involve 
spending a period of time in plaster. 
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Follow up 
Expected duration of patient participation will be one year from 
injury. 
Follow up and data collection will be performed at 6 weeks, 12 
weeks and 1 year and will take place in orthopaedic outpatient 
fracture clinic. 
Outcome measures consist of objective parameters, measured by 
the chief investigator and a trained research assistant with the 
relevant clinical aids. Also standard published valid questionnaires 
designed to be completed by the patient (see Outcome Measures). 
Inclusion criteria 
x Fractures which the referring physician considers require 
operative intervention. 
x Configuration is such that the fracture would be amenable to 
stabilisation via volar locking plate (not unreconstructable). 
x Adults (skeletally mature) with high demand requirements of 
their wrist in whom the radiological appearance of the bone 
suggests that it is robust enough to tolerate internal fixation and 
in whom the fracture pattern at presentation fulfils the criteria 
as described below. 
x Fractures of the distal radius which are: 
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1. 'RUVDOO\ GLVSODFHG q) extra-articular fractures (with or 
without an undisplaced intra-articular component) with dorsal 
cortical comminution as seen on the lateral radiograph. 
2. Displaced intra-articular fractures with an articular step or 
gap of in the radio carpal joint surface. 
Exclusion criteria 
x Patients with concomitant systemic diseases (diabetes with 
vascular or neurological complications, advanced cardiac, 
pulmonary or neurological disease) 
x Proximal metaphyseal fractures (more than one inch or 2.5 
centimetres from the articular surface)  
x Open fractures 
x 6PLWK¶VDQGYRODU%DUWRQ¶VFRQILJXUDWLRQ 
x Previous fractures of the distal radius of the same or contra-
lateral limb  
x Significant pre-existing radiological abnormality 
x Multiply injured 
x Bilateral injuries 
x Patients who are unable to consent for themselves to treatment 
x Patients who may have difficulties in adequate understanding of 
English 
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Outcome Assessments 
These will be clinical and radiological, performed at 6 weeks, 12 
weeks and 1 year. 
Subjective assessments will include the following measures: 
x Patient Rated Wrist Evaluation Measure 
x QuickDASH 
x PEM 
x EUROQUOL EQ-5D 
x SF-12 
x Ten point visual analogue score for pain 
Disease specific questionnaires are published and freely available 
for clinical use. The quality of life scores are available on an 
academic licence. 
Objective measurements will include 
x grip strength of the injured limb 
x range of forearm and wrist motion 
Radiographic assessment 
Measurements obtained from radiographs as undertaken during the 
course of normal clinical management for this type of injury. Taken 
at the time of injury, post treatment and prior to discharge (check 
X-ray), at six, twelve weeks and one year post injury. 
Established clinical practice for radiographic assessment includes a 
standardised series comprising of: 
x standard PA  
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x 20 degree lateral 
x 45 degree pronated oblique of the wrist 
The contra lateral wrist is X-rayed at week 6 and acts as a standard 
for the assessment of shortening, loss of radial angle, palmar tilt 
and presence of intra-articular malunion. 
x Radial length 
x Palmar tilt 
x Radial inclination 
Demographic and other data  
Written consent will be obtained for access to patient medical 
records by the chief investigator. 
Demographic data will be collected from the patient and the clinical 
notes and will include: 
x Hand dominance 
x Date of birth 
x Date of injury 
x Occupation and relevant classification: office, office and 
manual, light manual, heavy manual), full time or part time 
employment. 
x Date of return to work 
x Length of hospital stay 
x Number of outpatient and GP appointments 
x Number of therapy appointments 
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x Number of plaster cast changes 
x Attendance for fixator removal at six weeks 
x Total number of post-operative hospital attendances 
x Prescription of antibiotics 
x Complication (loss of reduction, pin site infections, tendon 
rupture, finger stiffness, CRPS, CTS). 
x :RUNHU¶VFRPSHQVDWLRQFODLPVDV established at one year) 
x A record of operative kit used  
x Surgery time  
Participant Safety 
Participants are not expected to be exposed to additional harm as a 
result of their participation in the study. The only deviation from 
routine clinical care consists of collection of specific demographic 
data and completion of short questionnaires at routine clinical 
follow-up. 
However, as part of routine clinical care participants will be 
undergoing surgical intervention which carries an inherent risk of 
complications. Patients will be informed of the risks of surgery as 
part of the process of surgical consent, by the treating surgical 
team as per standard clinical practice.  This is a separate process 
to the research consent obtained at recruitment. 
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Should a complication of surgery arise, treatment and follow-up 
would be dictated by the nature of the complication, as per routine 
clinical care. 
We aim to record all untoward medical events in study participants 
(such as complications of surgery, even if unrelated to the study, 
using the R&D Adverse Event or Serious Adverse Event Reporting 
Forms. These will be retained by the Chief Investigator and 
reported to the R& D department of the Trust. 
Stopping Criteria 
We will perform an interim analysis at the midpoint of recruitment 
for the study. Criteria for stopping the study would be  
x 10% difference in the rate of catastrophic infection (septic 
arthritis) requiring operative intervention to treat or leading 
to significant joint damage as visible on X-ray 
Method of allocation 
Participants will be allocated with equal probability to the 2 
treatment arms based on a computer generated random code using 
random permuted blocks of randomly varying size, created by the 
Nottingham Clinical Trials Support Unit (CTSU) in accordance with 
their standard operating procedure (SOP) and held on a secure 
server. In order to avoid surgeon bias each participating 
randomisation is stratified by surgeon. 
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Access to the sequence will be confined to the CTSU Data 
Manager. The trial coordinator will access the treatment allocation 
for each participant by means of a remote, internet-based 
randomisation system developed and maintained by the 
Nottingham CTSU. The sequence of treatment allocations will be 
concealed until interventions have all been assigned and 
recruitment, data collection, and all other trial-related assessments 
are complete. 
Data Access, Management and Record Keeping 
Data accessed by the principal investigator for the purpose of the 
VWXG\ZLOOLQFOXGHSDWLHQWV¶PHGLFDOKHDOWKUHFRUGVDQG radiographs. 
Patient written consent will be sought.  
Medical records of patients participating in the study will be 
identified by a sticker on the cover of the records denoting the 
patient is in the study and the date the notes will no longer be 
required for research purposes. 
Information will be recorded using data collection proformas and 
via completion of standardised outcome questionnaires.  
It is intended to use a unique trial number for each participant that 
is linked to their personal details so that all research data is 
anonymised. The encryption will happen at the point of 
randomisation.  
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All data relevant to the study will be transferred onto an Access 
database and held for ten years.  This will be password protected, 
stored on Trust premises, in a password protected network area 
accessible through an NHS Trust computer. Files will be backed up 
to a hard copy CD- ROM disk on the first working day of each 
month and this back up will  be kept with the Trial Master File in 
the Research Office, Level C, West Block, within the Academic 
Department of Orthopaedic and Accident Surgery on QMC 
premises. This is a locked, safe and secure location. 
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6.3 Ethics Committee confirmation of approval  
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6.4 Research and Development approval  
Nottingham University Hospitals NHS Trust 
Please reply to:       Research and Development 
E11 Curie Court 
Queen's Medical Centre Campus 
Derby Road 
Nottingham 
NG7 2UH 
Telephone: 0115 970 9049 
Fax: 0115 849 3295 
E-mail: janet.boothroyd@nuh.nhs.uk 
 28 September 2007 
Miss A Karantana  
C/O Mr Holdsworth's Secretary 
Level B, West Block 
Queen's Medical Centre, Derby Road 
Nottingham 
NG7 2UH 
Dear Miss Karantana 
ID:  07OR003 Unstable Fractures of the Distal Radius: a Randomised 
 Prospective Clinical Study Comparing their Treatment with 
 Volar Locking Plate and Conventional Method. 
The R&D Department have considered the following documents:  
 
   NHS REC Application form, version number 5.3 
   Protocol Version 3 dated 8 August 2007 
   GP/Consultant Information Sheets, Version 2 dated 8 August 2007 
   Participant Information Sheet, Version 2 dated 8 August 2007 
   Participant Consent Form, Version 1 dated 12 March 2007 
 
Your study now has R&D approval, on the understanding and provision that you will follow 
the conditions set out below.  
 
Conditions of Approval 
 
That you:  
1. Accept the responsibility of Chief/Principal Investigator as defined in the current 
Research Governance Framework.  
2. Request written approval from the R&D department for any change to the approved 
protocol/study documents you wish to implement 
3. Ensure all study personnel, not employed by the Queens Medical Centre, University 
Hospital NHS Trust Nottingham or the City Hospital NHS Trust Nottingham, hold 
honorary Contracts with this Trust, before they have access to any facilities, patients, 
staff, their data, tissue or organs. 
4. Report any Serious Adverse Event involving the Trust to the R&D department, using 
the Trust 'policy for research safety reporting in human subjects'. Policy available from 
the R&D Department. 
5. Complete the R&D Research Governance interim and final reports as requested. 
6. Comply with the regulatory requirements and legislation relating to: Data Protection, 
Trust Caldicott Guidelines, Health and Safety and the use of Human Tissue for 
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research purposes. 
7. Comply with the current Research Governance Framework, available at 
www.doh.gov.uk or via the R&D office or Research Governance Web-site. 
8. Agree to conduct this research project in accordance with ICH Good Clinical Practice 
and/or the MRC Guidelines for Good Clinical Practice (as appropriate) 
9. Must not start your project until you have received written approval from the relevant 
ethics committee.  
 
Please note that the R&D department has a database containing study related information, 
and personal information about individual investigators e.g. name, address, contact details 
etc. This information will be managed according to the principles established in the Data 
Protection Act. 
 
 
Yours sincerely 
Dr Brian Thomson / Mrs Janet Boothroyd 
Director of R&D / Assistant Director of R&D 
cc Nottingham Research Ethics Committee 
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6.5 Reference costs of consumables 
Figure 6.2 Reference cost of consumables. Sourced from NHS Supply 
Chain Catalogue 2011. 
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6.6 Reference of drugs used and costs 
6.6.1 Prophylactic antibiotics 
Induction 
x Flucloxacillin 2gr IV        
x Gentamycin 2mg/kgr IV (average patient 80 kgr) so 160mg 
Followed by  
x Three more doses Flucloxacillin 1gr IV 
If mild allergy to penicillin (rash) 
x Single  dose of Cefuroxime 1.5gr IV on induction  
If severe allergy to penicillin  
x Single  dose of Vancomycin 1gr IV before induction  
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6.6.2 Analgesics 
Post-op analgesics 
Paracetamol 1gr     qds x 24hrs   
Ibuprofen 400mg    tds x 24hrs   
Codeine Phosphate 60mgs   qds x 24hrs   
Oramorph® oral solution 10 mg/5 mL 20 mgs    
Discharge analgesics  
Paracetamol 500mg  1 pack  100-tab pack  
Ibuprofen 200 mg   1 pack  84-tab pack  
Codeine Phosphate 30 mg,  2 packs  28-tab pack  
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6.6.3 Anaesthetic drugs  
General anaesthetic  
1 amp fentanyl (2ml amp)    
1 amp propofol (20ml amp)    
1 amp midazolam (2 mg/mL, 5-mL amp)  
20mg morphine (2 x 1ml amp 1mg/ml)  
1gr paracetamol IV      
Axillary Block  
30mls of levobupivocaine 
1 amp clonidine (20mcgs used) 
1 amp midazolam  
Sonoplex stimulation cannula 22 gauge x 50mm 
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6.6.4 Pricing from BNF 2011 
x Atracurium (Non-proprietary) Injection, atracurium 
besilate 10 mg/mL, net price  5-mL amp = £3.19 
x Catapres® (Boehringer Ingelheim) Injection, clonidine 
hydrochloride 150 micrograms/mL, net price 1-mL amp = 
28p 
x Cefuroxime (Non-proprietary) Injection, powder for 
reconstitution, cefuroxime (as sodium salt), net price 1.5-g 
vial = £5.05 
x Chirocaine® (Abbot) Injection, levobupivacaine (as 
hydrochloride) 5 mg/mL, net 10-mL amp = £1.62 
x Codeine Phosphate (Non-proprietary) Tablets, codeine 
phosphate 30mg, net price, 28-tab pack = £1.18 
x Fentanyl (Non-proprietary) Injection, fentanyl (as citrate) 
50 micrograms/mL, net price 2-mL amp = 30p,  
x Flucloxacillin Injection, powder for reconstitution, 
flucloxacillin (as sodium salt), net price 1-g vial = £4.90 
x Gentamicin (Non-proprietary) Injection, gentamicin (as 
sulfate), net price 40 mg/mL,2-mL amp = £1.00 
x Ibuprofen (Non-proprietary) Tablets, coated, ibuprofen 
200 mg, net price 84-tab pack = £1.44  
 257 
 
x Midazolam (Non-proprietary) Injection, midazolam (as 
hydrochloride) 2 mg/mL, net price  5-mL amp = 65p  
x Morphine Sulfate (Non-proprietary) Injection, morphine 
sulfate 10, net price 1mL amp = 72p 
x Oramorph® oral solution, morphine sulfate 10 mg/5 mL, 
500-mL pack = £7.47 
x Paracetamol Tablets (and caplets), paracetamol 500 mg, 
net price 100-tab pack = £1.61.  
x Perfalgan® (Bristol-Myers Squibb) Intravenous infusion, 
paracetamol 10 mg/mL, net price 100-mL vial = £1.25 
x Propofol (Non-proprietary) 0.5% injection (emulsion), 
propofol 5 mg/mL, net price 20-mL amp = £3.46 
x Ropivacaine (Non-proprietary) Infusion, ropivacaine 
hydrochloride 2 mg/mL, net price 200 mL = £14.45 
x Sodium Chloride Intravenous Infusion (Non-
proprietary) Intravenous infusion, usual strength sodium 
chloride 0.9% (9 g, 150 mmol each of Na+ and Cl-/litre), this 
strength being supplied when normal saline for injection is 
requested. Net price 10-mL amp = 46p 
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x Vancomycin Injection, powder for reconstitution, 
vancomycin (as hydrochloride), for use as an infusion, net 
price 1-g vial = £12.99 
x Water for Injections Net price  10-mL amp = 34p 
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6.7 Derivation of complication costs 
This section details the approach in costing of complications, which 
is in line with the methodology, as detailed in Chapter 2. 
In costing the complications we have not included the cost of 
additional fracture clinic, plaster room and/or Accident and 
Emergency and physiotherapy attendances. These are incorporated 
in the patient-specific data, as they differ per patient, according to 
presentation and rate of recovery. This ensures use of outpatient 
resources is not counted twice. This approach was chosen due to 
the way data is recorded in hospital systems and subsequently in 
our database. Though we have the total number of attendances for 
each patient, it is very difficult to distinguish with confidence 
whether, for example, an extra plaster change performed in plaster 
room, was due to the plaster rubbing (not a complication) or a 
superficial infection (complication). As a result, if one wishes to use 
this data to model complication costs for a different study, they 
should collate and add the cost of any outpatient attendances to 
these figures.  
Tables 6.1. to 6.7 detail the costing for each complication. Lost 
wages were considered nil in the case of superficial infection. All 
cases of infection were early (within 3 weeks of surgery for the 
plate and six weeks of surgery for the control group) and patients 
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were already off work, recovering from the index procedure. The 
infection did not result in additional productivity loss.  
All infections in the study were superficial and treated on an 
outpatient basis. No implants (plate, wires, fixator pins) had to be 
removed because of infection. 
Tables 3.15 and 3.16 represent the detailed costing of dressing 
changes for each randomisation group, which are incorporated in 
Tables 6.3 and 6.4. 
  
 261 
 
Table 6.1 Costing of removal of buried k-wires as an outpatient 
procedure 
Removal of buried k-wires (outpatient 
procedure) 
Cost (£) 
Staff (nurse) 30 min 48.6 
Staff (doctor) 20 min 24.4 
Lidocaine 1% (10ml ampoule) 0.42 
Dressing pack sterile wound care with forceps  0.28 
Sterile gloves (one pair) 0.6 
Skin preparation  0.06 
20ml water for injection  0.68 
Blade stitch cutting carbon steel  0.05 
Sterile pack single use instrument suture 2.93 
Suture non absorbable monofilament 4/0  1.15 
Dressing vapour permeable adhesive with 
absorbent sterile pad (small) (n=2) 
0.38 
Overheads  1.31 
Lost wages (10 days)* 571.4 
GP nurse removal of sutures (12 min) 10.2 
Total 662.46 
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Table 6.2 Costing of removal of buried k-wires as a day-case 
procedure 
Removal of buried k-wires  
(day-case theatres) 
Cost (£) 
HRG code HB55C 924 
Lost wages (10 days) 571.4 
GP nurse removal of sutures (12 min) 10.2 
Total 1505.6 
 
Table 6.3 Costing of superficial infection (volar locking plate) 
Superficial infection (not requiring 
admission) Volar Locking Plate 
Cost (£) 
Flucloxacillin 1gr qds 7 days 6.94 
Analgesics  6.49 
Culture swab 0.17 
Processing of swab by microbiology  
(culture and sensitivity) 
1.39 
Overheads  3.00 
Dressing Changes (n=2)   53.98 
Lost wages*  0 
Total 71.97 
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Table 6.4 Costing of superficial infection (control) 
Superficial infection (not requiring 
admission) Wires and Fixator 
Cost (£) 
Flucloxacillin 1gr qds 7 days 6.94 
Analgesics  6.49 
Culture swab 0.17 
Processing of swab by microbiology (culture 
and sensitivity)3 
1.39 
Overheads 3.00 
Dressing Changes (n=2)   117.64 
Lost wages*  0 
Total 135.63 
 
Table 6.5 Costing of carpal tunnel decompression 
Carpal tunnel decompression Cost (£) 
 HRG4 code HB55C 924 
 Lost wages (4 weeks) 1600 
 GP nurse removal of sutures (12 min) 10.2 
 Total 2534.2 
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Table 6.6 Costing of plate removal 
Removal of plate Cost (£) 
 HRG4 code HB54C 1300 
 Lost wages (4 weeks) 1600 
 Total 2900 
 
Table 6.7 Costing of extensor pollicis longus (EPL) reconstruction 
EPL reconstruction Cost (£) 
HRG4 code HB54C 1300 
Lost wages (6 weeks) 2400 
GP nurse removal of sutures (12 min) 10.2 
Total 3710.2 
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6.8 The concept of the cost-effectiveness plane 
A cost-effectiveness plane  is a useful way of diagrammatically 
comparing two or more interventions (Figure 6.3) (Black, 1990). 
The horizontal axis measures differences in effectiveness and the 
vertical axis measures differences in cost. When comparing a new 
and an old treatment, there are four possibilities. The four 
quadrants are by convention identified as in a map. 
 
Figure 6.3 Cost-effectiveness plane 
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In the north-east quadrant the new treatment is more effective but 
also costs more. In the south-east quadrant the new treatment 
dominates the old treatment (Fox-Rushby and Cairns, 2009). 
The north-east quadrant is where attention is more often focused. 
Here the issue is how the additional effect compares to the 
additional cost. The ICER allows such assessments to be made. 
Cost-effectiveness threshold 
We should reject any alternatives that are dominated, where the 
dominated alternative has a greater cost with no greater benefits 
or lower benefits without lower costs. The choice amongst non-
dominated alternatives is more complex. Where only one 
alternative can be chosen, that with the lowest ICER should be 
chosen, but only if it is below a ceiling ratio, which is a level of the 
ICER which any alternative must meet if it is to be regarded as 
cost-effective (Parkin, 2009) 7KLV LV WKH ³FRVW HIIHFWLYHness 
WKUHVKROG´ EHORZ ZKLFK ZLWKLQ D SUH-specified budget, an 
intervention will be regarded as cost-effective (Figure 6.4). 
  
 267 
 
Figure 6.4 The cost effectiveness threshold and how it relates to 
the ICER of a new intervention 
 
 
 
Courtesy of Prof DK Whynes, University of Nottingham  
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But how do you determine the level at which to set the threshold? 
When there is no set budget, the outcome of cost-utility analysis 
&8$ FDQ EH H[SUHVVHG LQ WHUPV RI WKH H[WUD ³FRVW SHU 4$/<
JDLQHG´&4*7KLVLVWKHDPRXQWwe think it is reasonable to pay 
to gain a QALY and is sometimes referred to as the CQG threshold, 
because it is the dividing line between health care that is regarded 
to be cost-effective, and that which is not. 
The concept and reality of the NICE cost-effectiveness 
threshold 
Estimated cost-effectiveness for any intervention depends on the 
selected comparator (Fox-Rushby and Cairns, 2009). But how do 
you decide at what level to set the threshold? 
If there is a fixed annual budget and a list of mutually exclusive 
interventions for each medical condition, then decisions are 
straightforward, the irrefutable result of mathematical ranking 
according to cost and QALYs, with the aim of maximising health 
gain for a given level of spending. In this setting, a precise 
threshold can be calculated which determines which interventions 
³GRPLQDWH´DQGZKLFKDUHJRLQJWREH³GLVSODFHG´E\FRPSDULVRQ
In real life, decision-making is much more complex. Budgets are 
not precisely set, not all decisions are made at the beginning of a 
financial year, there is significant cross-over of resource use and, 
above all, most health interventions are not mutually exclusive. 
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When cost-effectiveness thresholds are used as an aid to decision-
making by national bodies such as NICE in England and Wales, the 
budget of the NHS may be considered fixed, however the Institute 
does not have complete information about the cost and QALYs for 
all existing and competing health care programmes. Therefore, any 
cost-effectiveness threshold is necessarily less explicit because of 
greater uncertainty about the opportunity cost of the programmes 
that would be displaced as a result of an adoption decision (Fox-
Rushby and Cairns, 2009). As a result, NICE does not use a fixed 
ICER threshold above which a technology would be automatically 
defined as not cost-effective or below which it would. It does, 
however, make reference to a cost-effectiveness range (NICE, 
2008). 
The National Institute for Clinical Excellence (NICE) was established 
LQWRDGGUHVVJHRJUDSKLFYDULDWLRQVLQSUHVFULELQJ³SRVW-code 
ORWWHU\´ E\ SURYLGLQJ QDWLRQDO-level guidance on the clinical and 
cost-effectiveness of new health technologies in the NHS. The role 
of NICE was strengthened by making implementation of its 
decisions mandatory in the NHS from 2002 (Devlin and Parkin, 
2004). 
When a new technology is more costly than existing technologies, 
the role of NICE is to decide whether the health expected to be 
gained by the use of this technology exceeds the health expected 
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to be foregone elsewhere as other NHS activities are displaced. 
When NICE issues positive guidance on a technology which 
imposes additional costs on the NHS, the resources required to 
deliver it must be found by disinvesting from services elsewhere. 
So the threshold represents the additional cost that has to be 
imposed on the system to forgo one QALY of health through 
displacement (Claxton 2013). 
NICE does not accept or reject healthcare technologies on cost-
effectiveness grounds alone, although it is undoubtedly a major 
deciding factor (Appleby et al., 2007). 
Current NICE guidelines state that, below a most plausible ICER of 
£20,000 per QALY gained, the decision to recommend the use of a 
technology is normally based on cost-effectiveness. Above an ICER 
of £20,000 per QALY, judgements about the acceptability of the 
technology as an effective use of NHS resources take account of 
the following factors: 
o The degree of certainty around the ICER 
o Whether there are strong reasons to indicate that the 
assessment of the change in HRQL has not been 
adequately captured, and may therefore misrepresent the 
health utility gained 
o The innovative nature of the technology, specifically if the 
innovation adds demonstrable and distinctive benefits of a 
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substantial nature which may not have been adequately 
captured in the QALY measure 
Technologies are considered in relation to the threshold range, 
such that the influence of these factors is greater as the ICER 
increases from £20,000 to £30,000. Above an ICER of £30,000, an 
increasingly stronger case for supporting the technology as an 
effective use of NHS resources is required, with regard to the 
factors listed above (NICE, 2008). 
There is therefore, no red line which determines approval or 
rejection, and no logarithm that can predict the outcome of a 
decision. In fact, the way decisions are made is the subject of both 
research and controversy. 
Rawlins and Culyer (Rawlins and Culyer, 2004) studied past 
decisions and identified an increasing likelihood of rejection as the 
ICER increased beyond £15,000, with few interventions being 
approved with an ICER >£30,000. This is reflected in Figure 6.5, 
which illustrates the relationship between cost-effectiveness and 
the probability of rejection. Devlin and Parkin (Devlin and Parkin, 
2004), in contrast, estimated the true threshold to be even higher 
than the £20,000-£30,000 which NICE has publicly identified. 
Outside the doors of the Institute, there is evidence to suggest a 
PLVPDWFK EHWZHHQ 1,&(¶V WKreshold range and that apparent 
elsewhere in the NHS (Appleby et al., 2007). Figures from 2007 
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suggest that the average primary care trust is willing to spend 
even less than NICE thresholds,  i.e. £12,000 to gain an extra 
QALY in circulatory disease and £19,000 in cancer (Martin S., 
2007). 
 
Figure 6.5 Relationship between cost effectiveness and probability 
of rejection. Reproduced Rawlins and Culyer (Rawlins and Culyer, 
2004). 
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It has been widely recognised for many years that the NICE 
threshold range of £20,000 to £30,000 per QALY is not based on 
evidence. The most recent and major project aiming to provide an 
evidence-based threshold was completed by the University of York 
Centre for Health Economics in January 2013 (Claxton 2013, 
Claxton K., 2013). The project was commissioned by the Medical 
Research Council Methodology Research Programme. The health 
economists at York estimated a more accurate threshold to be 
£18,317 per QALY (based on 2008 expenditure). The research 
found no evidence that the threshold had increased with the NHS 
budget (2007 to 2008) and found some evidence that the threshold 
is likely to fall as the NHS comes under greater financial pressure. 
So we are unlikely to see increased spending on new technologies 
adopted in the near future. 
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6.9 Calculating ICERs by simulation 
Assume our two randomised interventions, 1 & 2, with average 
costs C1 and C2 and average outcomes Q1 and Q2. The base 
model of the ICER is: 
ICER = (C1 ± C2) / (Q1 ± Q2) 
This is a point estimate and would only represent the true state of 
affairs if every patient were identical (zero variation between 
patients).  This we know to be untrue, because we have data on 
each individual which shows that they are all different.  Using this 
data, we can associate a variance or deviation within each of the 
four parameters.  Consequently, there are confidence intervals 
(CIs) around each parameter which will, in turn, determine the CI 
around the ICER.  Intuitively, the wider the CIs around each 
parameter, the wider the variation in the ICER will be. 
In principle, the ICER is a ratio of two means and there is a 
standard formula for calculating this, known as Fieller's theorem 
(Chaudhary and Stearns, 1996, Willan and O'Brien, 1996, Polsky et 
al., 1997). However, the assumptions required for the theorem to 
work are restrictive (e.g. normal distributions and zero correlation 
between variables).  These assumptions are sometimes met in 
randomised controlled trials and sometimes not.  In our case, the 
 275 
 
distributions are skewed (non-parametric) so the assumptions are 
not met. The alternative is to estimate the CIs by simulation. 
In cost-utility analysis based on economic modelling, distributions 
for costs and outcomes for a model population are often 
assumptive, estimated from data from the literature or from a 
sample population. This is partly why this type of analysis is called 
³SUREDELOLVWLF´RU³VWRFKDVWLF´ 
In economic analyses based on RCTs, the same process is used as 
in probabilistic sensitivity analysis. However, instead of assuming 
our distributions, we can calculate them from actual patient data 
and their parameters are known. 
We have four distributions, one each for C1, C2, Q1 and Q2.  In 
effect, the simulation instructs the computer to choose one value 
from each of the four distributions at random and use them to 
calculate the base model.  It repeats the calculation for four new 
values again...and again...thousands of times.  TKH ³UDQGRP
FKRLFH´ RI YDOXHV DW each iteration is not entirely random, but 
governed by the distributions. For example if 55% of C1 values in 
the actual data exceed 100, then around 55% of values above 100 
will be chosen in the simulation. This is called a Monte Carlo 
method simulation. 
In this way, we derive thousands of estimates for the ICER (25,000 
in our case) which we use to create a scatter plot. These estimates 
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are presented as a distribution, from which, in principle, a variance 
can be calculated, and therefore a confidence interval around the 
ICER. An example of a scatter plot produced in this was is given in 
Figure 6.6 borrowed from Weintraub et al. (Weintraub et al.). 
This approach is especially useful when costs and outcomes are 
correlated, e.g. where more expensive interventions tend to 
produce better outcomes.  Here the formal maths for the CIs would 
be even more complicated.  Correlation can be incorporated into 
WKH³UDQGRP´VHOHFWLRQRIYDOXHVthat form the simulation.  So the 
computer will be more likely to pick higher values of outcome when 
it picks high values of cost. The greater the correlation, the greater 
will be the association between the choices. 
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Figure 6.6 The distribution of cost-effectiveness in the cost-
effectiveness plane 
Each point represents an estimate of the ICER based on dual 
bootstrap of cost and efficacy. Potential $50 000 and $100 000 per 
QALY gained threshold lines are noted. Estimates of the 
incremental cost-effectiveness ratio below those benchmarks would 
be considered cost-effective. 
In quadrant A, the new therapy is more effective but more costly 
than the previous standard. In quadrant B, the new therapy 
dominates the standard, being more effective and less expensive, 
whereas in quadrant D, the new therapy is dominated by the 
standard, being less effective and more expensive (Weintraub et 
al.). 
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Cost-effectiveness acceptability curve (CEAC) 
Cost±effectiveness acceptability curves (CEACs) are widely adopted 
as a method of quantifying and graphically representing 
uncertainty in economic evaluation studies of health care 
technologies. They are useful for two main reasons (Fox-Rushby 
and Cairns, 2009): 
x They show how the decision to adopt a technology changes 
as the threshold value of health gain changes 
x They provide a way of combining information on the 
uncertainties associated with the variables 
They are also often used as an alternative to providing confidence 
intervals around the ICER, which as seen above, can be a statistical 
challenge 
A CEAC is constructed by calculating the probability that the 
estimated ICER falls below specified values of willingness-to-pay. 
In Figure 6.7, the diagonal line intersecting the axes indicates the 
maximum willingness-to-pay, a threshold value of Ǌ per additional 
QALY, wheUH Ǌ FDQEHDQ\ ILJXUH DQG WKHGLDJRQDO FDQ KDYHDQ\
slope. The proportion of the distribution that falls below and to the 
ULJKW RI WKLV OLQH LV ³DFFHSWDEOH´ KDV SRVLWLYH QHW PRQHWDU\
benefit). The proportion above and to the left of this line is 
³XQDFFHSWDEOH´(Glick, 2007).  
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Figure 6.7 Cost-effectiveness plane demonstrating the acceptability 
criterion 
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The CEAC (Figure 6.8) is constructed by counting the number of 
ICERs that fall within this area of acceptability and plotting the 
results. 7KLV LV UHSHDWHG IRU DOO WKUHVKROG YDOXHV Ǌ RI LQWHUHVW
starting at 0 and increasing to a maximum threshold value of 
choice. The X axis of this curve represents potential values for the 
willingness to pay and the Y axis represents the proportion of the 
GLVWULEXWLRQ WKDW LV ³DFFHSWDEOH´ ,Q &($& LQWHUSUHWDWLRQ WKLV
SURSRUWLRQLVODEHOOHG³WKHSUREDELOLW\WKDWWKHLQWHUYHQWLRQLVFRVW-
HIIHFWLYH´ 
Figure 6.8 Example of a typical cost-effectiveness acceptability 
curve for resurfacing hip arthroplasty from Edlin et al. (Edlin et al., 
2012) 
 
 
